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SECTION 1:
GENERAL
PATIENT CARE
Statewide Treatment Protocols 
Version 2015.1
RESPOND TO SCENE IN A SAFE MANNER:
· Review dispatch information. 
· Use lights and sirens and/or pre-emptive devices when responding as appropriate per emergency 
medical dispatch information and local guidelines. 
SCENE ARRIVAL AND SIZE-UP: 
· Utilize Body Substance Isolation, as appropriate. 
· Scene safety, bystander safety. 
· Environmental hazards assessment.
· Number of patients. 
· Determine need for additional resources.
· Utilize Mass Casualty Incident (MCI) and/or Incident Command System (ICS) procedures as 
necessary.
· Determine mechanism of injury/illness.
PATIENT APPROACH: 
· The presumption is that patients requesting EMS services should not walk to the stretcher or 
ambulance, but should be moved using safe and proper lifts and devices.  Specifically the 
condition of patients with cardiac, respiratory, or neurological conditions, and of patients with 
unstable vital signs, can be worsened by exertion, so patient effort in moving to the stretcher and 
ambulance should be minimized.  Unique circumstances and deviations from these principles 
must be clearly described in the Patient Care Report (PCR) and the service must have an internal 
performance improvement (PI) mechanism to review each case.  
· DO NOT allow sick or injured patients to walk or otherwise exert themselves. Use safe and proper 
lifts and carries and appropriate devices to extricate patients to the ambulance stretcher.
· Begin assessment and care at the side of the patient; avoid delay. 
· Bring all necessary equipment to the patient in order to function at your level of certification and 
up to the level of the ambulance service license.  
· Request and use available advanced life support (ALS) – paramedic resources in accordance with 
these protocols, initiate transport as soon as possible, with or without ALS.
· Activate air-medical transport early and if applicable to do so.
· Determine if a valid MOLST order or Comfort Care/DNR Verification form is in place, and act 
accordingly.
ASSESSMENT AND TREATMENT PRIORITIES 
· Determine unresponsiveness, absence of breathing and pulselessness; Initiate high quality CPR 
with minimal interruptions in chest compressions for patients  found to be in cardiac arrest and in 
the absence of a MOLST/CC/DNR.  
· Determine patient’s hemodynamic stability, symptoms, level of consciousness, ABCs, vital signs.  
· Maintain an open airway and assist ventilations as needed.
· Apply the cardiac monitor and obtain a 12-lead ECG tracing as soon as possible when clinically 
appropriate and within your scope of practice.
· Administer supplemental oxygen using the appropriate delivery device, if indicated.
· Within your scope of practice, obtain peripheral access via intravenous (IV) or intraosseous (IO) 
on all patients exhibiting signs and symptoms consistent with shock or who are hemodynamically 
compromised, or have the potential to become compromised.  
· When obtaining IO access in patients able to perceive pain, in adults, administer Lidocaine 40mg 
over two minutes, followed by a 10mL fluid bolus over five seconds. In pediatrics, 1mg/kg to a 
maximum of 20mg.  
· Patients who may be in need of medications for conditions such as but not limited to nausea or 
pain should also have IV access established if possible to do so.
1.0
NOTE: This protocol applies to all EMS calls.
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1.0
 Protocol Continues
2013
ASSESSMENT AND TREATMENT PRIORITIES (CONTINUED)
· Consider the use of advanced airway interventions as appropriate and if trained to do so.
· Ventilation rates are to be titrated to goal ETCO2 recommendations.
· Use quantitative, recordable waveform capnography for all patients with advanced airway 
interventions and consider its use with all respiratory compromised conditions.
· The capnography waveform must be recorded on all intubated patients and clinically significant 
data attached to the patient care report for the receiving facility.  In patients who are not in cardiac 
arrest, all efforts should be made to avoid end-tidal carbon dioxide levels that have been shown to 
be detrimental and to ensure quality ventilation and oxygenation.  In general this means that 
capno-ETCO2 values should be kept between 35-40 mm Hg in these patients; specific exceptions 
should be discussed with online medical control. 
· At a minimum, monitor and document vital signs every 15 minutes on stable patients and every 5 
minutes for patients with critical conditions. 
· Obtain a thorough assessment (O-P-Q-R-S-T) related to the event.
· Obtain a complete medical history (S-A-M-P-L-E).
· Initiate intravenous therapy by venous cannulation and/or intraosseous access and fluid 
resuscitation if applicable, according to hemodynamic stability. For pediatric patients, a 20mL/kg 
fluid bolus if applicable. 
· Obtain venous blood samples according to the receiving hospital policies.
· Obtain additional field diagnostic testing when clinically indicated, and if available; (not limited to) 
blood glucose, pulse oximetry, temperature, carbon monoxide, stroke scale.
· Administer medications in accordance with the specific patient condition and scope of practice. 
· Contact on-line Medical Control for all procedures outside the provisions of standing orders, which 
may include repeat doses of medications within the standing orders.
· Follow service or regional policies for all radio or communication failures.
· If indicated, contact the receiving hospital to provide a clear and concise report on the patient’s 
condition, all interventions, findings, and estimated time of arrival to the receiving department. 
· Continually reassess all patients, especially after any interventions and/or medication 
administration.  
· If no palpable, distal pulse is present following suspected extremity fracture, position injured 
extremity in correct anatomic position, and apply gentle traction along the axis of the extremity 
distal to the injury until the distal pulse is palpable and immobilize in place.  Note: This does not 
apply to dislocations.
· EMS crews should not begin or administer interventions that would require medical assessment if 
a patient is being brought to an environment where formal medical assessment will not be 
provided; for example, giving IV narcotics to a patient who is about to be left at home. 
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1.0
AMBULANCE STRETCHER OPERATIONS
· Operate the ambulance stretcher in accordance with your service training and manufacturer’s 
specifications at all times.
· When moving a patient on the ambulance stretcher, adjust the height of the ambulance stretcher 
from the “load position” to a safe position for travel.
· All EMTs moving the patient must keep both hands on the ambulance cot when elevated or in 
motion. Properly secure all patients using the required straps, including the over-the-shoulder 
harness, hip and leg restraining straps.
· If patient care requires the removal of any of the restraining straps, re-secure them as soon as 
practical to do so. 
§ Pediatric patients are to be transported in a properly secured child transport device/seat if spinal 
injury is not suspected (See 7.4 Pediatric Transport for more).
PATIENT CARE REPORTS AND DATA COLLECTION
· The EMS System regulations require an accurate, concise and properly documented patient care 
report to be completed at the time of the call or as soon as practicable afterwards for all patient 
encounters. Pertinent data must be left at the receiving hospital at the time of transport. The 
regulations also require that patient care reports include the minimum required data elements, as 
defined by the administrative requirement (A/R 5-403). 
· Clinically relevant data must be conveyed to a nurse, physician assistant or physician before 
leaving the receiving facility. 
· The patient care report(s) must include clinically relevant ECG tracings, 12-lead tracings and 
waveform capnography tracings when obtained.
· Additional data elements may be collected at the request of your Affiliate Hospital Medical 
Director. This data may pertain to, but is not limited to; trauma, cardiac arrest, stroke and 
infectious disease processes. 
MEDICATION USE AND STORAGE
· The adult medication reference list includes all those medications that are utilized in both the 
Statewide Treatment Protocols.
· Medications may be administered in divided doses up to the maximum noted in protocol.  
· The medication lists are to be considered a reference list only and may contain information and 
uses not intended for prehospital administration.  
· Inclusion of this information does not imply approval of and use of that medication unless 
specifically stated in the applicable protocol.  
· Securely maintain and store all medications and fluids at the appropriate temperatures as 
designated by manufacturer’s recommendations and in accordance with all Drug Control Program 
regulations.
· Pharmaceutical shortages and supply chain issues have become more frequent.  The Department 
will issue Advisories addressing these shortages and outlining alternative therapies when needed.  
· All EMTs and service providers must adhere to all advisories, memos and administrative 
requirements issued by the Department regardless of the topic.  
· Medications administered nasal atomizer (IN) should be with no more than 1mL of volume per 
naris. If additional medication must be administered, wait one minute before repeating IN. 
· Avoid hyperoxygenation, oxygen administration should be titrated to patient condition, and 
withheld unless evidence of hypoxemia, dyspnea, or an SpO2 <94%, especially in the presence of 
a suspected CVA/TIA or ACS. 
 Protocol Continues
 Protocol Continues
2013
MEDICATION USE AND STORAGE (CONTINUED)
· IV pumps are the preferred method of administering vasoactive medications and will be required 
by 2017. Norepinephrine must be administered via pump, Dopamine may be used until pump 
available. Those providers with the equipment and training may begin using pumps immediately. 
EXCEPTION PRINCIPLE OF THE PROTOCOLS
· The Statewide Treatment Protocols represent the best efforts of the EMS physicians to pre-
hospital providers of the Commonwealth and reflect the current state of out-of-hospital emergency 
medical care, and as such should serve as the basis for such treatment. 
· On occasion, good medical practice and the needs of patient care may require deviations from 
these protocols, as no protocol can anticipate every clinical situation. In those circumstances, 
EMS personnel deviating from the protocols should only take such actions as allowed by their 
training and only in conjunction with their on-line medical control physician.  
· Any such deviations must be reviewed by the appropriate local medical director, but for regulatory 
purposes are considered to be appropriate actions, and therefore within the scope of the 
protocols, unless determined otherwise on Department review by the State EMS Medical Director.
ADVANCED AIRWAY CONFIRMATION
· EMT-Intermediate, Advanced EMT and Paramedic treatment protocols require that EMTs provide 
advanced airway management when clinically indicated.  Specific training and airway adjuncts are 
necessary and require training in accordance with scope of practice and service specific devices.  
· Endotracheal tube insertion and supraglottic airway devices such as the King LT are commonly 
used in patients that require advanced airway management.  Airway devices must be secured, 
with depth noted as appropriate.
· All EMT-Intermediates and EMT-Paramedics must be able to insert NGT / OGT for those 
unconscious post-intubation patients who need gastric decompression. 
· The standard of care requires specific methods of verification to be used including capnography 
and at least two of the following, auscultation, colorimetric readings, visualization of the chords, 
the presence of condensation, and other clinical signs that the advanced airway is positioned 
correctly.  
· All patients with an advanced airway in place must have recordable waveform capnography 
documented.
· Documentation on the patient care report must include at least three evidence based methods of 
verification of tube placement (one being capnography) and must include at least three separate 
times in which verification was completed, including verification of tube placement at the time of 
arrival at the receiving department and staff. 
TRANSPORT DECISION
· Transport to the nearest appropriate treatment facility as defined in EMS regulations.  In rare 
circumstances, delayed transport may occur when necessary treatment cannot be performed 
during transport.  
· Request and use available Advanced Life Support (Paramedic) backup or intercept whenever 
clinically indicated and in accordance with these treatment protocols 
· EMS personnel shall make decisions about the destination hospital in accordance with the EMS 
System regulations and Department-approved point-of-entry (POE) plans.
· There are currently Department-approved condition-specific POE plans for trauma, stroke and 
STEMI, as well as a POE for a patient’s other condition or need, not covered in the specific POE 
plans.  
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TRANSPORT DECISION, CONTINUED
· Department-approved regional POE plans for trauma; stroke and STEMI identify specific hospitals 
to be used. The EMT must be aware of all these POE plans affecting his/her service when 
choosing the appropriate hospital destination.    
· EMS personnel may call medical control if they have a question about POE.
· Notify receiving facility as early as possible.
· Use of lights and sirens should be justified by the need for immediate medical intervention that is 
beyond the capabilities of the ambulance crew using available supplies and equipment.
CONTINUOUS QUALITY IMPROVEMENT (CQI)
· The Department’s Hospital Licensure regulations for medical control service (105 CMR 130.1501-
1504) require that hospital physicians providing medical direction must be knowledgeable in the 
communication system and its usage and must know the Statewide Treatment Protocols for each 
level of EMT.  
· Medical directors for ambulance services must take an active role in reviewing clinical 
performance and competency of its EMTs at all levels in the delivery of patient care and in 
overseeing and conducting the ambulance service’s CQI process.   
· Ambulance services with their medical directors must develop and implement a comprehensive 
and dynamic quality assurance program in accordance with the ambulance service’s affiliation 
agreement.   
· An ambulance service and medical director that uses certain optional diagnostic and treatment 
modalities must do so in accordance with Section 6: Medical Director Options and its program 
specific CQI requirements.  The affiliate medical director is responsible for overseeing of such 
programs and ensuring the ambulance service meets the CQI requirements and the Department’s 
data reporting requirements. 
1.0
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Adrenal Insufficiency/Adrenal Crisis
Adult & Pediatric
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Adrenal insufficiency results when the body does not 
produce the essential life-sustaining hormones cortisol 
and aldosterone, which are vital to maintaining blood 
pressure, cardiac contractility, water, and salt balance.
Chronic adrenal insufficiency can be caused by a number 
of conditions:
· Congenital or acquired disorders of the adrenal 
gland.
· Congenital or acquired disorders of the pituitary 
gland.
· Regular use of steroids (COPD, asthma, rheumatoid 
arthritis, and transplant patients).
Acute adrenal insufficiency can result in refractory shock 
or death in patients on a maintenance dose of 
hydrocortisone (SoluCortef)/prednisone who experience 
illness or trauma and are not given a stress dose and, as 
necessary, supplemental doses of hydrocortisone.
E · Routine Patient Care· Identify and treat the underlying condition· Consider paramedic intercept
· Obtain vascular access, if appropriate. 
P Stress Dose:· Adult: History of adrenal insufficiency; administer Hydrocortisone 100mg IV/IO/IM or Methylprednisolone 125mg IV/IO/IM. 
· Pediatric: History of adrenal insufficiency; administer Hydrocortisone 2mg/
kg, to a maximum of 100mg IV/IM/IO or Methylprednisolone 2mg/kg to a 
maximum dose of 125mg IV/IM/IO. 
A “stress dose” of hydrocortisone should be given 
to patients with known chronic adrenal insufficiency 
who have the following illnesses/injuries:
· Shock (any cause). 
· Fever >100.4°F and ill-appearing.
· Multi-system trauma. 
· Drowning. 
· Environmental hyperthermia or hypothermia.
· Multiple long-bone fractures. 
· Vomiting/diarrhea accompanied by 
dehydration.
· Respiratory distress. 
· 2nd or 3rd degree burns >5% BSA
· RSI (Etomidate may precipitate adrenal crisis).
· Hypoglycemia
EMT STANDING ORDERS – ADULT & PEDIATRIC
EMT-INTERMEDIATE/ADVANCED EMT STANDING ORDERS - ADULT & PEDIATRIC
PARAMEDIC STANDING ORDER – ADULT & PEDIATRIC
MEDICAL CONTROL MAY ORDER
2013
· Additional doses of above medications
· In patients who continue demonstrating the following signs and symptoms, 
consult medical control for repeat stress dose orders:
o Nausea, vomiting, weakness, dizzy, abdominal pain, muscle pain, 
dehydration, hypotension, tachycardia, fever, mental status changes.
· Additional Considerations:
o Aggressive volume replacement therapy.
o Treat other conditions according to specific protocols.
o Normalize body temperature.
2.1
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I
A/
Allergic Reaction/Anaphylaxis
Adult
· Routine Patient Care
MILD Distress
· Monitor for severe distress
SEVERE Distress
· Epinephrine auto-injector 0.3mg 
· 2nd auto-injector may be administered in 5 minutes if necessary
· FRs and EMTs must contact Medical Control if greater than 65 yrs.
· Hydrocortisone 100 mg IV/IO/IM, or Methylprednisolone 125 mg IV/IO/IM.
· Mild Distress:
· Diphenhydramine 25-50 mg IV/IO/IM
· Additional doses of above medications.
· Epinephrine 1:10,000: 0.1 mg – 0.5 mg IV/IO
· Epinephrine Infusion – 1-10 mcg/min IV/IO (for example: mix 1 mg of 1:1000 
Epinephrine in 250 ml Normal Saline). (15 micro drops/minute = 1 mcg / min.)
· Norepinephrine infusion: 0.1 mcg/kg/min IV/IO by pump, titrate to goal Systolic 
Blood Pressure of 90mmHg. 
· Dopamine infusion: 2-20 mcg/kg/min IV/IO (Rate determined by physician) 
P
· Albuterol 2.5mg via nebulizer. Repeat every 5 minutes up to 
4 doses. A
FIRST RESPONDER/EMT/EMT-INTERMEDIATE STANDING ORDERS
ADVANCED EMT STANDING ORDERS
PARAMEDIC STANDING ORDERS
2013
CAUTION: Epinephrine for anaphylaxis must be administered by Auto-Injector ONLY, 
except by medical control order. 
MEDICAL CONTROL MAY ORDER
NOTE: 
Mild Distress is defined by: itching, urticaria, nausea, and no respiratory distress. 
Severe Distress is defined by: stridor, bronchospasm, severe abdominal pain, respiratory 
distress, tachycardia, shock, edema of lips, tongue or face. 
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2.2A
FR        /      E         /         I
Clinical Criteria for Anaphylaxis:
If one of these criteria are fulfilled, treat for anaphylaxis
1.  Acute onset of skin or mucosal involvement with at least one of the following:
a. Respiratory compromise
b. Decreased SBP or evidence of end-organ hypoperfusion
2.  Two or more of these occurring rapidly after exposure to a likely antigen:
a. Skin or mucosal involvement
b. Respiratory compromise
c. Decreased SBP or evidence of end-organ hypoperfusion
d. Persistent GI symptoms
3.  Decreased BP after exposure to a known allergen for that patient
2013
· Routine Patient Care
· For anaphylaxis and patient is over 6 months, administer Epinephrine Auto-
Injector 0.15mg (for pediatric patient with a body weight less than 25 kg).  
If body weight is over 25 kg. use Adult dose Epinephrine Auto-Injector 
0.3mg.  A second injection in 5 minutes may be necessary.
· Contact Medical Control if second epinephrine auto-injection required 
after 5 minutes.
NOTE:  FRs and EMTs must contact Medical Control prior to administration 
of epinephrine by auto-injector when patient is under 6 months of age. 
· Give Hydrocortisone 2 mg/kg to max. 100 mg IV/IO/IM, or 
Methylprednisolone 2 mg/kg to max. 125 mg IV/IO/IM
· Diphenhydramine 1 mg/kg up to max. single dose of 50 mg IV/IO/IM
· Additional doses of above medications
· Epinephrine infusion 1:1,000 (1 mg/mL) 0.1-1 mcg/kg/min IV/IO 
· For example, mix 1mg of Epinephrine 1:1000 in 250mL of Normal Saline, (15 
micro drops/minute = 1 mcg / min.)
· Albuterol 0.5% (via nebulizer):
· If age less than 2 years, 1.25 mg by nebulizer
· If age 2 years or greater, 2.5-3 mg by nebulizer
· Epinephrine 1:10,000; 0.01mg/kg IV/IO to max. single dose 0.3 mg.
P
FIRST RESPONDER/EMT/EMT-INTERMEDIATE/ADVANCED EMT STANDING ORDERS
PARAMEDIC STANDING ORDERS
2013
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Allergic Reaction/Anaphylaxis
Pediatric
Massachusetts Department of Public Health Office of Emergency Medical Services
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CAUTION: Epinephrine for anaphylaxis must be administered by Auto-Injector ONLY, 
except by medical control order.
2.2P
MEDICAL CONTROL MAY ORDER
FR       /     E          /        I
         /         A
· Routine Patient Care
· If patient is unconscious or seizing, transport on left side (recovery position).
· Glucose is indicated only for documented hypoglycemia. If authorized and trained 
to do so, obtain a blood sugar reading.
· If glucose is known to be less than 70 mg/dL and the patient is conscious and 
can speak and swallow, administer oral glucose or other sugar source as 
tolerated. 
· Oral Glucose. One dose is one tube. 
o Other sugar sources are acceptable.
· A second dose may be necessary after 10 minutes if patient remains 
symptomatic.
EMT/EMT-INTERMEDIATE STANDING ORDERS
ADVANCED EMT STANDING ORDERS
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Altered Mental/Neurological 
Status/Diabetic Emergencies/Coma - Adult
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Statewide Treatment Protocols version 2015.1
2.3A
· For HYPOglycemic emergency:
· Dextrose up to 25 grams IV/IO. Recheck glucose 5 minutes after 
administration of Dextrose. 
· May repeat Dextrose up to 25 grams IV/IO if glucose level is <70mg/
dL with continued altered mental status.
· Glucagon 1mg IV/IO/IM/IN if unable to establish IV access 
· Recheck glucose 15 minutes after administration of glucagon.
· May repeat Glucagon 1mg IV/IO/IM/IN if glucose level is <70mg/dL 
with continued altered mental status.
· For HYPERglycemic emergency:
· Administer 500ml fluid bolus, then 250ml/hr.
A
PARAMEDIC STANDING ORDERS
· Glucagon 1mg SC if unable to establish IV access 
· Additional doses of above medications
P
MEDICAL CONTROL MAY ORDER
*Hypoglycemic Emergency:
· Glucose <70mg/dL with associated altered mental status
· Causes of hypoglycemia include medication misuse or overdose, missed meal, 
infection, cardiovascular insults (e.g., myocardial infarction, arrhythmia), or changes in 
activity (e.g., exercise)
· Sulfonylureas (e.g., glyburide, glipizide) have long half-lives ranging from 12-60 
hours.  Patients with corrected hypoglycemia who are taking these agents are at particular risk 
for recurrent symptoms and frequently require hospital admission.
**Hyperglycemic Emergency:
· Glucose > 300 mg/dL with associated altered mental status
CAUTION: If cerebrovascular accident is suspected, follow stroke protocols and 
notify Medical Control 
Dextrose may be administered in any concentration (D10, D25, D50), as long as the correct dose 
is given.
E   
  /
   I         
· Routine Patient Care
· If patient is unconscious or seizing, transport on left side (recovery position).
· Glucose is indicated only for documented hypoglycemia. If authorized and 
trained to do so, obtain a blood sugar reading.
· If glucose is known to be less than 70 mg/dL and the patient is conscious 
and can speak and swallow, administer oral glucose or other sugar source 
as tolerated. 
· Oral Glucose. One dose is one tube. 
o Other sugar sources are acceptable.
· A second dose may be necessary after 10 minutes if patient remains 
symptomatic.
2013
P
A
· Treatment for specific etiologies, or coma of unknown etiology:
· Known HYPOglycemia (glucose <70 mg./dl.):
· Dextrose 10% 0.5 gm/kg  IV/IO
· Glucagon 0.1 mg/kg IV/IO/IM/IN up to max. of 1 mg.
· Known HYPERglycemia
· Administer 20mL/kg fluid bolus
EMT/EMT-INTERMEDIATE STANDING ORDERS
ADVANCED EMT STANDING ORDERS
· Glucagon 0.1 mg/kg SC up to max. of 1 mg.
· For patients with confirmed adrenal insufficiency, see 2.1 Adrenal Insufficiency 
Adult/Pediatric.
· Additional doses of above medications
PARAMEDIC STANDING ORDERS
2013
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Altered Mental/Neurological Status/Diabetic
Emergencies/Coma – Pediatric
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
2.3P
MEDICAL CONTROL MAY ORDER
E     /   I         
2013
M
e
d
i
c
a
l
 
P
r
o
t
o
c
o
l
 
2
.
4
Behavioral Emergencies
Adult & Pediatric
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
Protocol Continues
Routine Patient Care, followed by:
1. One EMT should manage the patient while the other handles scene control, but no 
EMT or First Responder should be left alone with the patient.
2. Avoid areas/patients with potential weapons (e.g., kitchen, workshop), and avoid   
areas with only a single exit; do not allow patient to block exit.
3. Keep environment calm by reducing stimuli (may need to ask family/friends to  
     leave room, ask patient to turn off music/TV). Transport in a non-emergent mode  
    unless the patient’s condition requires lights and sirens.
4. Respect the dignity and privacy of the patient.
5. Make eye contact when speaking to the patient.
6. Speak calmly and in a non-judgmental manner; do not make sudden movements.
7. Maintain non-threatening body language (hands in front of your body, below your 
chest, palms out and slightly to the sides).
8. Establish expectations for acceptable behavior, if necessary.
9. Ask permission to touch the patient before taking vital signs, and explain what  
   you are doing.
10. Assess the patient to the extent that they allow without increasing agitation,  
     maintain a safe distance from a violent patient.
11. Stop talking with patient if they demonstrate increased agitation; allow time for   
    them to calm down before attempting to discuss options again.
12. Provide reassurance by acknowledging the crisis and validating the patient’s  
     feelings and concerns; use positive feedback, not minimization.
13. Determine risk to self and others (“Are you thinking about hurting/killing yourself  
     or others?”).
14. Encourage patient to cooperatively accept transport to the hospital for a  
    psychiatric evaluation and treatment.
15. Consider asking friends/relatives on scene to encourage patient to accept  
    transport, if needed; but only if they are not a source of agitation.
16. Ask law enforcement  or Online Medical Control to complete a MDMH Section 12 
application for uncooperative patients who acknowledge intent to self-harm or 
harm others, but do not delay transport in the absence of this  document.
17. Use restraints in accordance with 2.5 Behavioral Emergencies: Restraint if
      de-escalation strategy fails and the patient is a danger to him/herself or others.
Acute risk factors for violence include:
 Male gender
 Homicidal or violent intent or plans 
 Intoxication or recent substance use 
 Actions taken on plans/threats 
 Unconcerned with consequences 
 No alternatives to violence seen 
 Intense fear, anger, or aggressive speech/behavior
 Specified victim (consider proximity, likelihood of provocation)
2.4
E     /   I    /    A       /                P
M
e
d
i
c
a
l
 
P
r
o
t
o
c
o
l
 
2
.
4
Behavioral Emergencies
Adult & Pediatric
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
P
Protocol Continued
 Initiate an IV of Normal Saline at a KVO rate
 Apply cardiac monitor if clinically feasible, obtain 12 lead ECG-manage 
dysrhythmias per protocol.
 Position patient to ensure breathing is not impaired.
 If providing medication to patients >70 years of age, limit dose
ADULT STANDING ORDERS
 Haloperidol 5 mg IM; and/or
 Lorazepam 2mg IV/IO/IM; or
 Midazolam 2-6 mg IV/IO/IM/IN
 NOTE: In patients >70 years of age, limit medication to half these 
doses.
PEDIATRIC STANDING ORDERS
 Midazolam 0.1mg/kg IV/IO/IM/IN
Medical Control may order additional doses of above medications
2.4
Haloperidol is preferable for psychotic patients; but do not administer to patients with a 
history of seizures or prolonged QT intervals.
Lorazepam is preferable for patients experiencing alcohol withdrawal or the toxic 
effects from sympathomimetic drugs, e.g. cocaine (or pcp) 
Diazepam should NOT be administered to patients experiencing behavioral 
emergencies. 
PARAMEDIC STANDING ORDERS
Haloperidol should be administered by INTRAMUSCULAR injection ONLY
2013
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    Behavioral Emergencies: Restraint
Adult & Pediatric
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
OVERVIEW
In accordance with M.G.L. c. 111C, §18, the following guidelines may be followed to 
restrain a patient only when the patient presents an immediate or serious threat of 
bodily harm to him/herself or others. 
Adults (or emancipated minors as defined in A/R 5-610) who are competent with the 
functional capacity to understand the nature and effects of their actions and/or 
decisions have the right to refuse treatment and/or transport. Do not restrain these 
individuals. 
Procedures: 
1. Follow 2.4 Behavioral Emergencies.
2. Use the least restrictive method that assures the safety of the patient and others.
3. Use only soft restraints (leather restraints only if made with soft padding inside).
4. Remind law enforcement that for ambulance transport, patients who are 
handcuffed must have handcuffs in front (not behind) or to the stretcher and that 
the key must be readily available for removal; if needed. 
5. Apply restraints in a way that allows for airway, breathing, and circulation 
assessment.
6. Never restrain a patient in a prone position or use equipment that forms a 
“sandwich” around the patient.
7. Have a minimum of four (4) trained personnel coordinate the restraint effort and 
consider involving parents if patient is a child.
8. Secure the patient so that major sets of muscle groups cannot be used together, 
restraining the lower extremities to the stretcher first around the ankles and 
across the thighs with soft restraints and stretcher straps. 
9. Restrain the patient’s torso and upper extremities with one arm up and one arm 
down with soft restraints and stretcher straps; do not impair circulation.
10. Consider cervical-spine immobilization to minimize violent head/body 
movements. 
11. Pad under patient’s head to prevent self-harm.
12. Secure backboard or scoop stretcher (if used) to ambulance stretcher.
13. Transport OB patients in a semi-reclining or left lateral position.
14. Monitor/record vital signs every 5 minutes, ensuring patient’s airway remains 
clear.
15. Consider placing a non-rebreather mask (use only at 15 lpm) or a face mask 
(NOT a P100/N95) on the spitting patient’s face. 
16. Unless necessary for patient treatment, do not remove restraints until care is 
transferred at the receiving facility or condition has changes to necessitate 
removal. 
17. Notify receiving facility and tell them that patient is restrained. 
18. Document restraint use details in the patient care report, including:
a. reason for restraint use
b. time of application
c. type(s) of restraints used, in addition to cot straps
d. patient position
e. neurovascular evaluation of extremities
f. issues encountered during transport
g. other treatment rendered
h. police and/or other agency assistance
2.5
E     /   I    /    A       /                P
· Albuterol 2.5-3 mg via nebulizer.   Ipratropium Bromide 0.5mg may be combined 
with the Albuterol treatment.  Additional Albuterol treatments may be administered 
as necessary with or without Ipratropium Bromide.  
Note that a multi-dose inhaler may be used to give albuterol or ipratropium 
(instead of nebulizer) if infection control is an issue (e.g. influenza-like-illness).
A
EMT/EMT-INTERMEDIATE STANDING ORDERS
ADVANCED EMT STANDING ORDERS
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Bronchospasm/Respiratory 
Distress- Adult
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
2.6A
· Routine Patient care
· IF the patient has not taken the prescribed maximum dose of their own inhaler prior 
to the arrival of EMS, AND the inhaler is present:
· Encourage and/or assist patient to self-administer their own prescribed inhaler 
medication if indicated.
· If patient is unable to self-administer their prescribed inhaler, administer patient’s 
prescribed inhaler.
NOTE: EMT-B, EMT-I and AEMT administration of an inhaler is 
CONTRAINDICATED, if:
· the maximum dose has been administered prior to the arrival of the EMT.
· the patient cannot physically use the device properly.  (Patient cannot receive 
inhalation properly.)
· the device has not specifically been prescribed for the patient.
**If properly trained and authorized, use 6.1 BLS/ILS Assisted Albuterol
· In a patient with a known diagnosis of asthma or COPD, who does not have 
history or findings concerning for congestive heart failure, consider 
Hydrocortisone 100 mg. IV/IO/IM or Methylprednisolone 125 mg. IV/IO/IM. 
· In patients ≤40 years old, Epinephrine 0.15 mg-0.3 mg IM BY AUTOINJECTOR 
ONLY  as a one time dose.
· Continuous positive airway pressure (CPAP) assistance, if not contraindicated, 
and if nebulizer therapy can be continued with the CPAP device.
· For Asthma only, consider Magnesium Sulfate 2-4 gm. IV/IO over 5 minutes.
PARAMEDIC STANDING ORDERS
P
· Additional doses of above medications, if prescribed to patient or authorized, and if 
maximum dose has not been administered.
MEDICAL CONTROL MAY ORDER
· Additional doses of above medications
· Epinephrine 1:10,000, 0.1-0. 5 mg IV/IO very slowly
MEDICAL CONTROL MAY ORDER
CAUTION: The use of Epinephrine in patients over the age of 40 or with known cardiac 
disease and patients who have already taken high dosage of inhalant bronchodilator 
medications may result in cardiac complications. 
E   
  /
   I       
CAUTION: Epinephrine for bronchospasm must be administered by Auto-Injector ONLY, 
except by medical control order.
EMT/EMT-INTERMEDIATE STANDING ORDERS
2013
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Bronchospasm/Respiratory 
Distress- Pediatric
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
2.6P
· Routine Patient Care
· MILD DISTRESS:  The following may be considered if the patient has not taken the 
prescribed maximum dose of their own inhaler prior to the arrival of EMS: and the 
inhaler is present:
· Encourage and/or assist patent to self-administer their own prescribed inhaler 
medication if indicated or if not already done.
· If patient is unable to self-administer their prescribed inhaler, administer patient’s 
prescribed inhaler.
· Reassess vital signs.
MEDICAL CONTROL MAY ORDER:
· Repeat of a second dose if required, and if prescribed maximum dose has not been 
administered
NOTE: EMT-B, EMT-I and AEMT administration of an inhaler is 
CONTRAINDICATED, if:
· the maximum dose has been administered prior to the arrival of the EMT.
· the patient cannot physically use the device properly.  (Patient cannot receive 
inhalation properly.)
· the device has not specifically been prescribed for the patient.
**If properly trained and authorized, use 6.1 BLS/ILS Assisted Albuterol
· For a child age 2 years old or more who has a known diagnosis of asthma, consider:  
Hydrocortisone 2 mg/kg to max. 100 mg IV/IO/IM; or  Methylprednisolone       2 
mg/kg to max. 125 mg IV/IO/IM.
· For severe distress: If patient is over 5 years old, administer pediatric dose 
Epinephrine Auto-Injector (for pediatric patient with a body weight less than 
25 kg).  If body weight is over 25 kg use Adult Auto-Injector.  A second injection in 5 
minutes may be necessary.  
· Consider Magnesium Sulfate 25 mg/kg IV/IO over 10 min. (maximum dose 2 
grams)
PARAMEDIC STANDING ORDERS
P
 Protocol Continues
· If the condition is not improving with administration of supplemental oxygen, 
consider the following:
· Albuterol Sulfate 1.25 mg with Ipratropium Bromide, 250 mcg via nebulizer if 
less than 2 years of age.
· Albuterol Sulfate 2.5-3 mg with Ipratropium Bromide, 500 mcg via nebulizer if 
age 2 years or greater. 
· A second dose of Albuterol, with or without Ipratropium Bromide, may be 
administered as necessary. 
Note that a multi-dose inhaler may be used to give albuterol or ipratropium (instead of 
nebulizer) if infection control is an issue (e.g., influenza-like-illness).
A
ADVANCED EMT STANDING ORDERS
E   
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   I        
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Bronchospasm/Respiratory 
Distress- Pediatric
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
2.6P
Mild distress in children is evidenced by minor wheezing and good air entry.
Severe distress in children is evidenced by poor air entry, extreme use of accessory muscles, 
nasal flaring, grunting, cyanosis and/or altered mental status (weak cry, somnolence, poor 
responsiveness).  REMEMBER: Severe bronchospasm may present without wheezes, if there is 
minimal air movement.
Respiratory Distress is defined as inadequate breathing in terms of rate, rhythm, quality and/or 
depth of breathing.  Children who are breathing too fast or slow, or in an abnormal pattern or 
manner, may not be receiving enough oxygen to support bodily functions and may allow an 
increase in carbon dioxide to dangerous levels.  Cyanosis is usually a late sign and requires 
immediate treatment.
CAUTION: Epinephrine for bronchospasm must be administered by Auto-Injector ONLY, 
except by Medical Control order. 
· Additional doses of above medications
MEDICAL CONTROL MAY ORDER
P
Protocol Continued
· Routine Patient Care
· Provide rapid cooling as soon as possible.  
CAUTION: Do not over-chill patient, observe for shivering. If shivering occurs, 
discontinue active cooling procedures.
· Remove patient to cool area and place patient in a supine position.
· Loosen or remove all unnecessary clothing, while protecting privacy.
· Apply cool packs to armpits, neck and groin.
· Use evaporation techniques if possible (fans, open windows).
· Keep skin wet by applying water with wet towels or sponges.
· For Heat Cramps and/or Heat Exhaustion: administer water or oral re-hydration-
electrolyte solution if patient is alert and has a normal gag reflex and can 
swallow easily.  Elevate legs of supine patient with heat exhaustion.
Consider 500mL fluid bolus for dehydration even if vital signs are normal. 
Pediatrics: 20mL/kg bolus, if indicated.
EMT STANDING ORDERS
EMT-INTERMEDIATE/ADVANCED EMT/PARAMEDIC STANDING ORDERS
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Hyperthermia (Environmental) 
Adult & Pediatric
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
2.7
E
I / A   /    P
2013
E
· Routine Patient Care
· Avoid Rough Movement and Prevent Further Heat Loss:
· Insulate from the ground and shield from wind/water
· Move to a warm environment as soon as practical
· Remove any wet clothing
· Cover with warm blankets, particularly the head
· Determine patient’s hemodynamic status:  Assess pulse and respiratory rates 
for a period of 60 seconds to determine pulselessness or profound asystole, for 
which CPR would be required.
· If patient is in cardiopulmonary arrest, (refer to Protocol 3.4A/P Cardiac Arrest -
Asystole/Pulseless Electrical Activity and 3.5A/P Cardiac Arrest- Ventricular 
Fibrillation/Pulseless Ventricular Tachycardia).
· Initiate CPR and administer oxygen using appropriate oxygen delivery 
device, as clinically indicated.
· Use AED according to the ECC guidelines or as otherwise noted in these 
protocols and other advisories
· Whenever possible, use warmed, humidified oxygen (104°F – 107°F, 40°C – 
42°C) by non-rebreather mask, during resuscitation procedures for hypothermic 
patients.
CAUTION: Do NOT administer anything orally if patient does not have a 
reasonable level of consciousness and normal gag reflex.
· Manage hypoglycemia and narcotic overdose per protocol. 
· Warm IV Fluids should be used
EMT STANDING ORDERS
EMT-INTERMEDIATE / ADVANCED EMT STANDING ORDERS
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Hypothermia (Environmental)
Adult & Pediatric
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
2.8
PARAMEDIC STANDING ORDERS
· If pulse and breathing are absent, treat per Cardiac Arrest ProtocolsP
CAUTION: Do NOT massage extremities in an attempt to actively rewarm the patient
I    / A
· Routine Patient Care. 
· Assess for SLUDGEM (Salivation, Lacrimation, Urination, Defecation, Gastric 
upset, Emesis, Muscle twitching/miosis (constricted pupils) and KILLER Bs 
(Bradycardia, Bronchorrhea, Bronchospasm).
· Remove to cold zone after decontamination and monitor for symptoms.
· Antidotal therapy should be started as soon as symptoms appear.
· All antidote auto-injections must be administered IM.
Determine dosing according to the following symptom assessment and guidelines. 
2013
P
FIRST RESPONDER/EMT/EMT-INTERMEDIATE/ADVANCED EMT STANDING ORDERS
PARAMEDIC STANDING ORDERS
20132013
· If field conditions permit, initiate cardiac monitoring and consider the 
administration of IV medications.
· If symptoms persist after the administration of 3 DuoDote kits:
o Atropine 2mg IV/IO; repeat every 5 minutes until secretions clear
o Pralidoxime 1 – 2 gram IV/IO over 30 – 60 minutes 
o Diazepam 5mg IV/IO every 5 minutes; or 10mg IM or auto-injector (10mg) 
every 10 minutes, as needed. 
Instead of diazepam, may use either: 
§ Lorazepam 1mg IV/IO may repeat once in 5, or 2mg IM, may repeat once 
in 10 minutes, OR
§ Midazolam 2 mg IV/IO/IN every 5 minutes; or 6 mg IM every 10 minutes 
as needed
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Nerve Agents Organophosphate 
Poisoning – Adult & Pediatric
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
2.9
· Additional doses of above medications
· Pralidoxime maintenance infusion: up to 500mg per hour (maximum of 12 
grams/day). 
MEDICAL CONTROL MAY ORDER
FR       /     E          /        I
         /         A
Decontaminate
Administer 100% Oxygen
Administer One kit IM
OR
2mg Atropine IM only & either:
600mg IM pralidoximine OR
1mg IV pralidoxime
Severity Cholinergic AGENT Signs & Symptoms
ADULT TREATMENT 
STANDING ORDERS
Runny Nose
Cough
Pupils may be pinpoint
Eye Pain
Lacrimation
All the above, plus:
o Vomiting
o Diarrhea
o Drooling, copious 
respiratory secretions
o Significant weakness
o Seizures
o Decreased level of 
consciousness
o Apnea
Runny Nose
Cough
Sweating, twitching
Nausea, abdominal cramping
Weakness
Localized sweating (seen with 
dermal exposure)
Eye pain,  trouble seeing
Wheezing, shortness of breath
Decontaminate
Administer 100% Oxygen
Administer Three kits IM
OR
6mg Atropine IM only & either:
1200-1800mg IM pralidoxime OR
1gm IV pralidoxime
&
Diazepam 10mg IM Autoinjector 
(CANA kit),OR
Diazepam 10mg IV/IO/IM,OR
Lorazepam 2-4mg IV/IO/IM,OR
Midazolam 6-10mg IV/IO/IM
Decontaminate
Administer 100% Oxygen
Administer Two to Three kits IM
OR
4mg Atropine IM only & either:
600-1200mg IM pralidoxime OR
1gm IV pralidoxime
MILD
MODERATE
SEVERE
NOTE: Dermal absorption of nerve agents may lead to delayed symptom 
onset up to 18 hours after exposure. Initial symptoms/signs may only be 
local such as localized fasiculations and sweating. 
NOTE: Do not administer an adult dose to a child <50kg.
PROCEDURES FOR SELF-CARE AND CARE OF AUTHORIZED PUBLIC EMPLOYEES 
OR FIRST RESPONDERS
Remove self or fellow authorized public employee from area if possible.
1.  Assess degree of symptoms: Mild, Moderate or Severe.
2.  Administer 1 to 3 auto-injector kits IM (each kit with Atropine 2mg IM and Pralidoxime Chloride 
600mg IM) as guided by degree of symptoms.
3.  Seek additional medical support for further monitoring and transport of anyone receiving therapy.
4.  Disrobing will significantly enhance the decontamination process. Perform decontamination, and 
seek assistance in further decontamination measures.
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Nerve Agents Organophosphate 
Poisoning – Adult & Pediatric
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
2.9
PEDIATRIC DOSING FOR NERVE AGENT EXPOSURES
Kg Age Atropine Pralidoxime Midazolam Diazepam Lorazepam 
  0.02-0.05mg/kg 20-40 mg/kg 0.1mg/kg 0.25mg/kg 0.05-0.2mg/kg 
1 Preemie 0.1mg 20-40mg 0.05-0.1mg 0.25mg/kg 0.05-0.2mg/kg 
2 Newborn 0.1mg 40-80mg 0.1-0.2mg 0.5mg 0.1-0.4mg 
5 3 mos 0.1mg-0.25mg 100-200mg 0.25-0.5mg 1.25mg 0.25-1mg 
10 12 mos 0.2-0.5mg 200-400mg 0.5-1mg 2.5mg 0.5-2mg 
15 2-3 yrs 0.3-0.75mg 300-600mg 2mg 3.75mg 0.75-3mg 
20 4-7 yrs 0.4-1mg 400-800mg 2.5mg 5mg 1-4mg 
25 6-9 yrs 0.5-1.25mg 500mg-1g 3mg 6.25mg 1.25-4mg 
30 7-11 yrs 0.6-1.5mg 600mg-1g 3.5mg 7.5mg 1.5-4mg 
35 8-13 yrs 0.7-1.75mg 700mg-1g 4mg 8.75mg 1.75-4mg 
40 9-14 yrs 0.8-2mg 800mg-1g 4.5mg 10mg 2-4mg 
45 10-16 yrs 0.9-2mg 900mg-1g 5mg 10mg 2.25-4mg 
50 11-18 yrs 1-2mg 1g 5mg 10mg 2.5-4mg 
55 12-18 yrs 1.25-2mg 1g 5mg 10mg 2.75-4mg 
60 13-18 yrs 1.5-2mg 1g 5mg 10mg 3-4mg 
65 14-18 yrs 2mg 1g 5mg 10mg 3.25-4mg 
70 16-18 yrs 2mg 1g 5mg 10mg 3.5-4mg 
 
PEDIATRIC ATROPENS
Pediatric Atropine Dosing for Nerve Agent Toxicity Using Pediatric Atropens
Note: Pralidoxime reduced dose pediatric autoinjectors are not available
ADULT AUTOINJECTORS
Pediatric Dosing for SEVERE Nerve Agent Toxicity Using Adult Autoinjectors
(i.e. seizures, hypotension, coma, cardiac arrest)
Use only if Pediatric Atropen or when Atropine/Pralidoxime vials are not available
Approximate 
Age 
Approximate 
Weight 
Number of Auto-
injectors (each type) 
Atropine Dosing 
Range (mg/kg) 
Pralidoxime dosing 
range (mg/kg) 
3-7 yrs 13-25kg 1 0.08-0.13 24-46 
8-14 yrs 25-50kg 2 0.08-0.13 24-46 
>14 yrs >51kg 3 0.11 or less 35 or less 
 
Weight Mild Moderate Severe 
15-40 lb (7-18kg) 1 x 0.5mg Atropen 1 x 1mg Atropen 3 x 0.5mg Atropen 
40-90 lb (18-41kg) 1 x 1mg Atropen 1 x 2mg Atropen 3 x 1mg Atropen 
>90 lb (41kg) 1 x 2mg Atropen 2 x 2mg Atropen 3 x 2mg Atropen 
 
Ø NOTE: Mark I kits and Duodote are not approved for pediatric use, however, they should be used as 
initial therapy in circumstances for children with severe life-threatening nerve agent toxicity when IV 
therapy is not available.  This assumes 0.8 inch needle insertion depth.  
Ø NOTE: Potential high dose of atropine and pralidoxime for age/weight. However, these numbers are 
within the general guidelines recommended for the first 60-90 minutes of therapy after a severe 
exposure.
Ø NOTE: Administer injection in large muscle mass.  Avoid deltoid. Suggest using thigh. 
REFERENCE: Pediatric Preparedness for Disasters and Terrorism: A National Consensus Conference, Executive summary 2003.  
Markenson D, Redlener I.  AHRQ, DHHS, EMSC Program of the Maternal and Child Health Resources Services Administration 
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Nerve Agents Organophosphate 
Poisoning – Adult & Pediatric
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
2.9
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Obstetrical Emergencies
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 12.03
2.10
EMT / EMT-INTERMEDIATE / ADVANCED EMT STANDING ORDERS
· Routine Patient Care
· Expose as necessary to access for bleeding/discharge, crowning, prolapsed 
cord, breech, limb presentation.
· Do not digitally examine or insert anything into the vagina.
· Exceptions: fingers may be inserted to manage baby’s airway in breech 
presentation or to treat prolapsed or nuchal cord.
· Place mother in left-lateral recumbent position except as noted:
· Prolapsed cord:
· Knee-chest position or Trendelenburg position
· If only the cord has prolapsed and the presenting part has yet to go 
through the cervix, gently elevated the presenting part to remove 
pressure on the umbilical vessels to permit blood flow through cord.
PARAMEDIC STANDING ORDERS
· Eclamptic Seizures
· Lorazepam 2-4mg slow IV/IO/IM, OR 
· Diazepam 5-10 mg slow IV/IO, OR
· Midazolam 2 - 6 mg slow IV/IO/IM/IN
P
MEDICAL CONTROL MAY ORDER
· Administration of additional IV Normal Saline.
· Magnesium Sulfate 1- 4 gm IV/IO over 10 minutes (i.e., for eclampsia).
· Calcium Chloride 10% 2 mg-4 mg/kg slow IV/IO over 5  minutes. (Antidote for 
Magnesium Sulfate).
· Further anticonvulsant therapy.
E  /   I    /    A
2013
EMT/EMT-INTERMEDIATE/ADVANCED EMT/PARAMEDIC STANDING ORDERS
· Routine Patient Care—dry, warm, position, stimulate.
· For newborns requiring resuscitation, see 2.12 Newborn Resuscitation.
· Reassess airway by positioning and clearing secretions (only if needed):
o Place the newborn on back or side with head in a neutral or slightly extended 
position.
o Routine suctioning is discouraged even in the presence of meconium-stained 
amniotic fluid. Suction oropharynx then nares only if the patient exhibits 
respiratory depression and/or obstruction, see 2.12 Newborn Resuscitation.
· Clamp and cut the umbilical cord:
o After initial assessment and after the cord stops pulsating.
o Leave a minimum of 6 inches of cord.
· Prevent heat loss by rapidly drying and warming:
o Remove wet linen, wrap newborn in blankets or silver swaddler (preferred)  
and cover newborn’s head.
· Assess breathing by providing tactile stimulation:
o Flick soles of feet and/or rub the newborn’s back.
o If newborn is apneic or has gasping respirations, nasal flaring, or grunting, 
proceed to 2.12 Newborn Resuscitation.
· Assess circulation, heart rate, and skin color:
o Evaluate heart rate by one of several methods:
§ Auscultate apical beat with a stethoscope.
§ Palpate the pulse by lightly grasping the base of the umbilical cord.
o If the pulse is <100 bpm and not increasing, proceed to 2.12 Newborn 
Resuscitation.
o Assess skin color; examine trunk and face; and mucus membranes.
· Record APGAR score at 1 minute and 5 minutes (see chart).
· See A2 Pediatric Color Coded Appendix for vital signs reference.
2013
Active Movement
Over 100 bpm
Cry, sneeze, cough, 
active movement
Completely pink
Vigorous cry
Full breaths
Feature Evaluated
Activity
(Muscle Tone)
Pulse
Grimace
(Irritability/reflexes)
Appearance
(Skin Color)
Respiration
2 Points 1 Point
Arms and legs flexed
(Weak, some movement)
Below 100 bpm
Grimace (some flexion of 
extremities)
Body pink, 
Extremities blue
Slow, irregular, or gasping 
breaths, weak cry
0 Points
Limp or flaccid
Absent
No reflexes
Blue, pale
Absent
APGAR Scale
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Newly Born Care
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
PEARLS:  
· Newborn infants are prone to hypothermia which may lead to hypoglycemia, hypoxia and lethargy.  
Aggressive warming techniques should be initiated including drying, swaddling, and warm blankets 
covering body and head. 
· Raise temperature in ambulance patient compartment.
2.11
E     /   I    /    A            /            P
2013
P
EMT/EMT-INTERMEDIATE/ADVANCED EMT STANDING ORDERS
PARAMEDIC STANDING ORDERS
20132013
MEDICAL CONTROL MAY ORDER:
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Resuscitation of the Newly Born
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
2.12
· Routine Patient Care
· Maintain an open airway and suction the mouth, then nose.  If meconium (brown 
stained fluid) is present, suction the hypopharynx only if the infant is not vigorous 
(Contact ALS immediately if available for possible need of endotracheal 
intubation).
· Dry the infant, place on a dry blanket, cover the head and keep the infant warm.
· If ventilations are inadequate or chest fails to rise, reposition head and neck, 
suction and initiate positive pressure ventilation at room air for term newborns or 
for preterm (less then 38 weeks gestation) newborns at 40-60 breaths per 
minute, as clinically indicated.
· For heart rate less than 60, institute positive pressure ventilation with 100% 
oxygen for 1 minute and if heart rate remains at 60 start chest compressions.
· If meconium is present, consider early endotracheal intubation and suctioning. 
(Note: Do not suction or intubate a neonate with a vigorous cry).
· Newborn in distress and requiring emergency care:
· For heart rate 60-80 and rapidly rising: 
· Continue manual ventilation at room air for term newborns or for preterm 
(less then 38 weeks gestation) newborns at 40-60 breaths per minute
· Cardiac Monitor – Manage dysrhythmias per protocol 
· For heart rate less than 60:
· Initiate CPR as indicated.
· Institute positive pressure ventilation with 100% oxygen for 1 minute and if 
heart rate remains at 60, start chest compressions
· Continue manual ventilation with 100% oxygen after CPR is initiated
· Advanced airway management if not already done and perform 
capnography.
· Cardiac Monitor.  Manage dysrhythmias per protocol.  
· If defibrillation is indicated: initial energy level: 2 joules/kg subsequent: 4 
joules/kg.
· If synchronized cardioversion is indicated: 0.5-1 joules/kg.
· Establish IV or IO access, if indicated.  (Note: appropriately trained and 
authorized EMT-Paramedics may utilize umbilical lines when necessary).  
Treat for shock with 10cc/kg of normal saline over 5-10 minutes.
· Epinephrine 1:10,000 (0.01-0.03 mg/kg) IV/IO
· Epinephrine Infusion:  Administer 0.1-1 mcg/kg/min IV/IO 
· For example:mix 1mg of Epinephrine 1:1000 in 250mL of Normal Saline, 
(15 micro drops/minute = 1 mcg / min.)
NOTE:  The newborn should be evaluated for central cyanosis.  Peripheral cyanosis is common 
and may not be a reflection of inadequate oxygenation.  If central cyanosis is present in a 
breathing newborn during stabilization, early administration of 100% oxygen is important while the 
neonate is being assessed for need of additional resuscitative measures.
E  /   I    /    A
2013
P
PARAMEDIC STANDING ORDERS: ADULT
· Morphine Sulfate 0.1mg/kg IV/IO/IM/SC, every 5 minutes up to 10mg 
max; OR
· Fentanyl 1 mcg/kg slow IV/IO/IM/IN weight based (kg) to a max of 150mcg 
(150kg)
· Ondansetron 4 mg IV/IO/IM or PO-Ondansetron disintegrating tablet 
(ODT)
2013
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Pain & Nausea Management
Adult & Pediatric
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 12.03
2.13
· Routine Patient Care
EMT / EMT-INTERMEDIATE / ADVANCEDEMT STANDING ORDERS
PARAMEDIC STANDING ORDERS: PEDIATRIC
· Morphine Sulfate 0.1 mg/kg IV/IO/IM/SC (maximum individual dose 5 mg); OR 
Fentanyl 1 mcg/kg. to max. 150 mcg. slow IV/IO/IM/IN.
· Ondansetron, for child under or up to 25 kg. 2 mg. IV/IM or ODT; for a child over 
25 kg., 4 mg. IV/IM or ODT
· Additional doses of above medications
MEDICAL CONTROL MAY ORDER
E  /   I    /    A
· Routine Patient Care.
· Naloxone 2mg via Nasal Atomizer (IN) or 0.4mg via auto-injector (IM).
· If no response after 3-5 minutes, give second dose.
· First Responders may only administer if trained and authorized.
· If suspected or confirmed hypoglycemia, treat per protocol. 
2013
FIRST RESPONDER/EMT/EMT-INTERMEDIATE STANDING ORDERS
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Poisoning/Substance Abuse/
Overdose/Toxicology- Adult & Pediatric
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
2.14
MEDICAL CONTROL MAY ORDER
· Calcium Chloride 10%, 2-4 mg/kg IV/IO SLOWLY OVER FIVE (5) MINUTES 
(e.g., for calcium blocker toxicity).
· Sodium Bicarbonate 0.5 – 1 mEq/Kg IV/IO (e.g. TCA or Aspirin overdose).
· Atropine 2- 5 mg IV/IO (e.g., organophosphate poisoning management).
· Albuterol 2.5-3 mg by nebulizer (e.g., bronchospasm management).
· Furosemide 40 mg IV/IO (e.g., pulmonary edema management).
· Diazepam 5 mg-10 mg slow IV/IO/IM/PR; OR Lorazepam 2mg-4mg slow IV/IO/
IM (for seizures); OR Midazolam 2 – 6 mg IV/IO/IM/IN
· Amyl nitrite: administer vapors of a crushed inhalant or pearl under the patients 
nose for 15 out of every 30 thirty seconds with intermittent 100% oxygen 
administration.
· CYANIDE ANTIDOTE KIT if available by EMS service and/or industrial site:
· Two (2) Amyl Nitrite inhalants.
· 3% Sodium Nitrite (stop Amyl nitrite):
· ADULT: 10 mL slow IV/IO over 2-4 minutes.
· PEDI:  0.2 mL/kg (up to 10 mL) slow IV/IO over 5 minutes.
· Sodium Thiosulfate 25%:
· ADULT: 50 mL IV/IO.
· PEDI: 5 mL Sodium Thiosulfate per 1 mL Sodium Nitrate given.  NOTE:  
If hypotension develops, STOP all nitrites, treat for shock, and consider 
administration of Norepinephrine or Dopamine.
· Hydroxocobalamin 5 gm. IV/IO for cyanide toxicity.
· Glucagon 1 – 5 mg IV/IO/IM/SC, for beta-blocker or calcium-channel blocker 
overdose
· If suspected or confirmed nerve agent exposure, treat per protocol.
Poison Control may be reached at: 800-222-1222
A
ADVANCED EMT STANDING ORDERS
· Naloxone 0.4-2mg IV/IO/IM/IN. May be repeated as indicated.  
P
FR/E
I/
CAUTION:  Benzodiazepines may be contraindicated in head injury or hypotension; 
discuss with medical control.
2013
P
EMT / EMT-INTERMEDIATE STANDING ORDERS 
PARAMEDIC STANDING ORDERS
· Cardiac Monitor and if feasible 12 lead ECG – Manage dysrhythmias per 
protocol. 
· If patient is in Status Epilepticus, administer ONE of the following:
· Midazolam 2 - 6 mg slow IV/IO/IM/IN.
· Lorazepam 2– 4 mg slow IV/IO/IM.
· Diazepam 5–10 mg slow IV/IO/IM/PR.
NOTE:
· Post partum patients may experience eclamptic seizures up to several weeks after giving 
birth.
· Status epilepticus is defined as any generalized seizures lasting more than 5 minutes.  
This is a true emergency requiring rapid airway control, treatment (including 
benzodiazepines), and transport.
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Seizures - Adult
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
2.15A
ADVANCED EMT STANDING ORDERS 
A
· Routine Patient Care
· Manage hypoglycemia and narcotic overdose per protocol.
· Consider eclampsia in a woman of childbearing age 
CAUTION: Do NOT administer anything orally if the patient does not have 
a reasonable level of consciousness and normal gag reflex. 
· If Diazepam rectal gel (Diastat) has been prescribed by the patient’s 
physician, assist the caregiver with administration in accordance with 
physician’s instructions.
· If the patient has an implanted vagus nerve stimulator (VNS), suggest that 
the family use the VNS magnet to activate the VNS and assist if required.
· To use the VNS magnet, pass the magnet closely over the VNS 
device; if unsuccessful, repeat every 3-5 minutes for a total of 3 times.
Note:  Do not delay medication administration.
· Additional doses of above medications.
· Magnesium Sulfate 1-4 grams IV over 10 minutes if suspect eclampsia.
MEDICAL CONTROL MAY ORDER
2013
P
EMT/EMT-INTERMEDIATE STANDING ORDERS 
PARAMEDIC STANDING ORDERS
· If Glucose is less than 70mg/dL, treat per 2.3P Altered Mental/Neurological 
Status/Diabetic Emergencies/Coma- Pediatric.
· Midazolam 0.05mg/kg IV/IO/IM/IN to a maximum single dose of 4mg.
OR
· Lorazepam 0.05-0.1mg/kg IV/IO/IM Slowly (dilute 1:1 in Normal 
Saline), max. single dose of 2mg. 
OR
· Diazepam 0.25mg/kg IV/IO/IM to a maximum single dose of 5-10mg or a 
RECTAL DOSE of 0.5mg/kg unless contraindicated.
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Seizures - Pediatric
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
2.15P
ADVANCED EMT STANDING ORDERS 
A
· Routine Patient Care
· Prevent patient from accidental self-harm. DO NOT use a bite block.
CAUTION: Do NOT administer anything orally if the patient does not have 
a reasonable level of consciousness and normal gag reflex. 
· If Diazepam rectal gel (Diastat) has been prescribed by the patient’s 
physician, assist the patient or caregiver with administration in accordance 
with physician’s instructions.
· If the patient has an implanted vagus nerve stimulator (VNS), suggest that 
the family use the VNS magnet to activate the VNS and assist if required.
· To use the VNS magnet, pass the magnet closely over the VNS 
device; if unsuccessful, repeat every 3-5 minutes for a total of 3 times.
Note:  do not delay medication administration.
· Additional doses of above medications.
MEDICAL CONTROL MAY ORDER
HYPOVOLEMIC 
SHOCK
Control active bleeding 
using direct pressure, 
pressure bandages, 
tourniquets (commercial 
tourniquets preferred), 
or hemostatic bandage.
· Total volume 
administered is 
determined by 
hemodynamic 
stability.
OBSTRUCTIVE 
SHOCK
· Total volume 
administered 
is to be based 
on 
hemodynamic 
stability.
DISTRIBUTIVE 
SHOCK
· If patient has 
history of adrenal 
insufficiency, 
manage according 
to 2.1 Adrenal 
Insufficiency.
· Total volume 
administered is to 
be based on 
hemodynamic 
stability.
E
I /  A
BASIC STANDING ORDERS
Any patient with signs, symptoms, and history suggesting inadequate tissue perfusion should be considered 
to be in shock. Make every effort to determine and treat the underlying cause. Regardless of etiology, shock 
patients should be transported immediately to the nearest appropriate facility for definitive care. 
2013
· Routine Patient care
· Keep the patient supine
· Prevent heat loss by covering with warm blankets if available and if the patient is 
not febrile.
· Physiological signs:
· Altered mental status
· Radial pulse cannot be palpated.
· Systolic blood pressure less than 100 mmHg.
CARDIOGENIC 
SHOCK
· Assess and treat 
for pulmonary 
edema and/or 
congestive heart 
failure (CHF), 
per 3.6 
Congestive 
Heart Failure.
· No fluid bolus.  
EMT-INTERMEDIATE/ADVANCED EMT - STANDING ORDERS
Protocol Continues
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Shock - Adult
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
2.16A
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Shock – Adult
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
Protocol Continued
Etiology of Shock
· Cardiogenic Shock: History of cardiac surgery, rhythm disturbances, or post cardiac arrest. Assess for acute 
MI and pulmonary edema.
o Signs & Symptoms of cardiogenic shock: chest pain, shortness of breath, crackles, JVD, hypotension, 
tachycardia, diaphoresis.
· Distributive Shock: Anaphylaxis (see 2.2 Allergic Reaction/Anaphylaxis), neurogenic shock, sepsis. Assess for 
fever and signs of infection.
o Signs & Symptoms of neurogenic shock: sensory and/or motor loss, hypotension, bradycardia versus 
normal heart-rate, warm, dry skin.
· Hypovolemic Shock: Dehydration, volume loss, or hemorrhagic shock.
o Signs & Symptoms of hypovolemic shock: tachycardia, tachypnea, hypotension, diaphoresis, cool skin, 
pallor, flat neck veins.
· Obstructive Shock: Consider tension pneumothorax, pulmonary embolism, and cardiac tamponade.
o Signs and symptoms of tension pneumothorax: asymmetric or absent unilateral breath sounds, respiratory 
distress or hypoxia, signs of shock including tachycardia and hypotension, JVD, possible tracheal deviation 
above the sternal notch (late sign)
For patients with uncontrolled hemorrhagic or penetrating torso injuries:
· Restrict IV fluids.  Delaying aggressive fluid resuscitation until operative intervention may improve the 
outcome.
· Patients should be reassessed frequently, with special attention given to the lung examination to 
ensure volume overload does not occur.
· Several mechanisms for worse outcomes associated with IV fluid administration have been 
suggested, including dislodgement of clot formation, dilution of clotting factors, and acceleration of 
hemorrhage caused by elevated blood pressure.
HYPOVOLEMIC 
SHOCK
· Norepinephrine 
infusion: 
0.1mcg/kg/min 
IV/IO by pump, 
titrate to goal 
Systolic Blood 
Pressure of 
90mmHg, OR
· Dopamine 2-
20mcg/kg/min 
IV/IO
OBSTRUCTIVE 
SHOCK
· Needle 
Decompression, 
if tension 
pneumothorax 
suspected
· Norepinephrine 
infusion: 0.1mcg/
kg/min IV/IO by 
pump, titrate to 
goal Systolic 
Blood Pressure 
of 90mmHg, OR
· Dopamine 2-20 
mcg/kg/min IV/
IO
DISTRIBUTIVE 
SHOCK
· For patients with 
confirmed or 
suspected 
Adrenal 
Insufficiency, 
treat per 2.1 
Adrenal 
Insufficiency
CARDIOGENIC SHOCK
· Norepinephrine 
infusion: 0.1mcg/kg/
min IV/IO by pump, 
titrate to goal Systolic 
Blood Pressure of 
90mmHg, OR
· Dopamine 2-20 
mcg/kg/min IV/IO
PARAMEDIC - STANDING ORDERS
P
MEDICAL CONTROL MAY ORDER
· Consider fluid administration
· If signs and symptoms of hypoperfusion persist or symptoms worsen, regardless 
of etiology, consider norepinephrine or dopamine administration in the absence of 
hemorrhagic shock, with medical control approval. 
2.16A
HYPOVOLEMIC 
SHOCK
· Control active 
bleeding using direct 
pressure, pressure 
bandages,  
tourniquets 
(commercial 
tourniquets 
preferred), or 
hemostatic 
bandage,
· Obtain vascular 
access. Therapeutic 
end-points to fluid 
resuscitation (in 
order of importance) 
are: 
· Capillary refill,
· Normal pulses, 
· No difference 
between peripheral 
and central pulses,
· Warm extremities, 
Normal mental 
status, and
THEN normal blood 
pressure.
OBSTRUCTIVE 
SHOCK
DISTRIBUTIVE 
SHOCK
If patient has history of 
adrenal insufficiency, 
manage according to 
protocol 2.1 Adrenal 
Insufficiency.  
If suspected 
anaphylaxis, manage 
according to protocol.
If neurogenic shock is 
suspected:
Spinal immobilization.
· Obtain vascular 
access. 
Therapeutic end-
points to fluid 
resuscitation (in 
order of 
importance) are: 
o Capillary refill,
o Normal pulses, 
o No difference 
between 
peripheral and 
central pulses,
o Warm 
extremities, 
Normal mental 
status, and
o THEN normal 
blood 
pressure.
E
BASIC STANDING ORDERS
Any patient with signs, symptoms, and history suggesting inadequate tissue perfusion should be considered 
to be in shock. Make every effort to determine and treat the underlying cause. Regardless of etiology, shock 
patients should be transported immediately to the nearest appropriate facility for definitive care. 
2013
· Routine Patient Care.
· Keep the patient supine.
· Prevent heat loss by covering with warm blankets if available and if the patient is 
not febrile.
CARDIOGENIC 
SHOCK
EMT-INTERMEDIATE/ADVANCED EMT - STANDING ORDERS
Protocol Continues
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Shock - Pediatric
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 12.03
2.16P
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Shock – Pediatric
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 12.03
Protocol Continued
Etiology of Shock
· Cardiogenic Shock: History of cardiac surgery, rhythm disturbances, or post cardiac arrest. Assess for acute 
MI and pulmonary edema.
o Signs & Symptoms of cardiogenic shock: chest pain, shortness of breath, crackles, JVD, hypotension, 
tachycardia, diaphoresis.
· Distributive Shock: Anaphylaxis (see 2.2 Allergic Reaction/Anaphylaxis), neurogenic shock, sepsis. Assess for 
fever and signs of infection.
o Signs & Symptoms of neurogenic shock: sensory and/or motor loss, hypotension, bradycardia versus 
normal heart-rate, warm, dry skin.
· Hypovolemic Shock: Dehydration, volume loss, or hemorrhagic shock.
o Signs & Symptoms of hypovolemic shock: tachycardia, tachypnea, hypotension, diaphoresis, cool skin, 
pallor, flat neck veins.
· Obstructive Shock: Consider tension pneumothorax, pulmonary embolism, and cardiac tamponade.
o Signs and symptoms of tension pneumothorax: asymmetric or absent unilateral breath sounds, respiratory 
distress or hypoxia, signs of shock including tachycardia and hypotension, JVD, possible tracheal deviation 
above the sternal notch (late sign)
For patients with uncontrolled hemorrhagic or penetrating torso injuries:
· Restrict IV fluids.  Delaying aggressive fluid resuscitation until operative intervention may improve the 
outcome.
· Patients should be reassessed frequently, with special attention given to the lung examination to 
ensure volume overload does not occur.
· Several mechanisms for worse outcomes associated with IV fluid administration have been 
suggested, including dislodgement of clot formation, dilution of clotting factors, and acceleration of 
hemorrhage caused by elevated blood pressure.
HYPOVOLEMIC 
SHOCK
OBSTRUCTIVE 
SHOCK
DISTRIBUTIVE 
SHOCK
CARDIOGENIC SHOCK
PARAMEDIC - STANDING ORDERS
P
MEDICAL CONTROL MAY ORDER
· Consider fluid administration
· If signs and symptoms of hypoperfusion persist or symptoms worsen, regardless 
of etiology, consider norepinephrine or dopamine administration via length-based 
resuscitation tape in the absence of hemorrhagic shock, with medical control 
approval. 
2.16P
· Norepinephrine infusion: 0.1mcg/kg/min IV/IO by pump, titrate to goal Systolic 
Blood Pressure of 90mmHg, OR
· Dopamine 2-20 mcg/kg/min IV/IO
· Needle decompression for tension pneumothorax
1.  One or more abnormal findings of MASSACHUSETTS STROKE SCALE
FACIAL DROOP (Patient shows teeth or smiles) 
· Normal: Both sides of face move equally
· Abnormal: One side of face does not move as well as the other 
ARM DRIFT (Patient closes eyes and extend both arms straight out for 10 seconds.) 
· Normal: There is no drift at all or both arms drift the same 
· Abnormal: One arm drifts/moves down compared to the other arm or one arm noticeably 
weaker than the other. 
SPEECH (Score first attempt: Patient repeats, e.g. “The sky is blue in Boston.”) 
· Normal: The Patient says the correct words with no slurring of words on first attempt. 
· Abnormal: The patient slurs words, says the wrong words or is unable to speak on first 
attempt
OR
2.  One or more Sudden Acute Stroke Symptoms, including:
· Sudden numbness, weakness or paralysis of face, arm or leg – especially on one side of the 
body; 
· Sudden confusion, trouble speaking or understanding speech; 
· Sudden trouble seeing in one or both eyes; 
· Sudden trouble walking, loss of balance or coordination; or 
· Sudden severe headache with no known cause
2013
EMT / EMT-INTERMEDIATE / ADVANCED EMT / PARAMEDIC STANDING ORDERS
2013
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Stroke
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
2.17
Say “Stroke Alert” in Hospital Entry Note if patient meets the Stroke Criteria, 
even if symptoms have resolved 
/
/
/
I
P
· Routine Patient Care.
· Perform Massachusetts Stroke Scale, or equivalent nationally recognized 
stroke scale.
· Clearly determine time of onset of the symptoms or the last time seen well.
· If the patient wakes from sleep or is found with symptoms of stroke, the time 
of onset of first symptoms is defined as the last time the patient was 
observed to be normal. Notify the emergency department as soon as 
possible.
· If any one of the signs of the stroke scale is abnormal and onset of 
symptoms are less than 5 hours, notify receiving hospital of a “Stroke Alert”.
· Elevate the head of the stretcher 30 degrees.
· Do not delay transport for ALS intercept.
· Consider transporting a witness, family member, or caregiver with the patient 
to verify the time of the onset of stroke symptoms.
· If the onset of signs and symptoms PLUS transport time is <4.5 hours, 
consider transport to the most appropriate facility in accordance with local 
guidelines/agreements.
A
E
Avoid hyperoxygenation; oxygen administration should be titrated to patient condition, 
and withheld unless evidence of hypoxemia, dyspnea, or an SpO2 <94%, especially in 
the presence of a suspected CVA/TIA or ACS.
STROKE ALERT! Criteria:
Massachusetts Stroke Scale:
(Check if abnormal and new)
History:
Sudden Acute Stroke 
Symptoms:
Time last known well (TLKW) <5 hours?
Any abnormal finding not attributable to head 
trauma? 
Blood Glucose >60?
YES        NO   Unknown
Conditions:
q Head Trauma/
Seizures
q Cardiac Arrhythmias
q Recent/current 
bleeding, trauma, 
surgery or invasive 
procedure
q Bleeding disorder
q Pregnancy
q Sudden numbness, weakness or paralysis 
of face, arm or leg-- especially one side of 
the body
q Sudden confusion, trouble speaking or 
understanding speech
q Sudden trouble seeing in one or both eyes
q Sudden trouble walking, loss of balance or 
coordination; or
q Sudden severe headache with no known 
cause
Medications:
q Coumadin/
warfarin
q Pradaxa/
dabigatran
q Xaralto/
rivaroxaban
q Eliquis/apixaban
q aspirin
2.17
This checklist is included as a resource for EMTs and receiving hospitals. If used, please leave a 
copy with the patient and document all elements on Patient Care Report
If answer is YES to one or more criteria, say “Stroke Alert” in Hospital Entry Note, even 
if symptoms have resolved 
Stroke2.17
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Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
Date: Amb #: Pt. Age: q M       q  F
Patient’s Name: DOB:
mg/dL
:            AM/PM
F – (Face) Facial Droop: 
Have patient smile or show teeth (look 
for asymmetry) 
Abnormal: One side of the face does not move 
as well as the other. 
A – (Arms) Motor Weakness: 
Arm Drift (close eyes, extend arms, 
palms up) 
Abnormal: One arm drifts down or noticeably 
weaker than the other.
S – (Speech) 
Phrase: “The sky is blue in Boston” 
(repeat phrase, score first attempt) 
Abnormal: Words are slurred (dysarthria) or 
abnormal (asphasia) or none at first attempt
T – (Time) 
Time Last Known Well:
Blood Glucose Level: 
SECTION 3:
CARDIAC
PROTOCOLS
Statewide Treatment Protocols 
Version 2015.1
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EMT/EMT-INTERMEDIATE STANDING ORDERS
ADVANCED EMT STANDING ORDERS
A
· IV must be established before administration of nitroglycerin 
· Nitroglycerin 0.4mg SL every 3–5 minutes while symptoms persist and if systolic 
BP remains >120 mmHg.
· If patient has taken their own Nitroglycerin PTA, and you have determined 
that the pharmacologic potency of that nitroglycerin was normal (based upon 
standard side effects of the med, e.g., headache/tingling sensation) without 
pain relief, contact Medical Control for other treatment options.
· Routine Patient Care
· Aspirin 324-325 mg. Check allergy status. Check contraindications. 
· Nitroglycerin  1 tab/spray SL every 5 minutes to a maximum 3 doses
· Must be patient’s own NTG
· Include doses self-administered PTA
· SBP must be >120mmHg
· If suspected MI, determine patient eligibility for fibrinolytic therapy (within this 
protocol).
Not all patients with complaints of chest pain should be treated with aspirin, nitrates and oxygen. 
Consider the likelihood of ACS based on the nature of the symptoms, the patient’s age, cardiac risk 
factors, past medical history, etc.
Acute Coronary Syndrome
Adult
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
Protocol Continues
P
PARAMEDIC STANDING ORDERS
NOTE: A second IV line may be indicated for high-risk patient.
· Medication interventions based on risk for ACS, clinical presentation and/or 
diagnostic EKG changes. 
· Fentanyl 1 mcg/kg slow IV/IO/IM/IN weight based (kg) to a max of 150mcg 
(150kg)
Acute Coronary Syndrome-
lt3.1
I/
E
· Additional doses of above medications.
MEDICAL CONTROL MAY ORDER
· Avoid nitroglycerin in ALL patients who have used a phosphodiesterase inhibitor such as: 
sildenafil (Viagra, Revatio), vardenafil (Levitra, Staxyn), tadalafil (Cialis, Adcirca) within the 
last 48 HOURS. These medications are often used for erectile dysfunction and pulmonary 
hypertension. Also avoid use in patients receiving intravenous epoprostenol (Flolan) which is 
also used for pulmonary hypertension.
· Administer nitrates with extreme caution, if at all, to patients with inferior-wall STEMI or 
suspected right ventricular (RV) involvement because these patients require adequate RV 
preload.
2013
Protocol Continued
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Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
Acute Coronary Syndrome - 
Adult 3.1
Acute Coronary Syndrome (ACS) represents a spectrum of disease.  There are at least three 
conditions identified within the spectrum of ACS: Classic anginal chest pain; atypical chest pain; 
anginal equivalents; Patients experiencing a myocardial infarction or an ischemic event of 
unknown etiology may, based on 12-lead interpretation fall into one of three categories, “injury 
(STEMI)” or “Ischemia” or “Non-Diagnostic.”
If patient appears to be having a ST-elevation MI (STEMI), refer to the appropriate STEMI-Point 
of Entry (POE) plan, and transport accordingly.
Additional signs and symptoms of an ACS patient may be;
Sudden onset of diaphoresis (cool, clammy, wet skin often profuse), anxiety, restlessness, 
abnormal vital signs such as an irregular pulse rate, and nausea / vomiting. 
All ACS patients must be carefully monitored until a definitive diagnosis can be made at the 
hospital and shall have a 12-lead evaluation done by EMT-Paramedics.  All patients with ACS-
like symptoms of a non-traumatic etiology should be considered to be of cardiac origin until 
proven otherwise.   
Classical Anginal Chest Pain Atypical Chest Pain Anginal Equivalents 
Central Anterior Pain Epigastric discomfort Dyspnea 
Chest Pressure, tightness Musculoskeletal Syncope 
Crushing Pain Often Unilateral “Generally Weak” 
Pain radiating to arms, neck and back Nausea/Vomiting Palpitations 
 
Avoid hyperoxygenation; oxygen administration should be titrated to patient condition, 
and withheld unless evidence of hypoxemia, dyspnea, or an SpO2 <94%, especially in 
the presence of a suspected CVA/TIA or ACS.
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Acute Coronary Syndrome – Adult
Fibrinolytic Checklist
*Note:This checklist is intended only as a tool for the pre-hospital identification of 
patients with significant contraindication(s) to the administration of fibrinolytics in the 
acute ST elevation M.I. (STEMI) setting. It is not intended to be a comprehensive list of 
all factors to be considered prior to administration of these agents. Significant 
contraindications may warrant the triage of these patients to facilities capable of 
percutaneous intervention (PCI).  This list can also be used to determine if a possible 
ischemic stoke victim, is a candidate for ischemic stroke reperfusion. 
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
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EMT/EMT-INTERMEDIATE/ADVANCED EMT STANDING ORDERS
· Routine Patient Care
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
P
PARAMEDIC STANDING ORDERS
Atrial Fibrillation/Flutter 3.2
E
I
A
/
/
· If the rhythm appears to be amenable, e.g. “regular narrow SVT”, may attempt 
vagal maneuvers: “Valsalva” and/or cough.
· If the patient’s systolic blood pressure is unstable (less than 100 mm Hg, with 
signs of hypoperfusion): 
· In Atrial Fibrillation, synchronized cardioversion at 200 J, 300J, and 360 
J or the equivalent biphasic values as per manufacturer). 
· In Atrial Flutter, synchronized cardioversion beginning at 50J. 
· Check rhythm and pulse between each attempted cardioversion.
· If Cardioversion is warranted, consider use of 7.6 Sedation for Electrical 
Therapies.
· Diltiazem HCL 
· Heart rate greater than 150 and patient stable but symptomatic:
· Initial bolus: 0.25 mg/kg slow IV/IO over two (2) minutes.
· If inadequate response after 15 minutes, re-bolus 0.35 mg/kg SLOW IV/
IO over two (2) minutes.
CONTRAINDICATIONS:  Wolff-Parkinson-White Syndrome, second or third degree 
heart block and sick sinus syndrome (except in the presence of a ventricular pace 
maker), severe hypotension or cardiogenic shock.
· Heart rate less than 150 and patient stable but symptomatic: 
· Contact Medical Control.
· Additional doses of above medications
· Amiodarone 150 mg Slow IV/IO over 10 minutes.
· Metoprolol:  
· Bolus: 2.5-5 mg SLOW IV/IO over 2 minutes.  
· Repeat dosing in 5 minute intervals for a maximum of 15 mg.
MEDICAL CONTROL MAY ORDER
CAUTION: Do not use IV Metoprolol with IV Ca Blockers.
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· Routine Patient Care
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
P
PARAMEDIC STANDING ORDERS
· If patient is symptomatic (such as altered mental status or ischemia),
· Transcutaneous Pacing (TCP).
· Atropine Sulfate 0.5 mg IV/IO every three (3) to five (5) minutes up to total 
dose 3 mg may be considered while waiting for pacer set-up.
· If Transcutaneous Pacing (TCP) is warranted, consider 7.6 Sedation for 
Electrical Therapy.
Bradycardia-Adult3.3A
EMT/EMT-INTERMEDIATE/ADVANCED EMT STANDING ORDERS
E
I
A
/
/
· Additional doses of above medications
· Norepinephrine infusion: 0.1mcg/kg/min IV/IO via pump, titrate to goal Systolic 
Blood Pressure of 90mmHg, OR
· Dopamine 2-20 mcg/kg/min IV/IO
· Epinephrine Infusion 1-10 mcg/min IV/IO
· For example: mix 1mg of Epinephrine 1:1000 in 250mL of Normal Saline, (15 micro 
drops/minute = 1 mcg / min.)
· Glucagon 1 - 5 mg IV/IO/IM/SC for suspected beta-blocker or calcium-channel 
blocker toxicity.
· Calcium Chloride 10% 2 - 4 mg/kg max.1 gram IV/IO slowly over five (5) minutes 
for suspected calcium channel blocker toxicity.
MEDICAL CONTROL MAY ORDER
2013
· Routine Patient Care
· If pulse is less than 60 in a child, AND the patient is severely symptomatic, 
consider starting Cardiopulmonary Resuscitation (CPR).
Acute Coronary Syndrome
Adult
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
P
PARAMEDIC STANDING ORDERS
· If patient is severely symptomatic:
· Epinephrine 1:10,000, 0.01 mg/kg IV/IO (max. dose 0.5 mg) OR,
· Atropine 0.02 mg/kg IV/IO (min. single dose 0.1 mg, max. single dose 1 mg). 
If increased vagal tone or AV block suspected.
Bradycardia- Pediatric 3.3P
EMT/EMT-INTERMEDIATE/ADVANCED EMT STANDING ORDERS
E
I
A
/
/
· Additional doses of above medications
· Additional fluid boluses (10-20mL/kg)
· Transcutaneous pacing, if available.
· Epinephrine 1:10,000 – 0.01-0.03 mg/kg IV/IO (max. single dose of 0.5 mg)\
· Epinephrine Infusion 1:1,000, 0.1-1 mcg/kg/min IV/IO
· For example, mix 1mg of Epinephrine 1:1000 in 250mL of Normal Saline, (15 
micro drops/minute = 1 mcg / min.)
MEDICAL CONTROL MAY ORDER
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EMT STANDING ORDERS
EMT-INTERMEDIATE / ADVANCED EMT STANDING ORDERS
· Consider underlying causes for Asystole/PEA
· At all times, minimize interruptions of chest compressions, especially during IV/IO 
placement.
· Routine Patient Care
· EARLY DEFIBRILLATION.
· Perform CPR until AED device is attached and operable.
· Use AED according to Emergency Cardiovascular Care (ECC) Guidelines or 
as otherwise noted in these protocols and other advisories.
· Resume CPR when appropriate.
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
P
PARAMEDIC STANDING ORDERS
· Verify Asystole in 2 leads, if possible.
· Consider and treat underlying causes for Asystole/PEA: 
· If cause is unknown and Asystole/PEA persists:
· Epinephrine 1:10,000 1 mg IV/IO every 3-5 minutes; may substitute 
Vasopressin 40 UNITS IV/IO in place of first or second dose of epinephrine 
1:10,000.
Cardiac Arrest (ADULT):
Asystole/ Pulseless Electrical Activity3.4A
I/A
REVERSIBLE CAUSES OF CARDIAC ARREST INCLUDE:
· Hypothermia: initiate 2 large bore IVs (warm) normal saline
· Hyperkalemia: Contact Medical Control
· Hypoxia: provide high flow oxygen
· Hypovolemia: 250mL fluid bolus.
· Hydrogen Ion/Acidosis: Contact Medical Control
· Toxins/Tablets: see Toxicology protocol
· Thrombus (Coronary/Pulmonary): Contact Medical Control
· Tension Pneumothorax: Perform needle chest decompression.
· Tamponade (Pericardial): Contact Medical Control
MEDICAL CONTROL MAY ORDER
· Additional doses of above medications.
· Sodium Bicarbonate 1 mEq/kg IV/IO
· Atropine 1 mg IV/IO, repeated to max dose 3 mg.
C
a
r
d
i
a
c
 
P
r
o
t
o
c
o
l
 
 
 
3
.
4
P
2013
EMT / EMT-INTERMEDIATE / ADVANCED EMT STANDING ORDERS
· Routine Patient Care—with focus on CPR
· Ventilate with 100% oxygen 
· If unable to ventilate child after repositioning of airway: assume upper airway 
obstruction and follow Pediatric Upper Airway Obstruction Protocol.
· EARLY DEFIBRILLATION
a.   Use AED according to the guidelines of the ECC or as otherwise noted in 
these protocols and other advisories
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
P
PARAMEDIC STANDING ORDERS
· Consider treating for reversible causes. 
· Epinephrine: 
o For Bradycardia: 0.01 mg/kg (1:10,000) IV/IO every 3-5 minutes.
o For Asystole or PEA: 0.01 mg/kg (1:10,000) IV/IO every 3-5 minutes.
Epinephrine infusion: initial dose, 0.1 mcg/kg/min IV/IO. Titrate to desired effect 
to maximum dose of 1 mcg/kg/min. 
For example, mix 1mg of Epinephrine 1:1000 in 250mL of Normal Saline,  (15 
micro drops/minute = 1 mcg / min.)
Cardiac Arrest (PEDIATRIC):
Asystole/ Pulseless Electrical Activity 3.4P
REVERSIBLE CAUSES OF CARDIAC ARREST INCLUDE:
· Hypothermia: initiate 2 large bore IVs (warm) normal saline
· Hyperkalemia: Contact Medical Control
· Hypoxia: provide high flow oxygen
· Hypovolemia: 250mL fluid bolus.
· Hydrogen Ion/Acidosis: Contact Medical Control
· Toxins/Tablets: see Toxicology protocol
· Thrombus (Coronary/Pulmonary): Contact Medical Control
· Tension Pneumothorax: Perform needle chest decompression.
· Tamponade (Pericardial): Contact Medical Control
I/A
E/
MEDICAL CONTROL MAY ORDER
· Additional doses of above medications.
· Sodium Bicarbonate 1 mEq/kg IV/IO
· Atropine 0.02mg/kg IV/IO (minimum single dose 0.1mg, maximum combined 
doses 1 mg.) 
· All other treatment modalities based on suspected etiology for cardiopulmonary 
arrest. 
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EMT / EMT-INTERMEDIATE STANDING ORDERS
ADVANCED EMT STANDING ORDERS
A · Minimize interruptions of chest compressions for IV/IO placement. 
· Routine Patient Care
· Perform CPR until defibrillator is attached and operable.
· Use AED according to the ECC guidelines or as otherwise noted in these 
protocols and other advisories
· Resume CPR when appropriate.
Acute Coronary Syndrome
Adult
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
P
PARAMEDIC STANDING ORDERS
· Document presenting cardiac rhythm in two separate leads, if possible.
· Defibrillation when available, with minimum interruption in chest compressions 
(use 360 joules for monophasic and 120 – 200 joules for biphasic defibrillators); 
then CPR for 5 cycles/2 minutes; then rhythm check; Charge defibrillator while 
performing chest compressions to minimize hands-off-time.
· Consider Epinephrine (1:10,000) 1mg IV/IO; repeat every 3 – 5 minutes. May 
substitute Vasopressin 40 units IV/IO in place of first or second dose of 
epinephrine 1:10,000. 
· Continue CPR and defibrillate (each shock at 360J monophasic equivalent) per 
ECC guidelines if ventricular fibrillation/ventricular tachycardia is persistent.
· Consider Amiodarone 300 mg slow IV/IO push.
Cardiac Arrest (ADULT):
Ventricular Fibrillation/ Pulseless Ventricular Tachycardia
3.5A
I/
E
NOTE:
· Early CPR and early defibrillation are the most effective therapies for cardiac arrest care.
· Minimize interruptions in chest compression, as pauses rapidly return the blood pressure to zero and stop 
perfusion to the heart and brain.
· Switch compressors at least every two minutes to minimize fatigue.
· Perform “hands on defibrillation.”  
o Compress when charging and resume compressions immediately after the shock is delivered. 
· Do not hyperventilate as it increases intrathoracic pressure and decreases blood return to the heart.  
Ventilate at a rate of 8 – 10 breaths per minutes, with enough volume to produce adequate chest rise.
NOTE:
The need for early defibrillation is clear and should have the highest priority.  Since these patients 
will all be in cardiopulmonary arrest, use of adjunctive equipment should not divert attention or effort 
from Basic Cardiac Life Support (BCLS) resuscitative measures, early defibrillation and Advanced 
Cardiac Life Support (ACLS).  Remember: rapid defibrillation and high quality CPR is the major 
determinant of survival.  
· Additional doses of above medications
· Sodium Bicarbonate 1 mEq/kg IV/IO.
· Magnesium Sulfate 1 – 2 grams IV/IO over 5 minutes, in torsades de pointes or suspected 
hypomagnesemic state or refractory ventricular fibrillation/ventricular tachycardia.
· Amiodarone 150 mg. slow IV/IO if one dose already given or 300 mg slow IV/IO if not 
already given.
· Lidocaine 1.5 mg/kg IV/IO; subsequent dosage: 0.5 to 0.75 mg/kg IV/IO every 3 – 5 
minutes to a total dose of 3 mg/kg IV/IO.
MEDICAL CONTROL MAY ORDER
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EMT / EMT-INTERMEDIATE / ADVANCED EMT STANDING ORDERS
· Routine Patient Care—with focus on high quality CPR
· Apply AED and use as soon as possible (with minimum interruption of chest 
compressions). From birth to age 8 years use pediatric AED pads.
· If pediatric AED pads are unavailable, providers may use adult AED pads, 
provided the pads do not overlap. 
· If unable to ventilate child after repositioning of airway, assume upper airway 
obstruction and follow Pediatric Upper Airway Obstruction Protocol.
· Consider treatable causes
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
P
PARAMEDIC STANDING ORDERS
· Defibrillate once at 2-4J/kg.
· Epinephrine: 0.01mg/kg IV/IO (1:10,000, 0.1mL/kg); repeat every 3-5 minutes.
· Defibrillate 4-10 J/kg (do not exceed 10J/kg) every 2 minutes.
· Amiodarone 5 mg/kg IV/IO
· Defibrillate 4 J/kg 30-60 seconds after each medication. 
Cardiac Arrest (PEDIATRIC):
Ventricular Fibrillation/ Pulseless Ventricular Tachycardia
3.5P
NOTE:
· Early CPR and early defibrillation are the most effective therapies for cardiac arrest care.
· Minimize interruptions in chest compression, as pauses rapidly return the blood pressure to zero and stop 
perfusion to the heart and brain.
· Switch compressors at least every two minutes to minimize fatigue.
· Perform “hands on defibrillation.”  
o Compress when charging and resume compressions immediately after the shock is delivered. 
· Do not hyperventilate as it increases intrathoracic pressure and decreases blood return to the heart.  
Ventilate at an appropriate rate, with enough volume to produce adequate chest rise.
NOTE:
The need for early defibrillation is clear and should have the highest priority.  Since these patients 
will all be in cardiopulmonary arrest, use of adjunctive equipment should not divert attention or effort 
from Basic Cardiac Life Support (BCLS) resuscitative measures, early defibrillation and Advanced 
Cardiac Life Support (ACLS).  Remember: rapid defibrillation and high quality CPR is the major 
determinant of survival.  
I/ A/
E
· Additional doses of above medications
· Sodium Bicarbonate 1 mEq/kg IV/IO.
· All other treatment modalities based upon suspected cause of VT/FT.
MEDICAL CONTROL MAY ORDER
Avoid nitroglycerin in ALL patients who have used a phosphodiesterase inhibitor such as: 
sildenafil (Viagra, Revatio), vardenafil (Levitra, Staxyn), tadalafil (Cialis, Adcirca) which are 
used for erectile dysfunction and pulmonary hypertension within the last 48 HOURS.  Also avoid 
use in patients receiving intravenous epoprostenol (Flolan) which is also used for pulmonary 
hypertension.
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· Routine Patient Care
Acute Coronary Syndrome
Adult
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
P
PARAMEDIC STANDING ORDERS
· Nitroglycerin  0.4-0.8mg (1/150 gr.) tablet/spray, sublingual
· SBP must be >120 mm Hg 
· May be repeated every 5 minutes, as dictated by BP.
· Nitropaste 1 inch to chest wall if SBP >120 mm Hg.
· Continuous positive airway pressure (CPAP) assistance, if not contraindicated, 
and if nebulizer therapy can be continued with the CPAP device.
Congestive Heart Failure 
(Pulmonary Edema)3.6
EMT/EMT-INTERMEDIATE/ADVANCED EMT STANDING ORDERS
E
I
A
/
/
· Additional doses of above medications
· Furosemide 20-40mg IV/IO, or 40-80mg IV/IO if patient is already on diuretics.
· Norepinephrine infusion: 0.1mcg/kg/min IV/IO via pump, titrate to goal Systolic 
Blood Pressure of 90mmHg, OR
· Dopamine 2-20 mcg/kg/min IV/IO
· In patients who require emergent intubation, and cannot be intubated by 
conventional means, see 5.2 Difficult Airway Protocol 
MEDICAL CONTROL MAY ORDER
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· Routine Patient Care
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
P
PARAMEDIC STANDING ORDERS
· Cardiac Monitor: (12 lead ECG where appropriate) manage dysrhythmias per 
protocol. If STEMI present, transport to nearest STEMI Center. 
· Place esophageal thermometer probe to establish patient’s baseline body 
temperature (34º C or greater). (IF AVAILABLE)
· If patient has significant shivering, you may administer:
· Lorazepam 2 – 4 mg IV/IO/IM, OR
· Midazolam 2 - 6 mg IV/IO/IM/IN, OR
· Diazepam 5-10 mg IV/IO/IM/PR, OR
· Morphine 0.1mg/kg IV/IO/IM/IN every 5 minutes up to 10 mg max, OR 
· Fentanyl 50 mcg IV/IO/IM/IN every 5 minutes to max. 200 mcg
Induced Therapeutic Hypothermia –
Adult3.7
EMT STANDING ORDERS
E
Indications:
· > 16 years or older; If <16, contact Medical Control
· ROSC – patient demonstrates no purposeful 
movement to sternal rub or response to commands 
5 minutes into ROSC, and
· Palpable Carotid pulse with a stable cardiac rhythm, 
and
· Patient does not have existing hypothermia (< 34º 
C), and
· Patient is intubated or appropriate rescue airway.
· Post-cardiac arrest with return of spontaneous 
circulation (ROSC)
· Post-cardiac arrest in setting of STEMI
Contraindications:
· Traumatic arrest, or
· Hypothermia exists (< 34° 
C) by core temperature
· Identified Pregnancy, or
· Respiratory arrest 
MEDICAL CONTROL MAY ORDER
· Ice packs or equivalent in armpits, neck, torso and groin areas of patients that 
meet indications criteria.  
EMT-INTERMEDIATE/ADVANCED EMT STANDING ORDERS
I/A
· Airway interventions, as appropriate, according to protocol, prior to cooling. Do 
not hyperventilate; goal ETCO2 of around 40 mmHg.
· Ice packs or equivalent in armpits, neck, torso and groin areas of patient.
· Obtain 1-2 points of vascular access, and infuse chilled normal saline (2 – 4º C) 
wide open @ 500ml increments to a max of 2000ml or 30 ml/kg to a max of 2L 
monitoring for CHF. Target cooling body to temperatures 32-34º C.(If refrigerated 
saline available) 
REMINDER: This is an extremely unstable period.  The patient should be monitored 
closely and frequently.  Recurrent dysrhythmias, hypotension and re-arrest are not 
uncommon occurrences.  Avoid hyperthermia and hyperventilation.
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· Routine Patient Care
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
P
PARAMEDIC STANDING ORDERS
· Consider treatable causes such as overdose, cardiogenic shock and STEMI.  
· Manage dysrhythmias according to specific protocols.
· Perform a 12-lead ECG; If STEMI is present and the patient is stable enough follow 
the Department – approved STEMI POE plan.  Consult with medical control if 
questions arise.
· Begin induced therapeutic hypothermia (3.7 Induced Therapeutic Hypothermia), but 
do not delay transport
· Norepinephrine infusion: 0.1mcg/kg/min IV/IO via pump, titrate to goal Systolic 
Blood Pressure of 90mmHg, OR
· Dopamine 2-20mcg/kg/min IV/IO
Post Resuscitative Care/ROSC – 
Adult3.8
EMT/EMT-INTERMEDIATE/ADVANCED EMT STANDING ORDERS
E
I
A
/
/
· Additional doses of above medications
· Epinephrine Infusion - Administer 1 mcg to 10 mcg per minute IV or IO.
· For example, mix 1 mg of 1:1000 Epinephrine in 250 ml Normal Saline, then 15 
micro drops/minute = 1 mcg / min
· Amiodarone bolus as ordered followed by 1 mg/min IV/IO drip. 
· For example: 100mg/100ml - 1mg/minute.
· Lidocaine 1-1.5 mg/kg IV/IO followed by drip at 2-4 mg/min. 
MEDICAL CONTROL MAY ORDER
Avoid hyperoxygenation; oxygen administration should be titrated to patient condition, and 
withheld unless evidence of hypoxemia, dyspnea, or an SpO2 <94%, especially in the 
presence of a suspected CVA/TIA or ACS.
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· Vagal Maneuvers: Valsalva’s and/or cough.
· If Systolic BLOOD PRESSURE is unstable (less than 100mm Hg): Synchronized 
cardioversion at 50 J, 100 J, 200 J, 300 J and 360 J or the equivalent biphasic 
values as per manufacturer.  Check rhythm and pulse between each attempted 
cardioversion.
· If cardioversion is warranted, consider 7.6 Sedation for Electrical Therapy
· Adenosine 6 mg rapid IV/IO over 1-3 seconds. If previous dose failed to resolve 
rhythm disturbance, Adenosine 12mg rapid IV/IO over 1-3 seconds.  Repeat 
Adenosine 12 mg rapid IV/IO over 1-3 seconds if previous doses failed to 
resolve rhythm disturbance. 
Note: Follow all Adenosine with a 20 mL normal saline bolus and elevate extremity.
Supraventricular Tachycardia-
Adult 3.9A
· Routine Patient Care
EMT/EMT-INTERMEDIATE/ADVANCED EMT STANDING ORDERS
E
I
A
/
/
· Additional doses of above medications
· Administration of Diltiazem HCL: 
· Initial bolus: 0.25 mg/kg IV/IO over two (2) minutes.
· If inadequate response after 15 minutes, re-bolus 0.35 mg/kg IV/IO over two (2) 
minutes.
CONTRAINDICATIONS: Wolff-Parkinson-White Syndrome, second or third degree 
heart block and sick sinus syndrome (except in the presence of a ventricular pace 
maker), severe hypotension or cardiogenic shock.
OR
· Amiodarone 150 mg IV/IO slowly over 10 minutes. 
MEDICAL CONTROL MAY ORDER
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Massachusetts Department of Public Health Office of Emergency Medical Services
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· IV Normal Saline (KVO).  If hypovolemic component is suspected, administer 20 
mL/kg IV Bolus of Normal Saline.
Supraventricular Tachycardia-
Pediatric3.9P
· Routine Patient Care
· If tachycardia is related to acute injury or volume loss, see 2.16P Shock.
EMT/EMT-INTERMEDIATE/ADVANCED EMT STANDING ORDERS
E
I
A
/
/
REMINDER:  Vagal maneuvers may precipitate asystole and therefore should be 
employed with caution in the field and only in a cardiac-monitored child with IV access.
· Additional doses of above medications
· Synchronized cardioversion 0.5 joules/kg for symptomatic patients. Subsequent 
cardioversion may be done at up to 1 joule/kg.  If cardioversion is warranted, 
consider administration of 7.6 Sedation for Electrical Therapy, per protocol.
· See A2 Pediatric Color Coded Medication Reference for dosing.
· Adenosine 0.1 mg/kg rapid IV/IO.  If no effect, repeat Adenosine 0.2 mg/kg Rapid 
IV push.  MAXIMUM single dose of Adenosine must not exceed 12 mg.
· Consider Vagal maneuvers (see Reminder below).
MEDICAL CONTROL MAY ORDER
Synchronized cardioversion should be considered for only those children whose heart 
rate is in excess of 220, and who demonstrate one or more of the following signs of 
hypoperfusion:  Decreased level of consciousness, weak and thready pulses, capillary 
refill time of more than 4 seconds, or no palpable BLOOD PRESSURE.
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EMT/EMT-INTERMEDIATE/ADVANCED EMT STANDING ORDERS
· Routine Patient Care
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
P
PARAMEDIC STANDING ORDERS
· If Systolic BLOOD PRESSURE is unstable (less than 100mm Hg ): synchronized 
cardioversion at 100 J, 200 J, 300 J and 360 J or the equivalent biphasic values 
as per manufacturer.  Check rhythm and pulse between each attempted 
cardioversion.
· In Pediatric patients, synchronized cardioversion per Pediatric Color-Coded 
Appendix. 
· If cardioversion is warranted, see 7.6 Sedation for Electrical Therapy
· If systolic BLOOD PRESSURE is stable (greater than or equal to 100mm Hg) 
administer Amiodarone 150 mg in 10 cc Normal Saline, slow IV/IO over 8-10 
minutes.
· In Pediatric patients, Amiodarone dose per Pediatric Color-Coded Appendix.
Ventricular Tachycardia with Pulses – 
Adult & Pediatric 3.10
I/A/
E
· Additional doses of above medications or attempts at cardioversion
· Magnesium Sulfate (for Torsades de Pointes or suspected hypomagnesemic state 
or severe refractory VENTRICULAR TACHYCARDIA) 1 – 2 grams IV/IO over 5 
minutes. 
· CONTRAINDICATIONS: Heart Block, renal disease.
· Amiodarone infusion 1 mg/min IV/IO. 
· For example: 100mg/100ml – 1mg/minute
· Lidocaine 1 – 1.5 mg/kg IV/IO; subsequent dosage: 0.5 – 0.75 mg/kg IV/IO every 3 
– 5 minutes to a total dose of 3 mg/kg.  If dysrhythmia is successfully converted 
after administration of Lidocaine bolus, consider IV infusion of Lidocaine 2 – 4 mg/
min.
· Adenosine 6 mg or 12 mg IV push; in selected cases ONLY.
MEDICAL CONTROL MAY ORDER
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Burns/Inhalation/Electrocution and 
Lightning Strike Injuries – Adult & Pediatric
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
4.1
EMT STANDING ORDERS
E
Protocol Continues
EMT-INTERMEDIATE/ADVANCED EMT STANDING ORDERS
· Routine Patient Care
· Appropriately manage Thermal vs. Chemical burns.
THERMAL
· Stop burning process with water or saline.
· Remove smoldering, non-adherent clothing and jewelry.  DO NOT remove 
skin or tissue.  
· Cover burns with a CLEAN, DRY, STERILE DRESSING
· Large thermal injuries are susceptible to hypothermia-- attempt to reduce heat 
loss in burn victims  
CHEMICAL
· Determine offending agent(s) and consider HAZMAT intervention, if   
indicated.
· Wash with copious amounts of clean water and/or sterile normal saline for 10-
15 minutes, unless contraindicated by chemical agent (i.e., sodium, potassium 
and/or lithium metals).  CAUTION: Primary water irrigation is contraindicated 
for Dry Lime/Lye and/or Phenol exposure (may produce further chemical 
reactions).  Dry powders should be brushed off prior to flushing with large 
amounts of water.  It is advised to contact MEDICAL CONTROL for further 
advice.
· If chemical viscous, remove with tongue depressor
· Begin fluid resuscitation for treatment of the BURN INJURY if greater than 20% 
BSA including second and third degree injuries (1st degree [sunburn] not 
included in TBSA estimation),
· Adults: Bolus 1 Liter Normal Saline
· Pediatrics: 20 mL/kg Normal Saline
· Burn <20% age appropriate, maintenance fluids as follows:
· Adults: 500 mL Normal Saline
· Pediatrics: 10mL/kg Normal Saline
· For transport times GREATER THAN 1 HOUR, or further fluid administration, 
consult medical control 
MEDICAL CONTROL MAY ORDER
· Additional IV fluid boluses
I
A/
P
PARAMEDIC STANDING ORDERS
· After a complete patient assessment consider initiating the pain management 
protocol. 
· In a patient who may have experienced smoke inhalation with suspected cyanide 
toxicity (e.g. hypotension, altered mental status, seizure or other), if carried, 
consider Hydroxocobalamin 5 gm IV/IO over 15 minutes in an adult, and 70 mg/
kg (to maximum 5 gm) IV/IO over 15 minutes in a pediatric patient.
· In patients with suspected CO poisoning, initiate high flow oxygen
T
r
a
u
m
a
 
P
r
o
t
o
c
o
l
s
 
 
 
4
.
1
2013
2013
Burns/Inhalation/Electrocution and Lightning 
Strike Injuries – Adult & Pediatric
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
4.1
Protocol Continued
The committee on Trauma of the American College of Surgeons (ACS) and the American Burn 
Association (ABA) have identified certain injuries as those which generally require referral to a 
burn center.
The following injuries generally require referral to a burn unit:
1. Partial thickness burns greater than 10% total body surface area (TBSA)- 
2. Burns that involve the face, hands, feet, genitalia, perineum, or major joints
3. Third-degree burns in any age group
4. Electrical burns, including lightning injury
5. Chemical burns
6. Inhalation injury
7. Burn injury in patients with preexisting medical disorders that could complicate 
management, prolong recovery, or affect mortality. Burns in any patients with concomitant 
trauma (such as fractures) in which the burn injury poses the greatest risk of morbidity or 
mortality. In such cases, if the trauma poses a greater immediate risk than the burns, it 
may be necessary to stabilize the patient in a trauma center before being transferred to a 
burn unit. Physician judgment is necessary in such situations and should be in concert 
with established triage protocols.
  
 Estimation of Burn Size (Children) 
Area Age 0 1 yr. 5 yr. 10 yr. 15 yr. 
A - ½ of head 9 ½ % 8 ½ % 6 ½ % 5 ½ % 4 ½ % 
B - ½  of one thigh 2 ¾ % 3 ¼ % 4 % 4 ¼ % 4 ½ % 
C - ½ of one leg 2 ½ % 2 ½ % 2 ¾ % 3 % 3 ¼ % 
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Drowning/Submersion Injuries
Adult & Pediatric
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
4.2
EMT / EMT-INTERMEDIATE / ADVANCED EMT STANDING ORDERS
· Routine Patient Care
· Begin resuscitation efforts while removing the patient from the water
· Consider hypothermia.
Note:  Ensure spinal stabilization and immobilization if indicated (i.e., 
unwitnessed event, unconscious patient, or mechanism of injury).  
IA/
E
PARAMEDIC STANDING ORDERS
P
MEDICAL CONTROL MAY ORDER
· Additional fluid boluses.
/
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Eye Emergencies
Adult & Pediatric
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
4.3
EMT / EMT-INTERMEDIATE / ADVANCED EMT STANDING ORDERS
· Routine Patient Care
· Obtain visual history (e.g., use of corrective lenses, surgeries, use of 
protective equipment).
· Obtain visual acuity, if possible.
· Assist patient with the removal of contact lens, if applicable.
· Chemical irritants, including pepper spray: flush with copious amounts of 
water, or 0.9% NaCl.
· Thermal burns to eyelids: patch both eyes with cool saline compress.
· Impaled object: immobilize object and patch both eyes.
· Puncture wound: place rigid protective device over both eyes (e.g., eye 
shield).  Do not apply pressure.
· Foreign body: patch both eyes.
· If the patient cannot close their eyelids, keep their eye moist with a sterile 
saline dressing.
I
A/
E
PARAMEDIC STANDING ORDERS
P
MEDICAL CONTROL MAY ORDER
· Topical anesthetic: Tetracaine 1-2 eye drops as needed, if available.
· Use of Morgan lens for eye irrigation.
· Special consideration: Sudden painless loss of vision: If suspect central retinal 
artery occlusion in patient with acute non-traumatic, painless loss of vision in 
one eye (most common in elderly patient): apply vigorous pressure using heel of 
hand (massage) to affected eye for three(3) to five(5) seconds, then release.  
The patient may perform this procedure.  Repeat as necessary.  NOTE: Cardiac 
(EKG) monitor (12 lead ECG ) is required for this procedure (i.e., vagal stimulus: 
systoleou). CAUTION: If tetracaine has been administered, do not apply 
pressure to eye. 
· If chemical eye burn suspected in patients who wear contact lenses, contact 
medical control regarding removing contact lenses.
/
 SECURING IMPALED OBJECT IN AN EYE
1. Place a roll of gauze bandage or folded gauze 
pads on either side of the impaled object, along 
the vertical axis of the head.  These rolls or pads 
are placed so they stabilize the object.
2. Fit a paper or styrofoam cup or other protective 
cup/cone etc. over the impaled object.  The 
protective cup should not touch the impaled 
object and it must rest upon the rolls of gauze or 
gauze pads.
3. Secure the dressings and cup in place with self 
adherent roller bandage or wrapping of gauze.  
DO NOT secure bandage over the top of the 
cup.
4. Patch and bandage the uninjured eye to reduce 
eye movements.
CHEMICAL IRRITANTS: Eye(s) should be 
flushed as soon as possible using copious 
amounts of water for a period of fifteen (15) 
minutes with a controlled stream of Sterile 
Normal Saline, Sterile water or tap water.
BLUNT TRAUMA: Both eyes should be 
patched and protected.
PENETRATING TRAUMA: Puncture wound 
with no impaled object: Both eyes should be 
patched and protected.
NOTE: *If object is impaled in the eye, the 
object must be immobilized and both eyes 
should be patched and protected.  (Objects 
penetrating the eye globe should only be 
removed in-hospital.)
THERMAL BURNS: Both eyes should be 
patched and protected.
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Head Trauma & Injuries
Adult & Pediatric
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
4.4
EMT STANDING ORDERS
EMT-INTERMEDIATE / ADVANCED EMT STANDING ORDERS
· Routine Patient Care
· Ensure cervical spine stabilization and immobilization**
· Elevate head of patient to 20° - 30° unless contraindicated.
· Within your scope of practice, work to avoid hypoxia and hypotension. 
· Provide advanced airway management only if patient is not adequately 
oxygenating (defined as SpO2 maintained at > 95%) or ventilating and not 
corrected by BVM.  Maintain ETCO2 at 35-40 mmHg.
· When obtaining vascular access, avoid fluid overload, only give fluids to 
maintain SBP >100mmHg.
MEDICAL CONTROL MAY ORDER
· Further fluid boluses.
IA/
E
PARAMEDIC STANDING ORDERS
· In patients who require emergent intubation, and cannot be intubated by 
conventional means, see 5.2 Difficult Airway.P
**Note: Medical Director Option for Selective Spinal Assessment if trained and 
authorized, see 6.4 Selective Spinal Assessment.
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Multisystem Trauma
Adult & Pediatric
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
4.5
EMT STANDING ORDERS
EMT-INTERMEDIATE / ADVANCED EMT STANDING ORDERS
· Routine Patient Care
· Control/stop any identified life threatening hemorrhage (direct pressure, 
tourniquet, etc.), suspected pelvic fractures with commercial device (preferred) 
or bed sheet. 
IA/
E
PARAMEDIC STANDING ORDERS
· Additional fluid boluses.
P
MEDICAL CONTROL MAY ORDER
· In patients who require emergent intubation who cannot be intubated by 
conventional means – Consult 5.2 Difficult Airway.
· Initiate 1-2 large bore IV(s) Normal Saline (KVO) while en route to the hospital.     
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Musculoskeletal Injuries
Adult & Pediatric
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
4.6
EMT STANDING ORDERS
EMT-INTERMEDIATE / ADVANCED EMT STANDING ORDERS
· Routine Patient Care
· Manually stabilize the injury.
· Control bleeding and treat for shock (see shock protocol).
· Remove obvious debris, irrigate open wounds with saline solution, and cover with 
a dry sterile dressings.
· Assess CSMs distal to injury before and frequently after immobilization.
○ Splint extremity as required
○ Traction splinting is preferred technique for isolated adult and pediatric 
closed mid-shaft femur fractures (unless contraindicated by associated injury)
· Stabilize suspected pelvic fractures with commercial device (preferred) or bed 
sheet. 
· After thorough patient assessment, consider use of 2.13 Pain and Nausea 
Management.
IA/
E
PARAMEDIC STANDING ORDERS
· Additional fluid boluses.   
P
MEDICAL CONTROL MAY ORDER
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Soft Tissue / Crush Injuries
Adult & Pediatric
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
4.7
EMT/EMT-INTERMEDIATE/ADVANCED EMT STANDING ORDERS
· Routine Patient Care
· Control/stop any identified life threatening hemorrhage (direct pressure, 
tourniquet, etc.).
· Place dry sterile dressing on all open wounds and bandage as needed:
· If wound is grossly contaminated, irrigate with sterile water or normal 
saline.
· Stabilize all protruding foreign bodies (impaled objects) if noted.
· If severe crushing injury/compartment syndrome is suspected and  injury 
permits:
· Remove all restrictive dressings.
· Close monitoring of distal pulse, sensation, and motor function (CSM).
· Splint/immobilize injured areas as indicated. 
PARAMEDIC STANDING ORDERS
· Additional fluid boluses.
P
MEDICAL CONTROL MAY ORDER
· After patient assessment consider using 2.13 Pain and Nausea Management. 
Crush injury is associated with severe trauma and most commonly occurs in multiple casualty 
disasters, such as bombings, earthquakes, building collapse, train accidents and mining 
accidents.  It is the result of compression or pressure on various parts or all of the human 
body.  Crush injuries may result in fatal injury or severe metabolic abnormalities that may result 
in death.  Careful monitoring of these patients is essential.
Compartment syndrome is usually due to a crush injury and is a surgical emergency.  It 
occurs most commonly in the forearm, leg, gluteal region, thigh, and lumbar paraspinous 
muscles.  Compartment syndrome may result in ischemic swelling, muscle infarction, nerve 
injury and permanent loss of extremity function.
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Spinal Column/Cord Injuries
Adult & Pediatric
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
4.8
EMT STANDING ORDERS
· Routine Patient Care
· Control/stop any identified life-threatening hemorrhage (direct pressure, tourniquets) 
· Ensure cervical spine stabilization**.
· Determine presence or absence of significant neurologic signs and symptoms:  
decreased motor function, decreased sensory function, priapism, and loss of bladder/
bowel control. 
· Long backboards are NOT considered standard of care in most cases of potential 
spinal injury. Instead, use spinal motion restriction with a cervical collar and cot in most 
cases. Note that there are exceptions, such as a patient with a potential spinal injury 
who cannot be logrolled while being transported and may be at risk of a compromised 
airway. 
· Spinal Immobilization Procedure
1.  Establish manual c-spine stabilization in the position that the patient is found.
2.  Assess for correct size and properly apply a cervical collar.
3.  Move patient from the position found to the location of the ambulance stretcher utilizing a 
device such as a scoop stretcher, long spine board, or if necessary, by having the patient 
stand and pivot to the stretcher. DO NOT permit the patient to struggle to their feet from a 
supine position. 
4.  Position patient on the ambulance stretcher. 
5.  Remove scoop or logroll patient off long spine board or other device (if such device was 
utilized). 
6.  A blanket roll or blocks and tape attached to the stretcher may be used to minimize lateral 
movement of head during transport.
7.  Once on the ambulance stretcher, instruct patient to lie still.
8.  The head of the stretcher may be elevated 20-30 degrees in a position of comfort. 
9.  Secure cross stretcher straps and over-the-shoulder belts firmly.
10. Utilize a SLIDE BOARD at the destination to move the patient smoothly to the hospital 
stretcher.
11. Ensure appropriate documentation of procedure in patient care report 
E
EMT-INTERMEDIATE / ADVANCED EMT STANDING ORDERS
· Provide advanced airway management only if patient is not adequately oxygenating or 
ventilating and not corrected by BVM.  
· Additional fluid boluses
· NOTE: Bradydysrhythmias are commonly seen in high level spinal injuries.
· Consider 12 lead ECG
PARAMEDIC STANDING ORDERS
P
MEDICAL CONTROL MAY ORDER
MEDICAL CONTROL MAY ORDER
· For suspected neurogenic shock (without hypovolemia):
· Norepinephrine infusion: 0.1mcg/kg/min IV/IO, titrate to goal Systolic Blood 
Pressure of 90mmHg, OR
· Dopamine 2-20 mcg/kg/min IV/IO
IA/
**Note: Service Medical Director Option for Selective Spinal Assessment if 
trained and authorized, see 6.4 Selective Spinal Assessment.
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Thoracic Trauma
Adult & Pediatric
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
4.9
EMT STANDING ORDERS
EMT-INTERMEDIATE / ADVANCED EMT STANDING ORDERS
· Routine Patient Care
· Provide appropriate management for identified thoracic injuries:
OPEN PNEUMOTHORAX:
• immediately apply an occlusive dressing sealing 3 sides.
• monitor patient closely for evidence of tension pneumothorax.
TENSION PNEUMOTHORAX: (Respiratory distress or apnea, Difficult to 
ventilate with bag, distended neck veins, unilateral decreased or absent 
breath sounds, tracheal deviation away from the side without breath 
sounds.)
• if present following closure of open pneumothorax, release occlusive 
dressing temporarily.
FLAIL CHEST: (paradoxical movement of portion of chest wall)
• position patient with injured side down, unless contraindicated.
• provide manual stabilization of the flail segment
NOTE: Assisted positive pressure ventilations using a BVM device 
may be indicated and may also serve as an “internal splinting” of the 
flail segment due to lung expansion.
· Control/stop any identified life threatening hemorrhage (direct pressure, 
tourniquets, etc.).
· Impaled Objects:
- Secure in place with a bulky dressing.
· Open chest wound: 
- Cover with an occlusive dressing, sealed on 3 sides, or use a commercial 
device; if the patient’s condition deteriorates, remove the dressing 
momentarily, then reapply.
· Flail segment with paradoxical movement and in respiratory distress:
- Consider positive-pressure ventilation.
- Do not splint the chest. 
I
A
/
E
· Provide advanced airway management only if patient is not adequately 
oxygenating or ventilating and not corrected by BVM. 
PARAMEDIC STANDING ORDERS
P
· Needle chest decompression if indicated (2nd intercostal space, midclavicular 
line with at least 3.25 inch, 14g angiocath)
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Traumatic Amputations
Adult & Pediatric
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
4.10
EMT STANDING ORDERS
EMT-INTERMEDIATE / ADVANCED EMT / PARAMEDIC STANDING ORDERS
· Routine Patient Care
· Control/stop any identified life-threatening hemorrhage (direct pressure, 
tourniquets) 
IA/
E
P
MEDICAL CONTROL MAY ORDER
· Additional Fluid Boluses
· Provide advanced airway management only if patient is not adequately 
oxygenating or ventilating and not corrected by BVM. 
/
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Traumatic Cardiac Arrest 
Adult & Pediatric         
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
4.11
EMT STANDING ORDERS
EMT-INTERMEDIATE / ADVANCED EMT STANDING ORDERS
· Routine Patient Care
· If direct pressure and other methods cannot stop bleeding, apply an 
appropriate tourniquet.  Document the exact time of tourniquet application and 
notify receiving hospital staff.
· Provide appropriate management for identified injuries:
· 4.4 Head Trauma/Injuries
· 4.9 Thoracic Injuries
· Treat according to appropriate Cardiac Arrest Protocol
IA/
E
PARAMEDIC STANDING ORDERS
· Additional fluid boluses.   
P
MEDICAL CONTROL MAY ORDER
· For medication facilitated intubation, see 5.2 Difficult Airway Protocol 
· Needle Decompression, if indicated
· Provide advanced airway management only if patient is not adequately 
oxygenating or ventilating and not corrected by BVM. 
· Obtain 1-2 points of vascular access (IV, IO) while en route to the hospital
This page intentionally left blank
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EMT-INTERMEDIATE STANDING ORDERS
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Statewide Treatment Protocols version 2015.1
Upper Airway Obstruction-
Adult5.1A
I
EMT STANDING ORDERS
· Routine Patient Care
· If the obstruction due to a foreign body is complete or is partial with inadequate 
air exchange: follow ECC guidelines for foreign body obstruction. Maintain an 
open airway, remove secretions, vomitus and assist ventilations as needed. 
· If partial obstruction due to foreign body is suspected and there is adequate air 
exchange: transport to appropriate medical facility. Do not attempt to remove 
foreign body in the field. 
ADVANCED EMT STANDING ORDERS
· Provide advanced airway management if indicated for mechanical 
obstruction: If unable to remove obstructing foreign body, continue BLS 
airway management by providing positive pressure ventilations if needed. 
· Perform direct laryngoscopy if foreign body suspected. If foreign body is 
visible and easily accessible, attempt removal with Magill Forceps. 
A
E
P
PARAMEDIC STANDING ORDERS
· If foreign body is removed, proceed with endotracheal intubation if 
necessary and perform capnography.
· If unable to clear airway obstruction, unable to intubate as needed or 
unable to perform positive pressure ventilations, perform a needle 
cricothyrotomy, if permitted under 6.3 Needle Cricothyrotomy.
· Consult Medical Control for removal of tracheostomy tube 
MEDICAL CONTROL MAY ORDER
· Emergent removal of tracheostomy tube, if present, and evidence of obstruction 
resulting in inadequate air exchange. See 5.3 Tracheostomy Tube Obstruction 
Management for more information.
2013
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Statewide Treatment Protocols version 2015.1
Upper Airway Obstruction-
Pediatric 5.1P
I
EMT STANDING ORDERS
· Routine Patient Care
See 5.3 Tracheostomy Tube Obstruction Management, if applicable
ADVANCED EMT STANDING ORDERS
· Determine presence of upper airway obstruction (stridor):
· If the obstruction due to a foreign body is complete or partial with 
inadequate air exchange:  Follow ECC guidelines for foreign body 
obstruction. Maintain an open airway, remove secretions, vomitus and assist 
ventilations as needed. 
· If partial obstruction due to a foreign body is suspected and the child has 
adequate air exchange: transport to appropriate medical facility. Do not 
attempt to remove foreign body in the field.
· If suspected croup (barking cough, no drooling) or epiglottitis (stridor, 
drooling), maintain an open airway, place child in position of comfort and 
avoid upper airway stimulation. 
A
E
P
PARAMEDIC STANDING ORDERS
· Nebulized Racemic Epinephrine 11.25 mg in 2.5ml normal saline, for 
suspected severe croup, with stridor at rest and respiratory distress.
MEDICAL CONTROL MAY ORDER
· Emergent removal of tracheostomy tube, if present, and evidence of obstruction 
resulting in inadequate air exchange. See 5.3 Tracheostomy Tube Obstruction 
Management for more information.
EMT-INTERMEDIATE STANDING ORDERS
· Provide advanced airway management if indicated for mechanical obstruction: 
perform direct laryngoscopy if foreign body is suspected. If foreign body is visible 
and readily accessible, attempt removal with Magill forceps. If unable to remove 
obstructing foreign body, continue BLS airway management by providing positive 
pressure ventilations. 
· If foreign body is removed, proceed with endotracheal intubation if necessary and 
perform capnography. 
EMT-INTERMEDIATE STANDING ORDERS
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Difficult Airway - Adult
The Difficult Airway protocol is to be used only after conventional attempts at airway 
management have failed and the patient cannot be ventilated by ordinary means such as with 
the insertion of an oral or nasal pharyngeal airway and bag-valve mask ventilation or by 
insertion of a supraglottic airway device. The trip record documentation must include all 
attempts at airway management including failed attempts in order to illustrate the need for the 
use of this protocol. Midazolam is the recommended drug for facilitating intubation and the 
use of any other sedation such as Fentanyl can only be done with medical control direction 
and consult.   
In all cases adjustments to technique are to be made based on training and equipment (i.e. mask 
size/seal, positioning, suction, and use of adjuncts) It is necessary to correct all manageable causes 
of inadequate ventilation prior to utilizing this protocol. When confronted with an airway that is 
unstable and conventional intubation is determined to be unlikely (Mallampati IV), EMTs are to use 
alternative equipment such as supraglottic airway devices, in accordance with your certification and 
training.
An Unstable Airway situation can be defined as unable to clear a foreign body airway 
obstruction, OR airway grading** (Figure 1 & 2) suggests intubation unlikely, OR 
unsuccessful intubation after no more than a total of 3 attempts.
Assessment/Treatment Priorities:
· Routine Patient Care
· Maintain Grading of the patient’s airway (see below for figure 1 and 2)
· Continue Bag-Valve-Mask (BVM) management with supplemental oxygen with oropharyngeal or 
nasopharyngeal adjuncts, (OPA or NPA) in place.
· Initiate transport as soon as possible
· Follow AHA & ARC guideline for management of the adult FBAO.
5.2
o After completing your assessment as listed above:
o Provide Rescue Airway Management.
o If BVM failure is the result of a manageable cause.
o Apply countermeasures if applicable
o If the patient can be ventilated, but the airway is unstable insert the 
supraglottic device
I
PARAMEDIC STANDING ORDERS
P
a. If the airway is unstable and the adult patient can be ventilated.
I. In patients who require emergent intubation
II. Cannot be intubated by conventional means
To facilitate intubation: 
a. Midazolam 2 mg SLOW IV/IO/IM/IN. Repeat as necessary to total of 6 mg.
b. If intubation is unsuccessful, Insert the supraglottic device
c. If the airway is unstable and the patient cannot be ventilated perform a 
needle cricothyrotomy and provide oxygen via jet ventilation.
Figure 1 depicts the Cormack & LeHane laryngoscopy classifications. 
Figure 2 depicts the Mallampati system of airway grading, generally 
performed with patient sitting in full fowlers position with tongue 
extended.
Fig 2
Fig 1
Tracheostomy Tube Obstruction 
Management Adult & Pediatric
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
EMT/EMT-INTERMEDIATE/ADVANCED EMT/PARAMEDIC STANDING ORDERS
In the patient with an obstructed tracheostomy tube, in whom no effective 
ventilation/oxygenation is possible, the following are to be considered Standing 
Orders:
· Wipe neck opening with gauze
· Attempt to suction tracheostomy tube
· Remove tracheostomy tube if necessary
· Once airway is open, begin ventilations as necessary/possible
· EMT-Intermediates and Paramedics may attempt intubation of the patient if no 
other means of ventilating/oxygenating the patient are possible
/
A
E
/
/
I
P
MEDICAL CONTROL MAY ORDER
· Clearing of the tube and re-insertion, for those whose tracheostomy tube is 
noted to be plugged.
· In patients able to be oxygenated and ventilated by the above criteria, 
· Wipe neck opening with gauze
· Attempt to suction tracheostomy tube
· Remove tracheostomy tube as necessary
· Once airway is open, begin ventilations as possible/necessary
· Paramedics or EMT-Intermediates may attempt to intubate the patient 
Signs of inadequate oxygenation/ventilation are:
· Falling pulse oximetry
· Change in patient’s color
· Change in patient’s vital signs
· Inability to deliver oxygenation by all other means
5.3
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Medical Director Options
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
6.0
The following conditions must be met in order for your service to provide any of the 
following optional treatments as listed in this section:
1. Your service has a written policy adopting use of the procedure, in accordance with 
the terms of this Protocol section, and such policy is signed by the service’s affiliate 
hospital medical director.
2. Your service’s affiliate hospital medical director must have authorized you as an 
EMT to utilize the procedures in this section, based on your level of certification.
3. You must be trained to use the procedure, in accordance with the minimum 
standard training component as outlined by DPH/OEMS, and as approved by the affiliate 
hospital medical director.
BLS: a.   Albuterol Administration via Nebulizer (Service Option), 
  see advisory of 4/9/10, at OEMS website and 6.1 BLS/ILS Albuterol.
b.  Glucometry, see AR 5-520, at OEMS website.
c.  Selective Spinal Assessment (Service Option), replacing cervical spinal 
assessment/precaution procedures of 4.8 Spinal Column/Cord Injuries
d.   Cardiocerebral Resuscitation/High-performance CPR, see 6.2
ALS: a.   Needle Cricothyrotomy, see 6.3.
b.  Selective Spinal Assessment (Service Option), replacing cervical spinal 
assessment/precaution procedures of 4.8 Spinal Column/Cord Injuries
c.  Cardiocerebral Resuscitation/High-performance CPR, see 6.2.
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BLS/ILS Assisted Albuterol
Adult & Pediatric
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
6.1
EMT/EMT-INTERMEDIATE STANDING ORDERS
E
I/
· If trained and authorized by your medical director, treat bronchospasm in known 
Asthmatics, and confirmed Reactive Airway Disease (Asthma/COPD), in 
accordance with the flowchart below, with:
· For a patient between 6 months and 2 years of age,
· Albuterol 1.25mg in 3ml Normal Saline, via nebulizer, x1 dose
· For a patient older than 2 years of age,
· Albuterol 2.5-3mg in 3ml Normal Saline, via nebulizer, x1 dose
· ALS intercept must be arranged for and confirmed whenever possible and 
available.
Does the patient have a diagnosis of 
reactive airways disease (e.g. asthma/
COPD)?
Patient NOT eligible. Treat 
per protocol.Is the patient older than six months?
Does the patient have a known history of 
cardiac disease (past MI or angina)
Does the patient have a current prescription 
for an inhaler or nebulizer to be used when 
they are having an attack? 
Eligible Medications:
· albuterol sulfate (Airet, Proventil, 
Ventolin)
· bitolterol mesylate (Tornalate)
· isoetharine (Bronkometer, Bronkosol)
· isoproterenol hydrochloride (Isuprel)
· metaproterenol sulfate (Alupent, 
Metaprel)
· pirbuterol acetate (Maxair)
· other beta agonists
Ask the patient or caregiver, “Would you like 
us to ASSIST (you) in taking the same type of 
medication that (you) take when (you) have 
an attack?”
NO
Y
E
S
Y
E
S
YES
N
O
Y
E
S
NO
ASSISTED ALBUTEROL FLOWCHART:
NO
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Cardio-Cerebral Resuscitation
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
6.2
Policy Continues
Purpose: To improve the overall survival rate of sudden out-of-hospital cardiac arrest 
patients.
Indication: Patients in Cardiac Arrest who have reached their 18th birthday
Contraindications: 
1. Patients meeting criteria for cessation of resuscitation.
2. Patients that have not reached their 18th birthday.
Procedure for CCR/HPCPR:
The first provider at the patient’s side with assess and initiate compressions.
1. Effective Compressions - Manual chest compressions should be initiated immediately 
upon identification of cardiac arrest, as long as the scene is safe. When compressions are done 
manually, compressors should ideally be rotated every 2 minutes in order to maintain high-
quality compressions. Ideally, one compressor is on each side of the patient’s chest; one person 
compressing the chest and the other person ready to start. Chest compressions will be 
performed at a depth of at least two inches allowing for complete recoil of the chest after each 
compression. Compressions should be accomplished with equal time given for the down and up 
motion, and achieve a rate of 100-120/min. Use of a metronome to ensure accuracy in rate is 
advised.
2. Continuous Compressions - Chest compressions will be performed at a rate of 100 to 120 
per minute and will NOT be interrupted during the two minute cycle for any reason.  Other 
treatments IV  or IO access attempts will be done while compressions are ongoing.  After 
completion of a two minute cycle, a phase to assess pulses and/or defibrillate will be limited to < 
10 seconds.  
3. Defibrillation – placement of the defibrillator pads will not interrupt chest compressions
      Automatic External Defibrillation
The AED will be powered on as soon as the cardiac arrest is confirmed. Do not interrupt chest 
compressions to remove clothing or place defibrillation pads. If the AED charges after analyzing, 
chest compressions will be performed while the device charges, then the patient will be “cleared” 
and defibrillated. Compressors will hover over the patient with hands ready during defibrillation 
so compressions can start immediately after a shock. Another two minute cycle of compressions 
will be immediately performed. Pulse checks will not occur after a shock, but only after the AED 
prompts “no shock advised”. If no pulse is palpated, or if unsure, immediately perform another 
two minutes of CPR.
Cardiac Monitor/Defibrillator 
When a manual defibrillator is in use, it will be charged to the appropriate energy level as the end 
of the compression cycle nears (approximately 1 minute and 45 seconds into a 2-minute cycle). 
At the end of the 2 minute cycle, the patient will be cleared, the rhythm will then be interpreted 
rapidly and the patient will either be defibrillated or the defibrillator energy charge will be 
cancelled. This sequence must be performed within 10 seconds. During this sequence, the 
compressors will hover over the patient with hands ready. If a shock is delivered, the compressor 
will immediately resume CPR. Rhythm interpretation will not occur after a shock, but only after 
the 2 minute cycle of CPR is performed. If a shock is not indicated, check for a pulse. If patient 
remains pulseless, immediately resume CPR.
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Cardio-Cerebral Resuscitation
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
6.2
CCR/HPCPR, Continued
1. Ventilations 
Ventilations will not be performed until four cycles of chest compressions have been performed [8 
minutes of hands only CPR]. Upon the arrival of EMS the first medic will initiate chest 
compressions as noted above, the second medic will place an oral airway and will provide high-
flow oxygen via a face mask or nasal cannula. At the end of four cycles  [8 minutes] ventilations will 
commence. One ventilation will be given every 10th compression during recoil (upstroke). Once an 
advanced airway is in place, ventilations will be asynchronous with compressions (1 ventilation 
every 6 to 8 seconds). High performance, continuous compressions remain the priority. Once 
ventilations have begun, ensure ventilations are adequate using BVM attached to high-flow 
oxygen.  Providers will not interrupt compressions to obtain an advanced airway. 
Once the 8 minutes of CCR are completed-if an advanced airway has been established continue 
chest compressions and provide 1 ventilation every 6-8 seconds.
If an advanced airway has not been established continue resuscitation using High Performance 
CPR with continuous compressions at a rate of 30 compressions to 2  ventilations (30:2).
2. Advanced Life Support
ALS providers will address defibrillation, IV/IO access, medication administration, and advanced 
airway placement, as indicated with in these protocols, however the placement of an advanced 
airway will no longer  be attempted in the first 8 minutes after the arrival of EMS If an advanced 
airway is placed after the first 8 minutes , it will not interrupt chest compressions.
Nasal capnography may be utilized to optimize CPR performance and evaluation of ROSC with 
use of bag value mask ventilation.
3.Return of Spontaneous Circulation (ROSC)
Implement the hypothermic resuscitation protocol as indicated and transport.  Following 
stabilization, post-ROSC, obtain a 12 lead ECG.
All services using this procedure must have a written policy indicating that they are doing so, 
approved by their affiliate hospital medical director.
Policy Continued
2013
2013
ALS:           Needle Cricothyrotomy (Approved for Paramedics Only)
The following is a general description of one of several accepted techniques being used 
throughout the Commonwealth, and may be used as a guideline. Due to differences in medical 
devices used by individual systems, the procedure may vary slightly. Refer to your local and 
regional guidelines for the technique and equipment used in your system.
Note: Appropriate body substance isolation precautions are required whenever caring for the 
trauma patient.
Indications: The indications for performing a needle Cricothyrotomy on a patient will be:
1. The patient is in imminent danger of death.
2. No alternative airway device/maneuver has been successful.
3. The patient cannot be oxygenated or ventilated by any other means
The local EMS Medical Director has appropriately trained and authorized the treating EMT-
Paramedics. 
Examples of types of patients potentially meeting the above criteria include (but are not limited to):
1. Patients suffering traumatic arrest
2. Patients suffering multiple traumatic injuries
3. Patients suffering an upper airway obstruction
Recognizing the time critical nature of the emergency, Needle Cricothyrotomy will be a Standing 
Order for patients/systems/paramedics meeting all of the above criteria.
1.  Assemble and prepare oxygen tubing by cutting a hole toward one end of the tubing.  
Connect the other end of the oxygen tubing to an oxygen source, capable of delivering 50 
psi or greater at the nipple, and assure free flow of oxygen through the tubing.
2.  Place the patient in a sitting position.
3.  Assemble a #12 or 14-gauge, 8.5 cm, over-the-needle catheter to a 6- to 12-mL syringe.
4.  Clean the neck with an aseptic technique, using antiseptic swabs.
5.  Palpate the cricothyroid membrane, anteriorly, between the thyroid cartilage and cricoid 
cartilage.  Stabilize the trachea with the thumb and forefinger of one hand to prevent 
lateral movement of the trachea during the procedure.
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Needle Cricothyrotomy
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
6.3
Policy Continues
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Needle Cricothyrotomy
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
6.3
6.  Puncture the skin midline with the needle attached to a syringe, directly over the 
cricothyroid membrane (i.e., mid-saggital).  
7.  Direct the needle at a 45 degree angle caudally, while applying negative pressure to the 
syringe.
8.  Carefully insert the needle through the lower half of the cricothyroid membrane, aspirating 
as the needle is advanced.
9.  Aspiration of air signifies entry into the tracheal lumen,
10. Remove the syringe and withdraw the stylet while gently advancing the catheter 
downward into position, being careful not to perforate the posterior wall of the trachea,
11. Attach the oxygen tubing over the catheter needle hub (you may use a 4.0 ET tube 
connector), and secure the catheter to the patient's neck.
12. Intermittent ventilation can be achieved by occluding the open hole cut into the oxygen 
tubing with your thumb for one second and releasing it for four seconds.  After releasing 
your thumb from the hole in the tubing, passive exhalation occurs.  Note: Adequate PaO2, 
can be maintained for only 30 to 45 minutes.
13. Continue to observe lung inflations and auscultate the chest for adequate ventilation.
Complications of Needle Cricothyrotomy
1. Asphyxia
2. Aspiration
3. Cellulitis
4. Esophageal perforation
5. Exsanguinating hematoma
6. Hematoma
7. Posterior tracheal wall perforation
8. Subcutaneous and/or mediastinal emphysema
9. Thyroid perforation
10. Inadequate ventilations leading to hypoxia and death
Policy Continued
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Selective Spinal Assessment
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
6.4
Policy Continues
ALS and BLS:           Selective Spinal Assessment
This procedure, if used, should be in conjunction with Protocol 4.8 Spinal Column/Cord 
Injuries and/or A3 Interfacility Transfer Protocols.
SELECTIVE SPINAL ASSESSMENT   
Spinal cord injury may be the result of direct blunt and/or penetrating trauma, compression 
forces (axial loading), abnormal motion (hyper-flexion, hyperextension, hyper-rotation, lateral 
bending and distraction, i.e., hanging).  Most spinal injuries result from motor vehicle crashes, falls, 
firearms, and recreational activities. 
Spinal injuries may be classified into sprains, strains, fractures, dislocations and/or actual 
cord injuries.  Spinal cord injuries are classified as complete or incomplete and may be the result of 
pressure, contusion or laceration of the cord.   
Individuals should be assessed and treated for possible spinal injury, and immobilized if 
necessary, if they have sustained an injury with a concerning mechanism, and either have 
symptoms of injury and/or have a reason not to adequately perceive or to be able to communicate 
the symptoms of such injury.
Long backboards are NOT considered standard of care in most cases of potential spinal 
injury. Instead, use spinal motion restriction with a cervical collar and cot in most cases. Note that 
there are exceptions, such as a patient with a potential spinal injury who cannot be logrolled while 
being transported and may be at risk of a compromised airway. 
Concerning mechanisms that may result in spinal column injury: 
· Fall from over 3 feet, including adult fall from standing, or 5+ stair steps 
· MVC at 30+ mph, or rollover or ejection 
· Motorcycle, bicycle, other mobile conveyance, or pedestrian-vehicle accident 
· Diving or axial load 
· Electric shock
Symptoms of spinal column injury may include:  
· Posterior neck or back pain or tenderness;
· Paresthesias or loss of sensation in extremities; 
· Weakness or paralysis of extremities;  
Conditions placing individuals at risk to not perceive or complain of the symptoms of spinal 
column injuries:
· Altered mental status due to disease, injury, intoxication, or other causes; 
· Inability to adequately communicate;
· History of cervical spine injury or abnormality, or conditions causing fragile bones;  
· Distracting injury (such as long-bone fracture); 
· Age extremes (including >65 years of age);  
Individuals sustaining lesser injuries, patients who do not have  symptoms of spinal column injury 
and do not experience a condition that would impair the patient’s ability to perceive or communicate 
symptoms of spinal column injuries do not require spinal immobilization 
Penetrating injuries to the neck generally do not require spinal immobilization.
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Selective Spinal Assessment
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
6.4
ASSESSMENT / TREATMENT PRIORITIES 
1. Ensure scene safety, appropriate universal precautions, request additional EMS resources 
(BLS or ALS), perform thorough primary survey, treat any life threatening injuries immediately, 
appropriate oxygen and IV therapy
MEDICAL CONTROL OPTIONS
a. ADVANCED EMT, EMT-INTERMEDIATE AND PARAMEDIC: Additional Normal Saline 
250 mL - 500 mL bolus(es), wide open or titrated to patient's hemodynamic status. 
b. PARAMEDIC: For suspected neurogenic shock (without hypovolemia): Norepinephrine 
infusion: 0.1mcg/kg/min IV/IO via pump, titrate to goal Systolic Blood Pressure of 90mmHg, 
OR Dopamine 2-20mcg/kg/min IV/IO.
If patient is assessed as stable and there is a suspicion of possible c-spine injury begin assessment 
and history to determine if the patient needs to be placed in a collar and undergo spinal motion 
restriction. Mechanism of Injury should be used as a historical component of the assessment and 
lead to further spine assessment (i.e. Axial loading (diving), blunt trauma, motor vehicle crash 
(MVC)*, fall >3ft, adult fall from standing height. 
*MVC applies to crashes of all motorized vehicles: e.g. automobile, motorcycle, snowmobile, etc.)
SPINAL IMMOBILIZATION PROCESS
1. Establish manual c-spine stabilization in the position that the patient is found.
2. Assess for correct size and properly apply a cervical collar.
3. Move patient from the position found to the location of the ambulance stretcher utilizing a 
device such as a scoop stretcher, long spine board, or if necessary, by having the patient 
stand and pivot to the stretcher. 
DO NOT permit the patient to struggle to their feet from a supine position. 
4. Position patient on the ambulance stretcher. 
5. Remove scoop or logroll patient off long spine board or other device (if such device was 
utilized).  
6. A blanket roll or blocks and tape attached to the stretcher may be used to minimize lateral 
movement of head during transport.
7. Once on the ambulance stretcher, instruct patient to lie still.
8. The head of the stretcher may be elevated 20-30 degrees in a position of comfort.  
9. Secure cross stretcher straps and over-the-shoulder belts firmly.
10. Utilize a SLIDE BOARD at the destination to move the patient smoothly to the hospital 
stretcher.
11. Ensure appropriate documentation of procedure in patient care report.
Policy Continued
If it is determined through a complete assessment that the patient is 1) Reliable 
(including ability to communicate adequately) 2) Has no distracting injuries 3) Has 
no abnormal sensory/motor deficits 4) Has no spine pain/tenderness – DO NOT 
IMMOBILIZE
Policy Continues
Spine Assessment Protocol
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Selective Spinal Assessment
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
6.4
Selective Spinal Assessment, Continued
Policy Continued
Mechanism of Injury: Axial Load, Blunt Trauma, MVC* or 
bicycle, fall >3ft, adult fall from standing height
Patient 
Unreliable?
IMMOBILIZEYES
Distracting 
Injury? 
NO
YES
Abnormal Sensory 
Exam/Motor Exam? 
NO
YES
Spine Pain/
Tenderness?
NO
YES
Don’t 
Immobilize
NO
Patient Reliability
Is the patient intoxicated, have an altered 
mental status, is having an acute stress 
reaction, at the extremes of age or any other 
reason that results in an inability to either 
adequately perceive or communicate 
symptoms, etc. – If the patient is unreliable 
based on the assessment  - Immobilize 
(See Spinal Assessment Protocol)
Distracting Injury?
Distracting injuries include any injury that 
produces clinically apparent pain that might 
distract the patient from the pain of a spine 
injury – pain would include medical as well as 
traumatic etiologies of pain – If, based on the 
assessment, the patient has distracting 
injuries - Immobilize (See Spinal 
Assessment Protocol)  
Abnormal Sensory/Motor Exam?
If, based on the assessment, the patient has 
any abnormal neurological findings (including, 
but not limited to, paresthesias or loss of 
sensation in extremities, weakness or paralysis 
of extremities, loss of urethral or sphincter 
control, etc.) –Immobilize (See Spine 
Assessment Protocol)
Complaints of Pain or Examination 
Tenderness?
Complete an assessment of the patient’s spine 
for pain or tenderness. The assessment should 
include, but is not limited to, palpation of the 
entire spine (posterior, midline spine, and 
cervical spine), range of motion (if appropriate). 
– If, based on the assessment, the patient is 
experiencing any pain or tenderness along 
the spine - Immobilize (See Spinal 
Assessment Protocol)
Age 65 or 
older?
NO YES
CAUTION: This protocol cannot be used to rule out need for immobilization in any 
patient age 65 or older.
SECTION 7:
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Introduction: 
The use of air medical services has become the standard of care for many critically ill or injured patients 
who require transport to specialized medical facilities such as Trauma Centers. 
The purpose of these Guidelines is to establish a clinical framework for prehospital EMS personnel upon 
which to make decisions regarding when to access air medical support services. The following constitute 
the philosophical foundation for these Guidelines. 
o EMS personnel should consider requesting ground advanced life support (ALS) and air 
medical support when operational conditions listed below exist and the following patient 
conditions are present; 
o Patients with an uncontrolled or compromised airway should be brought to the nearest 
appropriate facility unless advanced life support (ALS) service (by ground or air) can 
intercept in a more timely fashion; and: 
o Patients in cardiac arrest subsequent to blunt trauma should be taken to the nearest facility. 
These guidelines have been established so that air medical support does not require prior Medical 
Control approval. However, Medical Control contact should be considered whenever appropriate for 
patient management issues. 
Operational Conditions: 
1. When a patient meets patient criteria defined below and scene arrival time to estimated arrival time at 
the nearest appropriate hospital, including extrication time, exceeds 20 minutes: 
2. Patient location, weather or road conditions preclude the use of standard ground ambulance; or 
3. Multiple casualties / patients are present which will exceed the capabilities of local hospital and 
agencies. 
Patient Conditions 
1. Physiologic Criteria: 
a. Unstable Vital Signs 
2. Anatomic Injury: 
a. Evidence of Spinal Cord injury including paralysis or paresthesia. 
b. Severe Blunt Trauma: 
· Head injury (Glasgow Coma Scale of twelve [12] or less) 
· Severe chest or abdominal injury
· Severe pelvic injury excluding simple hip fractures. 
c. Burns: 
· Greater than 20% Body Surface Area (BSA) second or third degree burns;
· Evidence of airway or facial burns; 
· Circumferential extremity burns; or 
· Burns associated with trauma. 
d. Penetrating injuries of head, neck, chest, abdomen or groin. 
e. Amputation of extremities, excluding digits. 
Special Conditions: The following should be considered in deciding whether to request 
air medical transport, but are not automatic or absolute criteria: 
1. Mechanism of Injury 
a. Motor Vehicle Crash: 
· Patient ejected from vehicle. 
· Death in same passenger compartment. 
b. Pedestrian struck by a vehicle and thrown more than 15 feet, or run over by a vehicle. 
2. Significant Medical History 
a. Age greater than 55. 
b. Significant coexistent illness (such as anticoagulation). 
c. Pregnancy. 
2013
Air Medical Transport
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
7.1
EMT / EMT-INTERMEDIATE / ADVANCED EMT / PARAMEDIC STANDING ORDERS
2013
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Electronic Control Weapons 
2013
In some situations, state and local law enforcement utilize devices known as electronic control 
weapons (ECW), such as a  TASER®, to assist with controlling persons.  When used, the device 
discharges a wire that, at the distal end, contains an arrow-like barbed projectile that penetrates the 
suspect’s skin and embeds itself, allowing the officer to administer an incapacitating electric shock. 
Current medical literature does not support routine medical evaluation for an individual after an 
ECW application.  In most circumstances, probes can be removed by law enforcement 
without further medical intervention. 
7.2
EMS should be activated following ECW application in the following circumstances:
· The probe is embedded in the eye, genitals, or bone.
· Seizure is witnessed after ECW application.
· There is excessive bleeding from probe site after probe removal.
· Cardiac arrest, complaints of chest pain, palpitations.
· Respiratory distress.
· Change in mental status after application.
· Pregnancy.
Removal must be done by law enforcement unless lodged in a vulnerable area
CONTRAINDICATIONS TO REMOVAL
· Patients with probe penetration in vulnerable areas of the body as mentioned 
below should be transported for further evaluation and probe removal.
· Genitalia, female breast, or skin above level of clavicles.
· Suspicion that probe might be embedded in bone, blood vessel, or other sensitive 
structure.
1. Routine Patient Care
2. Ensure wires are disconnected from weapon.
3. Secure probe with padded dressing
4. Transport to Emergency Department
/
A
E
/
/
I
P
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
2013
Medical Orders for Life Sustaining Treatment (MOLST) and
Comfort Care/Do Not Resuscitate (DNR) Order Verification
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Massachusetts Department of Public Health Office of Emergency Medical Services
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Policy Continues
Introduction
EMS personnel at all levels are required to provide emergency care and transport patients to 
appropriate health care facilities. EMS personnel are further required to provide treatment to the 
fullest extent possible, subject to their level of certification and the level of licensure of the 
ambulance service for which they are working. However, more and more patients, where it is 
medically appropriate, are opting for limitations on life-sustaining treatments, such as 
cardiopulmonary resuscitation (CPR), in the event of cardiac arrest. Thus, EMS personnel may 
encounter a patient who has chosen such options and has either a Massachusetts Medical Orders 
for Life Sustaining Treatments (MOLST) or the Comfort Care/DNR Order Verification Form or 
bracelet (CC/DNR). These documents provide for a statewide, standardized form, approved by 
the Massachusetts Department of Public Health (DPH), Office of Emergency Medical Services 
(OEMS), that EMS personnel can instantly recognize as an actionable order (MOLST) or 
verification of such an order (CC/DNR) regarding the use of life sustaining treatments. This 
protocol governs EMS personnel response to a patient with a MOLST or CC/DNR form.
Implementation Procedures
1.  Confirm the identity of the individual with the MOLST or CC/DNR Order Verification Form or 
bracelet;
2.  Check validity: 
a. CC/DNR: To assure that a DNR order is recognized in any out-of-hospital setting, an 
attending physician, nurse practitioner, or authorized physician assistant, who is licensed in 
Massachusetts, must provide a patient who has a current DNR order, with a fully executed 
CC/DNR Order Verification form to verify the existence of a DNR order. To be valid, the CC/
DNR Order Verification Form shall contain:
i. the patient’s name, and all other patient identifiers requested on the form; 
ii. date of issuance;
iii. the signature and telephone number of an attending physician, nurse practitioner, or 
authorized physician assistant; 
iv. the signature and printed name of the patient, guardian or health care agent signing the 
form, and:
v. a date of expiration, if any, of the underlying DNR order. If there is a date of expiration, 
and that date has passed, the CC/DNR is not valid.
b. MOLST: a. Alternatively, to assure a patient with a desire to document decisions 
regarding DNR and/or other life-sustaining treatments (LST, which includes CPR, intubation 
with ventilation, and non-invasive ventilation, such as continuous positive airway pressure, or 
CPAP) has those preferences honored, a Massachusetts-licensed attending physician, nurse 
practitioner or authorized physician assistant can provide a patient with a MOLST form. The 
MOLST form represents actual medical orders to EMS personnel related to a patient’s 
preferences for resuscitation, ventilation and hospitalization. To be valid, the  MOLST form 
must contain:
i. patient name and appropriate identifiers as requested on the form,
ii. box D and E of the MOLST form must be fully completed for page 1 to be considered 
valid – which is all that is relevant for EMS personnel. A MOLST order that has an 
expiration date or revocation date that is in the past is not valid.
c. Revocation: A MOLST order for DNR or CC/DNR form may state it has been revoked. If that 
is the case, the order or form is not valid.
7.3
Medical Orders for Life Sustaining Treatment (MOLST) and
Comfort Care/Do Not Resuscitate (DNR) Order Verification
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
3.  Action of EMS if no valid CC/DNR or no valid MOLST that includes a DNR order: In accordance 
with standard EMS Statewide Treatment Protocols, EMS personnel will resuscitate patients 
without a valid CC/DNR Order Verification Form or without a MOLST that has documented a 
DNR order, as well as a patient who has a MOLST form indicating a preference FOR 
resuscitation. Remember, if there is any doubt about the current validity of a MOLST or CC/
DNR Order Verification form, EMS personnel are to resuscitate and provide care in accordance 
with the Statewide Treatment Protocols.
4.  Patient Care for confirmed valid CC/DNR or MOLST with orders for DNR:
a. If the patient is in full respiratory or cardiac arrest, the EMS personnel shall not 
resuscitate, which means: 
i. do not initiate CPR, 
ii. do not insert an oropharyngeal airway (OPA), 
iii. do not provide ventilatory assistance, 
iv. do not artificially ventilate the patient (e.g. mouth-to-mouth, bag valve mask) 
v. do not administer chest compressions, 
vi. do not initiate advanced airway measures
vii. do not administer cardiac resuscitation drugs, and 
viii. do not defibrillate. 
b. If the patient is not in full respiratory or cardiac arrest, but the patient’s heartbeat or 
breathing is inadequate, EMS personnel shall not resuscitate but shall provide, within the scope 
of their training and level of certification, full palliative care and transport, as appropriate, 
including: 
i. additional interventions a patient has indicated be given on the MOLST form, including 
intubation with ventilation or non-invasive ventilation such as CPAP. 
ii. emotional support; 
iii. suction airway; 
iv. administer oxygen; 
v. application of cardiac monitor; 
vi. control bleeding; 
vii. splint; 
viii. position for comfort; 
ix. initiate IV line; and, 
x. contact Medical Control, if appropriate for further orders, including necessary 
medications. 
c. If the patient is not in respiratory or cardiac arrest, and the patient’s heart beat and breathing 
are adequate, but there is some other emergency illness or injury, the EMS personnel shall 
provide full treatment and transport, as appropriate, within the scope of their training and level 
of certification. 
5.  Questions about the MOLST or CC/DNR:  If EMS personnel have any questions regarding the 
applicability of the MOLST or CC/DNR form with regard to any specific individual, or a good-
faith basis to doubt the continued validity of the MOLST or CC/DNR form, EMS personnel shall 
verify with the patient if the patient is able to respond. If the patient cannot respond, EMS 
personnel shall provide full treatment and transport, or contact Medical Control for further 
orders. In all cases, EMS personnel shall document the circumstances on the trip record.
Policy Continued
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Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
6.  Previously-initiated CPR: In the event of respiratory or cardiac arrest and resuscitative efforts 
are initiated prior to EMS confirmation of the valid DNR order on the MOLST form or a valid 
CC/DNR Order Verification form, EMS shall discontinue the following measures: a) CPR; b) 
cardiac medications, and c) advanced airway measures. 
7.  Documentation: EMS personnel must document the existence and validity of the MOLST order 
or CC/DNR form on their trip record. For a MOLST form, EMS personnel must specifically 
document on the trip record all clinical information on the MOLST form regarding the patient’s 
preferences for care. For both MOLST and CC/DNR Order Verification Form, EMS personnel 
must also document on the trip record all care they provided to the patient, including palliative 
measures. 
8.  Revocation on scene: The MOLST order with DNR or CC/DNR may be revoked by the patient 
at any time, regardless of mental or physical condition, by the destruction or affirmative 
revocation of the MOLST or CC/DNR Order Verification, or by the patient’s direction that the 
MOLST or CC/DNR Order Verification not be followed by EMS personnel or be destroyed. 
EMS personnel, upon witnessing or verifying a revocation, shall communicate that revocation 
in writing to the hospital to ensure its inclusion in the patient's medical record. EMS personnel 
shall also document the revocation on their trip record. 
Policy Continued
7.3
2013
2013
Pediatric Transport
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Policy Continues
PATIENT TRANSPORT
Massachusetts statute requires that all children under the age of 8 traveling in a motor vehicle 
must be secured in a child passenger restraint (aka car seat), unless they are 57 inches or taller, 
in which case, they need to be using a seat belt. An ill or injured child must be restrained in a 
manner that minimizes injury in an ambulance crash. The best location for transporting a pediatric 
patient is on the ambulance cot. The method of restraint will be determined by various 
circumstances including the child’s medical condition and weight.  
1.  Convertible car seat with two belt paths (front and back) with four points for belt attachment to 
the cot is considered best practice for pediatric patients who can tolerate a semi-upright 
position.
· Position safety seat on cot facing foot-end with 
backrest fully elevated. 
· Secure safety seat with 2 pairs of belts at both 
forward and rear points of seat. 
· Place shoulder straps of the harness through 
slots just below child’s shoulders and fasten 
snugly to child.
· Follow manufacturer’s guidelines regarding 
child’s weight. 
Note: Non-convertible safety seats cannot be 
secured safely to cot. If child’s personal safety 
seat is not a convertible seat, it cannot be used 
on the cot. 
2. Car bed with both a front and rear belt path 
· For infants who cannot tolerate a semi-upright 
position or who must lie flat.
· Position car bed so infant lies perpendicular 
to cot, keeping infant’s head toward center of 
patient compartment.
· Fully raise backrest and anchor car bed to cot 
with 2 belts, utilizing 4 loop straps supplied 
with car bed.
· Secure the car bed at the foot end to ensure 
that it cannot slide forward and off the end of 
the stretcher during a sudden stop.
· Only appropriate for infants from 5 – 20 lbs.
3. Restraint device (marketed to EMS) with 5-point harness  
· Attach securely to cot utilizing upper back strap behind cot and lower straps around cot’s 
frame. 
· 5-point harness must rest snugly against child. 
· Adjust head portion of cot according to manufacturer’s recommendation.
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Pediatric Transport
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
4. Child belted directly to backboard and/or cot in manner to prevent ramping or sliding in a front 
or rear end crash
· Loop narrow belt under each arm and extend over child’s shoulder securing belt at 
shoulder level so no gap exists above shoulder. 
· Use soft, sliding, or breakaway connector to hold shoulder straps together on chest.
· Anchor 2 belts to non-sliding cot member and route over thighs and hips, not around 
waist.  
· Secure the foot end of the backboard by using a foot strap or harness looped through 
the bottom of the device and then tighten to the foot end of the cot to ensure stability in 
the event of a sudden stop.
5. Isolette restraint device with 3-point harness 
· Rest harness securely on child with no blanket or sheet between harness and child.
· Attach to isolette tray at four points.
· Additional soft Velcro straps may be added for lateral security.
· Blanket or towels may be used to provide stabilization of the head.
· Infants under 5 lbs should ideally be secured in a transport isolette.
NON-PATIENT TRANSPORT
Best practice is to transport well children in a vehicle other than the ambulance, whenever 
possible, for safety. 
If no other vehicle is available and circumstances dictate that the ambulance must transport a 
well child, he/she may be transported in the following locations:
· Captain’s chair in patient compartment using a size appropriate integrated seat or a 
convertible safety seat that is secured safely in relationship to the orientation of the 
captain’s chair. 
· Passenger seat of the driver’s compartment if child is large enough (according to 
manufacturer’s guidelines) to ride forward-facing in a child safety seat or booster seat. 
Airbag should be turned off. If the air bag can be deactivated, an infant, restrained in a 
rear-facing infant seat, may be placed in the passenger seat of the driver’s 
compartment. 
MOTHER AND NEWBORN TRANSPORT
Transport the newborn in an approved size-appropriate child restraint system that complies with 
the injury criteria of the Federal Motor Vehicle Safety Standard (FMVSS) No. 213 in the rear-
facing EMS provider seat /captain’s chair) that prevents both lateral and forward movement, 
leaving the cot for the mother. Use a convertible seat with a forward-facing belt path). Do NOT 
use a rear-facing only seat in the rear-facing EMS provider’s seat. You may also use an 
integrated child restraint system certified by the manufacturer to meet the injury criteria of 
FMVSS No. 213. 
USE OF PATIENT’S CHILD PASSENGER SAFETY SEAT AFTER INVOLVEMENT IN 
MOTOR VEHICLE CRASH
The patient’s safety seat may be used to transport the child to the hospital after involvement in 
a minor crash if ALL of the following apply:
· It is a convertible seat with both front and rear belt paths.
· Visual inspection, including under movable seat padding, does not reveal cracks or 
deformation. 
· Vehicle in which safety seat was installed was capable of being driven from the scene of 
the crash. 
· Vehicle door nearest the child safety seat was undamaged.
· The air bags (if any) did not deploy. 
Policy Continued
7.4
2013
M
e
d
i
c
a
l
 
P
o
l
i
c
i
e
s
 
&
 
P
r
o
c
e
d
u
r
e
s
 
7
.
5
2013
Refusal of Medical Care and 
Ambulance Transport
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
Protocol Continues
PURPOSE: 
Establish guidelines for the management and documentation of situations where patients 
refuse treatment or transportation.
Under the Commonwealth’s EMS System regulations, at 105 CMR170.355 (A) “Responsibility 
to Dispatch, Treat and Transport,” ambulance services and their agents may not refuse any of 
these responsibilities, absent a documented patient refusal. Ambulance services and their 
EMS personnel must be extremely cautious about accepting patient refusals. 
Refusal of care
There are three components to a valid refusal of care. Absence of any of these components 
will most likely result in an invalid refusal. The three components are as follows: 
1. Competence: In general, a patient who is an adult or a legally emancipated minor * is 
considered legally competent to refuse care. A parent or legal guardian who is on-scene 
may refuse care on his or her minor children’s behalf. 
2. Capacity: In order to refuse medical assistance a patient must have the capacity to 
understand the nature of his or her medical condition, the risks and benefits associated 
with the proposed treatment, and the risks associated with refusal of care. A health care 
agent who is named in a health care proxy document for the patient may refuse care on 
behalf of the patient only if 1) he or she is on-scene and 2) he or she has his/her health 
care proxy document in hand to show EMS. If the patient objects to the health care agent’s 
decision, there is no effective refusal. If there is any doubt about the health care agent’s 
authority, EMS is to transport the patient
3. Informed Refusal: A patient must be fully informed about his or her medical condition, 
the risks and benefits associated with the proposed treatment and the risks associated 
with refusing care. 
Patients who meet criteria in this Protocol shall be allowed to make decisions regarding 
their medical care, including refusal of evaluation, treatment, or transport. These criteria 
include: 
1. Initiated solely by the patient, not suggested/prompted by the EMTs.
2. Adults (≥ 18 years of age) and legally emancipated minors*
3. Orientation to person, place, time, and situation. 
4. No evidence of altered level of consciousness resulting from head trauma, medical 
illness, intoxication, dementia, psychiatric illness or other causes. 
5. No evidence of impaired judgment from alcohol or drug influence. 
6. No language communication barriers. Reliable translation available (e.g., on scene 
interpreter, language line). 
7. No evidence or admission of suicidal ideation resulting in any gesture or attempt at 
self-harm. No verbal or written expression of suicidal ideation regardless of any 
apparent inability to complete a suicide. 
Definitions
Minor: A person under the age of 18, who is not an emancipated minor (see below).
Emancipated Minor: For the purpose of making decisions regarding medical care and 
treatment, an emancipated minor is a person under the age of 18 who is
1. married, widowed or divorced;
2. the parent of a child;
3. a member of the armed forces;
4. pregnant or believes herself to be pregnant; or
5. living separate and apart from a parent/legal guardian and is managing his or 
her own financial affairs.
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Refusal of Medical Care and 
Ambulance Transport
EMS providers will make every reasonable effort to convince reluctant patients to access medical 
care at the emergency department via the EMS system before accepting a refusal of medical care 
and ambulance transport.
Contact on-line medical control for all patients who present a threat to themselves, present with an 
altered level of consciousness or diminished mental capacity, or have history or examination 
findings consistent with a high-risk refusal. The physician is to be provided all relevant information 
and may need to speak directly with the patient by radio or preferably a recorded landline. 
Although a minor cannot legally consent to medical treatment, consent is legally implied in an 
emergency.  In assessing whether there is an emergency, particularly with regard to motor vehicle 
crashes, EMTs must include the mechanism of injury in their analysis.
Procedure
1. Perform an assessment of the patient’s medical/traumatic condition, and, to the extent 
permitted by the patient, a physical exam including vital signs. Your assessment, or the 
patient’s refusal of assessment, must be fully documented in the trip record.
2. Explain to the patient the nature and severity of his/her illness or injury, the treatments 
being proposed, the risks and consequences of accepting or refusing treatment, and the 
potential alternatives. Fully document the explanation given to the patient in your trip 
report. 
3. Prepare and explain the refusal of medical care and ambulance transport document.
4. Documentation of refusal of medical care and ambulance transport must be signed by the 
patient (or, in the case of a minor patient, by the minor patient’s parent, legal guardian, or 
authorized representative) at the time of the refusal. Documentation should include, when 
possible, a signature by a witness, preferably a competent relative, friend, police officer, or 
impartial third person.
5. The fact that the patient refused medical care and transport must be documented in the trip 
record, and the signed refusal of medical care and ambulance transport document must be 
included as part of the trip record.
6. If on-line medical control was consulted for a refusal of care, obtain and document the 
physician’s name in the patient care report.
Protocol Continued
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Sedation for Electrical Therapy
Adult & Pediatric
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
PARAMEDIC STANDING ORDERS
· If cardioversion or pacing is warranted, consider administration of any 
of the following for sedation:
· Diazepam:
· If patient <70kg, 2.5 mg Slow IV/IO/IM/PR
· If patient >70kg, 5 mg Slow IV/IO/IM/PR; OR
· Midazolam
· 0.5mg-2 mg Slow IV/IO/IM/IN; OR
· Lorazepam
· 2-4 mg slow IV/IO/IM; OR
· Morphine
· 0.1 mg/kg IV/IO/IM/SC, maximum dose 10 mg; OR
· Fentanyl
· 1 mcg/kg slow IV/IO/IM/IN weight based (kg) to a max of 
150mcg (150kg)
For Pediatric Doses, see A2 Pediatric Color Coded Medication 
Reference
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Withholding and Cessation of Resuscitation
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
Policy Continues
Purpose: 1) To clarify for EMS services and their EMTs when resuscitative measures may be 
withheld for patients in cardiac arrest and 2) to define when EMTs can cease resuscitative 
measures already initiated. 
Background and EMS Services’ Training/Support Services Obligations: 
Emergency Medical Technicians must begin or continue resuscitative measures for all patients in 
cardiac arrest except as indicated in this Protocol (also issued as Administrative Requirement (A/R) 
5-515). If in doubt, begin resuscitative efforts. 
All EMS services must provide appropriate training on management of death in the field, including 
legal, procedural, and psychological aspects; and access to support services. 
EMS services and EMS personnel should be aware that the nursing staff of a health care facility, 
such as a skilled nursing facility, may need a physician order (including a medical control 
physician’s order, if allowed by nursing home policy) to halt resuscitation attempts, even in the case 
of patients meeting EMS “obvious death” criteria, as set out below. Nursing staff and EMS 
personnel should come to a cooperative decision on continuation or termination of resuscitation; 
this process may include obtaining physician input and orders. If the medical professionals at the 
bedside are unable to reach agreement on attempting or terminating efforts, the presumption 
should be to continue resuscitative efforts and transport the patient to an emergency department. 
I. Exceptions to Initiation of Resuscitation 
Other than in overriding circumstances such as a large mass-casualty incident or a hazardous 
scene, the following are the only exceptions to initiating and maintaining resuscitative measures in 
the field: 
1. Current, valid DNR, verified per the Medical Orders for Life Sustaing Treatment (MOLST)/
Comfort Care Protocol. 
2. Trauma inconsistent with survival 
a. Decapitation: severing of the vital structures of the head from the remainder of the 
patient’s body 
b. Transection of the torso: body is completely cut across below the shoulders and 
above the hips 
c. Evident complete destruction of brain or heart 
d. Incineration of the body 
e. Cardiac arrest (i.e. pulselessness) documented at first EMS evaluation when such 
condition is the result of significant blunt or penetrating trauma and the arrest is 
obviously and unequivocally due to such trauma, EXCEPT in the specific case of 
arrest due to penetrating chest trauma and short transport time to definitive care (in 
which circumstance, resuscitate and transport) 
3. Body condition clearly indicating biological death. 
a. Complete decomposition or putrefaction: the skin surface (not only in isolated 
areas) is bloated or ruptured, with sloughing of soft tissue, and the odor of decaying 
flesh. 
b. Dependent lividity and/or rigor: when the patient’s body is appropriately examined, 
there is a clear demarcation of pooled blood within the body, and/or major joints 
(jaw, shoulders, elbows, hips, or knees) are immovable. 
Procedure for lividity and/or rigor: All of the criteria below must be established and 
documented in addition to lividity and/or rigor in order to withhold resuscitation: 
7.7
Withholding and Cessation of Resuscitation
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
Exemptions to Initiation of Resuscitation, Continued
i. Respirations are absent for at least 30 seconds; and 
ii. Carotid pulse is absent for at least 30 seconds; and 
iii. Lung sounds auscultated by stethoscope bilaterally are absent for at 
least 30 seconds; and 
iv. Both pupils, if assessable, are non-reactive to light. 
II. Cessation of Resuscitation by EMTs 
Emergency Medical Technicians must continue resuscitative measures for all patients in cardiac 
arrest unless contraindicated by one of the exceptions below. 
1. EMTs at all levels of certification may cease resuscitative efforts at any time when any 
“Exception to Initiation of Resuscitation” as defined in I., above, is determined to be 
present. 
2. EMTs certified at the Paramedic level only may cease resuscitative efforts in an adult 
patient 18 years of age or older, regardless of who initiated the resuscitative efforts, 
without finding “obvious death” criteria only by the following procedure, and only if 
the EMS system’s Affiliate Hospital Medical Director has approved of use of this 
procedure, as follows: 
a. There is no evidence of or suspicion of hypothermia; AND 
b. Indicated standard Advanced Life Support measures have been 
successfully undertaken (including for example effective airway support, 
intravenous access, medications, transcutaneous pacing, and rhythm 
monitoring); AND 
c. The patient is in asystole or pulseless electrical activity (PEA), and 
REMAINS SO persistently, unresponsive to resuscitative efforts, for at 
least twenty (20) minutes while resuscitative efforts continue; AND 
d. No reversible cause of arrest is evident; AND 
e. The patient is not visibly pregnant; AND 
f. An on-line medical control physician gives an order to terminate 
resuscitative efforts. 
Special Considerations and Procedures: 
1. a. If during transport, EMTs cease resuscitation of a patient in accordance with the 
requirements above, they shall continue to the closest appropriate hospital for 
pronouncement of death. This is always a special circumstance that is in the interest of 
public health and safety, and thus meets the requirements of 105 CMR 170.365. 
b. During transports when resuscitative efforts have appropriately been ceased in 
accordance with the requirements above, EMTs must cover the person with a sheet, 
transport without the use of emergency vehicle audible and visual warning devices, and 
notify the receiving hospital in advance. 
2. In all cases where EMTs have withheld or ceased resuscitative efforts in accordance with the 
requirements above, and left the person in the field, procedures must include notification of 
appropriate medical or medico-legal authorities, such as police. 
3. EMS trip record documentation must reflect the criteria used to determine obvious death or 
allow cessation of resuscitative efforts. 
Policy Continued
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Ventricular Assist Devices (VADs)
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols Version 2015.1
EMT/EMT-INTERMEDIATE/ADVANCED EMT/ PARAMEDIC STANDING ORDERS
PURPOSE
To provide an overview of how Left Ventricular Assist Device (LVAD) works and how EMS 
provider assessment and treatment differs for a patient with an LVAD.
Highlights of Assessing and Treating an LVAD patient
· Recognize that you have a patient with an LVAD
· Determine if your patient has an LVAD problem, or an unrelated illness or injury
· A completely stable patient may have no palpable pulse or measurable blood pressure
· Mental status and skin color must be used to determine patient stability
· CPR should almost never be performed on an LVAD patient
· Patients with an LVAD should almost never be pronounced dead at the scene
Overview of an LVAD
The LVAD, or Left Ventricular Assist Device, is a mechanical device that takes over some or 
all of the pumping function of the heart’s left ventricle. This device is used for patients of 
any age or gender with advanced heart failure who would not otherwise survive without this 
device. Heart failure can result from chronic/long-term hypertension and heart disease, 
congenital heart defects, mechanical damage to the heart, infection, postpartum 
complications and many other reasons.
Some LVAD patients will have an LVAD while they are waiting for a heart transplant (called 
Bridge-to-Transplant). Other LVAD patients, who are not eligible for a heart transplant for 
some reason, will live with the device for the rest of their lives (called Destination Therapy, 
or Lifetime use)
How the Heart Works versus How LVAD works
The normal pumping function of the heart is achieved by the contraction of the left 
ventricular muscle, which pushes a bolus of blood forward in the cardiovascular system with 
each contraction. This contraction is what we feel when checking a pulse, and what we hear 
when taking a blood pressure. If the heart is not contracting, blood is not moving forward in 
the system, and we don’t feel or hear a pulse. The LVAD, in contrast, flows constantly and 
therefore creates no “pulse” to feel or hear.
The LVAD is a tube that is about ½ -1 inch in diameter with a pump in the middle. One end 
of the tube (inflow) is surgically inserted into the left ventricle, and the other end (outflow) is 
sewn into the aorta, just above where it exits the heart.
The pump on the LVAD spins constantly. The right side of the heart still pushes blood 
through the lungs and back to the left ventricle, but then the LVAD pump pulls the blood out 
of the left ventricle and pumps it out to the body, taking over most or all of the failed 
pumping action of the left ventricle.
The drive unit for the pump, which includes the power source and programming controls, is 
outside of the body and connects to the LVAD by a cord that exits the body through the 
abdomen, usually in the right upper quadrant.
NOTE: The important part to us as EMS providers is that the pump is a constant flow pump. 
There is no rhythmic pumping as there is with the ventricle, and therefore there is little to no 
pulse. This means you can have a perfectly stable and healthy looking person who has no 
palpable pulse and whom you may or may not be able to take a blood pressure!
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Ventricular Assist Devices (VADs)
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols Version 2015.1
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Assessing the LVAD Patient
1. Recognize you have an LVAD patient!
The LVAD patient has a control unit attached to their waist, or in a shoulder bag. 
The control unit is attached to a power cord exiting from the patients’ abdomen. 
The control unit will be attached to batteries mounted to the belt , in shoulder 
holsters, or in a shoulder bag. At home, it could be attached to a long cord that 
connects to a large power unit.
2. DECIDE if you have a patient with an LVAD problem, or a patient with a medical 
problem who just happens to have an LVAD. Patients with LVADS will have all the 
same illnesses and injuries as any other patient you see. Their LVAD may have 
nothing to do with the reason you were called.
3. LOOK:
Alarms on the control unit will most likely indicate an LVAD problem. Follow 
resource guides with the patient to trouble shoot.
Skin color and mental status are the most reliable indicators of patient stability for 
the LVAD patient.
4. LISTEN:
Listen over the LVAD pump location to make sure you can hear it running. This will 
be just to the left of the epigastrium, immediately below the base of the heart. You 
should hear a low hum with a stethoscope if the pump is running. Don’t assume 
the pump is running just because the control unit looks OK.
The patient and their family are experts on this device. Listen to what they have to 
say about any problems with the LVAD.
5. FEEL:
Feel the control unit. A hot control unit indicates the pump is working harder than it 
should and often indicates a pump problem such as a thrombosis (clot) in the 
pump. The use of pulse and blood pressure to assess stability can be unreliable in 
an LVAD patient, even if they are very stable.
6. VITALS:
Pulse: generally, you will be unable to feel a pulse.
Blood Pressure: you may or may not be able to obtain one, standard readings are 
unreliable and may vary from attempt to attempt. If NIBP machine can detect a 
blood pressure, adjust it to display Mean Arterial Pressure (MAP). This is a more 
reliable measure of perfusion and the calculation for MAP can overcome variations 
in standard readings. A MAP of 60-70 is normal.
Pulse-oximetry:  readings seem to be fairly accurate and consistent, according to 
data, despite the manufacturer stating that pulse oximetry often doesn’t work.
Quantitative Continuous Waveform Capnography: This should remain accurate, as 
it relies on respiration, not pulse. Normal (printed) waveform shape with a normal 
respiratory rate and low CO2 readings (<30) can indicate low perfusion = poor 
pump function.
Temperature: infection and sepsis are common, check temperatures!
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Process for Changes to the Statewide 
Treatment Protocols
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
All changes (any addition, deletion, or any other type of amendment) to the Massachusetts Statewide 
Pre-Hospital Treatment Protocols require statewide dissemination and often require training of EMTs 
and Medical Control physicians prior to implementation.  Therefore, to ensure a thorough review and 
orderly implementation, all protocol changes shall be approved and implemented on an ANNUAL basis, 
with the exception of those arising out of procedures described in Part B below.
Any protocol change must be approved pursuant to the following procedures.
PART A
Procedures for ANNUAL Protocol Changes
1. All requests for protocol changes shall be submitted by at least one Regional Medical Director to 
the Medical Services subcommittee by October 1 of the preceding year.  The request for a 
protocol change shall include the following:
a. A detailed description of the proposed change;
b. A formal written endorsement from the Region(s) of origin for the proposed change;
2. The Medical Services subcommittee shall review and make a recommendation regarding each 
proposed change to the protocols.  Where training is required for implementation of the protocol 
change, the Medical Services subcommittee shall timely distribute the approved protocol changes 
to the Training subcommittee for its approval of the training component.
3. All protocol changes approved by the Medical Services Committee, with Training Committee 
approval of training if appropriate, shall be forwarded to the Executive Committee.  The EMCAB 
Executive subcommittee shall review the proposed protocol changes and make a final 
recommendation at its meeting.
4. A presentation of the approved changes shall be made at the first meeting of the full EMCAB 
following the Executive subcommittee recommendation.
5. Recommendations go to DPH/OEMS for review and final action. DPH/OEMS shall timely notify all 
providers of approved protocol changes and any requirements regarding implementation (i.e. 
training and implementation date).
6. Protocol changes to be implemented by the department shall be issued no later than February 1 
of each year, with implementation no later than March 15 by EMS services unless the department 
specifies a longer window of issue or implementation.
Policy Continues
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Process for Changes to the Statewide 
Treatment Protocols
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
7.9
PART B
Procedures for Protocol Changes Allowable Other Than on an Annual Basis
1. The State Medical Director shall have the discretion to implement immediate protocol changes when 
such action is deemed by the Department to be necessary for the protection of public health and 
safety.
a. The State Medical Director shall base such action on a thorough review of relevant 
literature, any applicable national and/or state standard(s) and, when feasible, consultation 
with EMS Regional Councils, the Medical Services subcommittee and/or the EMCAB 
Executive subcommittee.
b. When feasible, the State Medical Director shall convene an emergency meeting of the 
Medical Services subcommittee.  The Medical Services subcommittee shall recommend 
any change to the protocols, and refer its recommendation and all supporting documents 
relating to the proposed change to the EMCAB Executive subcommittee for action.  The 
EMCAB Executive subcommittee shall review the recommendation and make a final 
recommendation to DPH/OEMS.
c. DPH/OEMS shall review such recommendation and take final action. It can also establish 
reasonable time frames for said implementation, particularly if a change requires training, 
and shall timely disseminate such a protocol change and any relevant implementation 
requirements.
2. DPH/OEMS shall always have the discretion to make changes to bring the Protocols into compliance 
with national standards of care.
a. This shall be done, when feasible, in consultation with Regional EMS Councils, the Medical 
Services subcommittee, and/or EMCAB Executive subcommittee.
b. OEMS shall establish reasonable time frames for said implementation, particularly if a 
change requires training, and shall timely disseminate such a protocol change and any 
relevant implementation requirements.
Policy Continued
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SPECIAL
OPERATIONS
PRINCIPLES
Statewide Treatment Protocols 
Version 2015.1
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2013
EMS Principles for Rehab at Emergency Incidents
EMS personnel may be designated by the Incident Commander (IC) at the scene of an 
emergency or training exercise to perform the function as rehab providers to assure the 
safety and well-being of the emergency responders, and the overall integrity of the 
operation. The need for establishing a Rehab Sector shall be based upon the duration, 
complexity, intensity of the incident and the climatic conditions, but shall not be the sole 
criteria for establishing REHAB.
The IC may establish a Rehab Manager as his/her designee. The Rehab Manager shall 
assure that all resources necessary to operate the Rehab Sector are communicated to the 
Logistics Officer or IC.  The Rehab sector shall provide rest for the emergency responders. 
Adequate resources for re-hydration, cooling/warming, medical screening, and 
accountability shall be available.  Multiple Rehab locations may be necessary based on the 
size of the incident. Each Rehab area shall have its own manager and identification, i.e.: 
Rehab 1, Rehab 2.
The Rehab Manager shall assure that adequate EMS staffing (paramedic level preferred) 
shall be available for responder screening and medical treatment if necessary.  A dedicated 
ambulance (ALS level preferred) shall be assigned to the Rehab Sector for the duration of 
the incident.  Easy access by EMS vehicles to the Rehab Sector shall be maintained at all 
times.
All emergency responders directed to the Rehab Sector by the IC shall be screened 
according to local protocol, and the attached “Rehab Flow Chart”.   Any emergency 
responder who presents at the Rehab Sector with an acute medical condition shall be 
considered a patient under the definition of 105 CMR 170.020  and shall be treated in 
accordance with the appropriate Statewide Treatment Protocol. The Rehab Manager shall 
be responsible for tracking all responders entering and exiting the Rehab area, or who are 
transported from Rehab to a medical facility.
2013
Fire and Tactical EMS Rehabilitation
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
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PHYSICAL SCREENING 
Mental status – CAOx3 
    Skin color – Warm, Dry 
 Vital signs – 
BP: Systolic <160 mm Hg or Diastolic <100 mm Hg 
 Pulse: <130 bpm and regular  
O2 Sat: >95% on environmental air 
Temperature: <101 F 
Respiratory Rate: <26 
Carbon Monoxide Assessment: <10% COHb 
 
 
 
1. Hydrate Orally with water or electrolyte 
enhanced sports drinks 
2. Cooling/Warming as needed (ambient air, 
shelter, etc) 
3. Rest 10-20 minutes 
4. Reassess vital signs  
Physical Screening Abnormal? 
Responder vital signs 
have returned to normal 
resting levels** 
1. Implement active cooling/warming (warm blankets, cool 
towels, etc.) 
2. Orally Hydrate with water or electrolyte enhanced sports 
drinks 
3. Rest for 20 Minutes 
4. Reassess vital signs and condition every 5 minutes 
Responder shows 
improvement of vital signs 
toward normal resting 
levels.** 
 
1. Consider moving to Medical Treatment area* 
2. Continue active cooling/warming 
3. Continue oral hydration 
4. Rest for 10 minutes 
5. Medically reassess every 5 minutes 
Release from Rehab 
1. PCR Created 
2. Move to treatment area 
3. Provide care per EMS Protocol 
4. Notify IC 
5. Transport to ED or obtain refusal  
YES 
YES 
 
No 
 
YES 
 
YES 
 
NO 
 
NO 
 
NO 
 
**Range of Resting Vital Signs** 
Heart Rate – 60 – 100 bpm 
Respiratory Rate – 12-20 breath/min 
Blood Pressure - >90  or <130 mmHg systolic and <100mmHg 
diastolic 
Pulse Oximetry – 95-100% on atmospheric air 
Carbon Monoxide Assessment - <5% COHb 
Temperature – 98.6 – 100.6 F 
 
YES 
 
INITIAL SCREENING 
1: Check into Rehab sector 
2: Remove PPE 
3: Initiate Rehab accountability card 
 
Responder vital signs 
have returned to 
normal resting 
levels** 
 
1. Continue active 
cooling/warming 
2. Continue oral 
hydration 
3. Rest for 10 minutes 
4. Reassess vital signs 
and condition every 5 
minutes 
Responder vital signs have returned to 
normal resting levels** 
 
Responder vital signs have returned to normal 
resting levels** 
 
Responder vital 
signs have not 
changed or still 
has 
signs/symptom/
complaints 
 
YES 
 
Passive Cooling/Warming Active Cooling/Warming 
*If at any time the member exhibits symptoms 
or presents with a medical complaint, 
immediately move to treatment area.* 
 
This screening process does not 
require PCR of the responders’ 
physical screening unless the 
responder is moved to the 
treatment area 
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
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Multiple Casualty Incidents (MCI Triage)
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Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
Protocol Continues
Each MCI/Disaster scene presents its own unique hazards and difficulties.  This plan is a 
general guide to the management of MCIs.  It should be understood that modifications may need 
to be made by command personnel on scene as such changes are needed. When the Statewide 
MCI plan is officially in place, nothing in this protocol shall be intended to replace or supersede the 
statewide plan.
A multiple casualty incident (MCI) is any situation where the number of sick or injured 
patients exceeds the available local, regional or state EMS system resources to provide adequate 
care in a timely manner to minimize injury and death.  An MCI may be the result of a man made 
disaster or a natural event.  Successful management of an MCI will require preplanning and 
organization of local, regional and state EMS, fire, law enforcement  and emergency management 
resources.  CMED, Hospital resources and specialized care services must also be included in 
preparing your MCI plan.
MCI management process is defined in the Incident Command System (ICS).  In general, 
the Fire Department or Emergency Medical Service Agency having jurisdictional authority 
establishes the overall command and designates the incident commander (IC) at an MCI scene.  
NOTE: Other agencies may function as the IC, for example, Law Enforcement agencies at a 
crime scene or hostage situation.  Other agencies may assist the IC.  Clear precise inter-agency 
communication networks must be established for successful MCI management.
MCIs within the Commonwealth assessed by EMS will be classified by 
levels.  Response to an MCI is based on the number of potential victims generated by the 
incident.  The following levels indicate the number of potential MCI casualties, should 
regional EMS providers require a mutual aid response:
       Level 1:        1-10 potential victims
       Level 2:        11-30 potential victims
       Level 3:        31-50 potential victims
       Level 4:        51-200 potential victims
       Level 5:        Greater than 200 victims
       Level 6:        Long-Term Operational period(s)
TRIAGE 
Triage is a special process of sorting patients by the severity of injury or illness to 
determine the need of emergency care and transportation.  This needs to be a continuous 
process throughout the management of an MCI.  The initial triage process should be performed by 
the first crew to arrive on scene and needs to be continuously reevaluated since the patient's 
triage status may change.  Presently there are no national standard guidelines established for 
triage.  Massachusetts services in general will be using a form of the SMART TAG system, while 
New England services in general use START triage and compatible tagging methods. 
MCI triage and treatment priorities are generally defined as: 
Zero priority (BLACK): Deceased or live patients with obvious fatal and non-resuscitatable 
injuries 
First priority (RED): Severely injured patients requiring immediate care and transport. 
(e.g., respiratory distress, thoracoabdominal injury, severe head or 
maxillofacial injuries, shock/severe bleeding, severe burns) 
Second priority (YELLOW): Patients with injuries that are determined not to be immediately life 
threatening. (e.g., abdominal injury without shock, thoracic injury 
without respiratory compromise, major fractures without shock, head 
injury/cervical spine injury, and minor burns) 
Third priority (GREEN): Patients with minor injuries that do not require immediate 
stabilization. (e.g., soft tissue injuries, extremity fractures and 
dislocations, maxillofacial injuries 
8.2
Multiple Casualty Incidents (MCI Triage)
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Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
Scene Assessment and Triage Priorities
1. Maintain universal blood and body fluid precautions.
2. The initial response team should assess the scene for potential hazards, safety and number 
of victims to determine the appropriate level of response.
3. Notify agency dispatch to declare an MCI and need for interagency support as defined by 
incident level. Agency dispatch should coordinate request for additional resources and 
contact local mutual aid, regional and state level agencies for assistance and notification as 
needed.
4. Identify and designate the following positions as qualified personnel become available: EMS 
Command responsible for overall command of all EMS resources and tactics; Triage Officer 
responsible for overseeing all triage group activities; Treatment Officer responsible for 
overseeing all treatment group activities; Staging Officer responsible for overseeing staging 
of all arriving ambulances and other mobile EMS resources; Loading Officer responsible for 
overseeing loading of all treated patients into ambulances, buses and helicopters and 
logging patient info, tag numbers and coordinating hospital destinations with CMED.
5. Identify and designate EMS sector areas of MCI including Triage, Treatment, Staging, and 
Loading
6. Post incident MCI Plan
EMT, EMT-Intermediate, Advanced EMT and Paramedic MCI Procedure Summary
All EMT level personnel will eventually be involved in the management of an MCI.  It is imperative 
that all EMTs implement the above incident command system (ICS) in all MCI situations.  Every 
EMT must be aware and have a thorough knowledge of their particular role and responsibilities in 
the rescue effort.
Due to the many complexities of MCI/Disaster situations, it is recommended that all EMTs should 
participate and receive additional training in MCI/Disaster management.
Protocol Continued
8.2
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Adult Medication Reference
 
See Pediatric Color Coded Reference Appendix for pediatric dosages 
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Medication Adult Dosing 
Adenosine 
(Adenocard) 
 
Indications: 
 Specifically for treatment or 
diagnosis of Supraventricular 
Tachycardia.  
 Consider for regular or wide 
complex tachycardia 
 
Tachycardia 
 6 mg rapid IV/IO push over 1-3 seconds. 
 May repeat 12 mg after 1 – 2 minutes X 2, if no conversion. 
Albuterol  
Beta-Agonist 
  
Indications: 
 Nebulized treatment for use in 
respiratory distress with 
bronchospasm. 
Allergic Reaction/Anaphylaxis 
 2.5mg via nebulizer. 
 May repeat 2.5mg. 
 
Asthma/COPD/RAD 
 2 puffs per dose of MDI. 
 May repeat every 5 minutes. 
 Albuterol is second line drug, the initial treatment should be 2.5mg 
albuterol and 0.5mg ipratropium (DuoNeb). 
 May repeat every 5 minutes. 
Amiodarone 
(Cordarone) 
  
Indications/Contraindications: 
 Antiarrhythmic used mainly in 
wide complex tachycardia and 
ventricular fibrillation. 
 Avoid in patients with heart block 
or profound bradycardia. 
 Contraindicated in patients with 
iodine hypersensitivity. 
Cardiac Arrest  
V-Fib/Pulseless V-Tach 
 300 mg IV push. 
 Repeat dose of 150 mg IV/IO push for recurrent episodes. 
Post-Arrest 
 150mg in 10mL normal saline slow IV/IO push over 8-10 minutes. 
 If successful, consider maintenance infusion of 1 mg/minute 
Tachycardia 
Wide complex tachycardia 
 150 mg in 50 – 100mL normal saline infused over 10 minutes. 
 If successful, consider maintenance infusion of 1 mg/minute. 
Aspirin 
 
Indications/Contraindications: 
 An antiplatelet drug for use in 
cardiac chest pain. 
 History of anaphylaxis to aspirin 
or NSAIDs 
 Not used in presence of active GI 
bleeding 
Acute Coronary Syndrome 
 324 mg chewed PO. 
Adult Medication Reference
 
See Pediatric Color Coded Reference Appendix for pediatric dosages 
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Medication Adult Dosing 
Atropine 
   
Indications: 
 Anticholinergic drug used in 
bradycardias and 
organophosphate poisonings. 
 
Bradycardia 
 0.5 - 1 mg IV/IO every 3 – 5 minutes up to maximum of 3 mg. 
 
Organophosphate Poisoning and Nerve Agent 
 2-6 mg IM/IV/IO every 5 minutes as needed. 
Atropine and 
Pralidoxime Auto-
Injector (DuoDote) 
Nerve Agent Kit  
 
Indications:  
 Antidote for Nerve Agents or 
Organophosphate Overdose. 
Nerve Agents 
 Patients experiencing: apnea, convulsions, unconsciousness, flaccid 
paralysis administer 3 DuoDote and 1 atropine (10 mg) auto-injectors. 
 Patients experiencing: dyspnea, twitching, nausea, vomiting, sweating, 
anxiety, confusion, constricted pupils, restlessness, weakness administer 1 
DuoDote. 
Calcium Chloride 
10% solution 
 
Indications: 
 For calcium channel blocker 
overdose. 
Bradycardia 
 2-4mg/kg slow IV over 5 minutes, maxium 1g. 
 Avoid use if pt is taking digoxin. 
Cyanide Antidote Kit 
Amyl Nitrate, Sodium Nitrite and 
Sodium Thiosulfate 
Indications: 
 Antidote for Cyanide 
Posioning 
Posioning: 
 Amyl Nitrate: (2) Inhalants 
 Sodium Nitrite: 3%, 10mL slow IV/IO over 2-4 minutes. 
 Sodium Thiosulfate: 25% 50mL IV/IO bolus 
Cyanokit 
(Hydroxocobalamin) 
Indications: 
 Antidote for Cyanide 
Posioning 
Poisioning: 
 5gm IV/IO over 15 minutes. 
Dextrose  
Glucose solutions 
  
Indications:  
 Sympomatic hypoglycemia. 
Diabetic Emergencies 
 25g IV/IO 
Name Concentration Volume (25g) 
D50 0.5g/mL 25g/50mL 
D25 0.25g/mL 25g/100mL 
D10 0.1g/mL 25g/250mL 
 
Adult Medication Reference
 
See Pediatric Color Coded Reference Appendix for pediatric dosages 
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Medication Adult Dosing 
Diazepam  
(Valium) 
Benzodiazepine 
 
Indications: 
 Seizure control. 
 Sedation. 
 Anti-anxiety (anxiolytic) 
 
Sedation for Electrical Therapy 
 2.5-5 mg IV/IO/IM/IN/PR 
Nerve Agent 
 10 mg IV/IN/IO/IM/PR OR  
 10 mg IM via auto-injector 
Seizure/Poisioning/Substance Abuse/OD 
 5-10 mg IV/IO/IM/PR 
Induced Therapeutic Hypothermia 
 5-10 mg IV/IO/IM/PR (for shivering) 
 
Diltiazem 
(Cardizem) 
 
Indications/Contraindications: 
 Calcium channel blocker used to 
treat narrow complex SVT. 
 Contraindicated in patients with 
heart block, ventricular 
tachycardia, WPW, and/or acute 
MI. 
Tachycardia 
Narrow Complex Tachycardia 
 0.25 mg/kg slow IV/IO push. 
 May repeat dose in 15 minutes at 0.35 mg/kg if necessary. 
Diphenhydramine 
(Benadryl) 
  
Indications: 
 Antihistamine used as an 
adjunctive treatment in allergic 
reactions. 
  
Allergic Reaction/Anaphylaxis 
 25-50 mg IV/IO/IM 
 
Dopamine 
Indications: 
 A vasopressor used in shock or 
hypotensive states. 
 Used when infusion 
pump/Norepinrphrine not 
available 
Bradycardia, Post-Resuscitation and Shock 
 Infusion 2-20 mcg/kg/min IV/IO. 
 
Epinephrine 1:1000 
(Auto-Injector ONLY) 
Indications:  
 Bronchodilation in Asthma and 
COPD exacerbation.  Primary 
treatment for anaphylaxis  
Allergic Reaction/Anaphylaxis 
 0.3 mg IM 
 Repeat every 5 minutes to a total of 3 doses.  
 
Asthma/COPD/RAD 
 0.3 mg IM (no repeat). 
Adult Medication Reference
 
See Pediatric Color Coded Reference Appendix for pediatric dosages 
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Medication Adult Dosing 
Epinephrine 1:1000 
(by infusion only) 
Indications: 
 Vasopressor Post-Resuscitation, 
Bradycardia, allergic reaction 
 
Post-Resuscitation 
 2-10 mcg/min IV/IO infusion 
 
Bradycardia 
 2-10 mcg/min IV/IO infusion 
 
Allergic Reaction 
 1-10 mcg/min IV/IO infusion (maintenance)  
Epinephrine 1:10,000 
 
Indications:  
 Vasopressor used in cardiac 
arrest. 
Cardiac Arrest 
 1 mg IV/IO 
 Repeat every 3 – 5 minutes per AHA guidelines 
 
Epinephrine 
(Racemic, for 
Inhalation) 
Indications:  
 Croup 
Croup 
 11.25mg in 2.5mL solution  
Fentanyl 
(Sublimaze) 
 
Indications:  
 Opioid analgesic 
Pain  
 1 mcg/kg up to 150 mcg slow IV/IO/IM/IN 
 
Therapeutic Hypothermia, Shivering 
 50mcg every 5 minutes, maximum 200mcg IV/IO/IM/IN 
Furosemide (Lasix) 
Indications: 
 Congestive Heart Failure, 
Pulomary Edema, Hypertensive 
Emergencies, Toxicology 
Congestive Heart Failure, Pulmonary Edema 
 20-40mg IV/IO 
Hypertensive Emergencies 
 0.5-1mg/kg IV/IO 
Toxicology 
 40mg IV/IO 
Glucagon 
Indications:  
 Hypoglycemia 
 Beta Blocker or Calcium Channel 
Blocker Overdose 
Diabetic Emergencies 
 1 mg IV/IO/IM/IN/SC 
Beta Blocker/Calcium Channel Blocker Overdose 
 1-5mg IV/IO/IM/IN/SC 
Bradycardia 
 1-5 mg IV/IO/IM/IN/SC 
Adult Medication Reference
 
See Pediatric Color Coded Reference Appendix for pediatric dosages 
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Medication Adult Dosing 
Glucose Oral 
Glucose Solutions 
 
Indications:  
 Use in conscious hypoglycemic 
states. 
Diabetic Emergencies 
 Administer 1-2 tubes of commercially prepared glucose gel or equivalent. 
Haloperidol 
(Haldol) 
Phenothiazine 
Preparation 
 
Indications/Contraindications:  
 Medication to assist with sedation 
of agitated patients. 
Behavioral Emergencies 
 5 mg IM; 
 
Hydrocortisone 
(Solu-Cortef) 
Indications/Contraindications 
 Adrenal Insufficiency/Crisis 
 Other inflamatory processes 
(COPD/Asthma) 
Adrenal Insufficiency/Crisis 
 100mg IV/IO/IM 
 
Respiratory Distress (COPD/Asthma) 
 100mg IV/IO/IM 
Ipratropium Bromide 
(Atrovent) 
 
Indications/Contraindications:  
 Anticholinergic bronchodilator.  
Blocks the muscarinic receptors 
of acetylcholine. 
 Relief of bronchospasm in 
patients with reversible 
obstructive airway disease and  
bronchospasm.  
 
Asthma/COPD/RAD 
 2-3 puffs per dose of MDI combination of albuterol/ipratropium bromide.  
 May repeat as necessary every 5 minutes OR 
 0.5mg ipratropium and 2.5mg albuterol(DouNeb). 
 May repeat as necessary every 5 minutes. 
 0.5mg ipratroprium nebulized 
 May repeat as necessary every 5 minutes 
Adult Medication Reference
 
See Pediatric Color Coded Reference Appendix for pediatric dosages 
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Medication Adult Dosing 
Lidocaine 
 
Indications/Contraindications:  
 Antiarrhythmic used for control of 
ventricular dysrhythmias. 
 Used prior to intubation of 
patients with suspected 
increased intracranial pressure 
(e.g., TBI, ICH) to reduce 
increases in intracranial pressure 
 Anesthetic for nasotracheal 
intubation and intraosseous 
procedures. 
Cardiac Arrest 
 1-1.5mg/kg IV/IO.  
 Repeat dose 0.75 mg/kg up to a maximum dose of 3 mg/kg, followed 
by; 
 2-4 mg/min maintenance infusion. 
Ventricular Tachycardia (with pulses) 
 1 – 1.5mg/kg IV/IO. (considered second-line therapy to Amiodarone). 
 Repeat dose of 0.5-0.75mg/kg every 3-5 minutes up to total dose of 3 
mg/kg, followed by; 
 2-4 mg/min maintenance infusion.  
Post-Resuscitation 
 1-1.5 mg/kg IV/IO, followed by; 
 2-4mg/min maintenance infusion 
 
Nasotracheal Intubation 
 2% lidocaine jelly. 
 
Intraosseous  
 40mg 2% lidocaine, slow bolus over two minutes, followed by 10mL 
normal saline flush, then use IO access for medications 
 
Lorazepam 
(Ativan) 
Benzodiazepine 
 
Indications/Contraindications: 
 Seizure control. 
 Sedation. 
 Anti-anxiety (anxiolytic). 
 
Behavioral 
 2-4 mg IV/IO/IM  
 
Nerve Agent/ Seizures 
 2-4 mg slow IV/IO/IM 
Magnesium Sulfate 
 
Indications/Contraindications:  
 Elemental electrolyte used to 
treat eclampsia during the third 
trimester of pregnancy. 
 A smooth muscle relaxor used in 
refractory respiratory distress 
resistent to beta-agonists. 
 Torsades de Pointes. 
Asthma/RAD 
 2 grams in 100ml NS given IV over 10 minutes. 
 
Seizures 
 4 grams IV over 10 minutes in the presence of seizure in the third trimester 
of pregnancy or post partum. 
 
Cardiac Arrest/Tachycardia – Torsades de Pointes. 
 1 – 2 grams IV over 5 minutes.  
Adult Medication Reference
 
See Pediatric Color Coded Reference Appendix for pediatric dosages 
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Medication Adult Dosing 
Methylprednisolone 
(Solu-medrol) 
Indications/Contraindications:  
 Steroid used in respiratory 
distress to reverse inflammatory 
and allergic reactions. 
Asthma/COPD/RAD 
 125 mg IV/IO/IM 
Metoprolol 
(Lopressor) 
Indications/Contraindications:  
Rate control for adult patients who 
are already prescribed a beta blocker  
NOTE: Do not use IV Beta-blockers 
with IV Calcium channel blockers  
Tachycardia 
 2.5mg to 5mg slow IV over 2 – 5 minutes. 
 May repeat every five minutes to a maximum of 15mg  
Midazolam 
(Versed) 
Benzodiazepine 
 
Indications/Contraindications: 
 Seizure control. 
 Sedation. 
 Anxiolytic. 
 
Behavioral/Seizures/Induced Therapeutic Hypothermia 
 2 – 6 mg IV/IO/IM/IN 
 
Nerve Agent/Organophosphate Poisioning 
 2 mg IV/IO/IN every 5 minutes; or 6 mg IM every 10 minutes as needed 
 
Sedation for Electrical Therapy 
 0.5 - 2 mg IV/IO/IM/IN   
 
Difficult Airway  
 2 mg slow IV/IO/IM/IN; Repeat of necessary to a total dose of 6 mg   
 
Morphine Sulfate  
Indications/Contraindications:  
 Opioid analgesic 
 Avoid use if BP < 100 mmHg. 
Pain 
 0.1mg/kg every 5 minutes IV/IO/IM/SC, up to 10mg max. 
 
Naloxone 
(Narcan) 
Opioid Antagonoist 
 
Indications/Contraindications:  
 Opioid overdose. 
Pain 
 Antidote: For hypoventilation from opiate administration by EMS 
personnel, administer naloxone 0.4mg-2.0mg SQ/IV/IM/IN as needed. 
Poisoning/Substance Abuse/Opioid OD 
 0.4 – 2mg IV/IM/SQ/IN.  
 If no response, may be repeated as needed  
 First Responders and EMTs may administer by auto-injector or nasal 
atomizer. 
Adult Medication Reference
 
See Pediatric Color Coded Reference Appendix for pediatric dosages 
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Nitroglycerin 
 
Indications/Contraindications:  
 Vasodilator used in the treatment 
of chest pain secondary to acute 
coronary syndrome and CHF 
 Hypertensive emergencies. 
 Not used in presence of 
Hypotension orrecent use of 
phosphodiesterase-type-5-
inhibitor within last 48 hours.  
 
Cardiac Conditions/Hypertensive Emergencies 
 0.4mg SL tabs or 1 spray every 3 – 5 minutes while symptoms persist and 
if systolic BP remains >100 mmHg. 
 1 inch paste to chest wall, transdermal 
Norepinephrine 
(Levophed) 
 
Indications/Contraindications: 
 Alpha and Beta 1 receptor 
adronergic receptor agonist 
vasopressor 
 Infusion pump required 
Hypotension 
 0.1mcg/kg/min IV/IO titrate to goal SBP of 90mmHg 
o 4mg mixed in 250mL of D5 diluent packaged with medication 
 
 
Ondansetron  
(Zofran) 
Anti-emetic 
  
Indications: 
 Used to control Nausea and/or 
Vomiting.  
 
 Nausea/Vomiting 
 4mg IV/IO/IM/ODT.  
  
 
Oxygen 
 
Indications:  
 Any condition with increased 
cardiac work load, respiratory 
distress, or illness or injury 
resulting in altered ventilation 
and/or perfusion.  Goal oxygen 
saturation ≥94%.   
 Used for pre-oxygenation 
whenever possible prior to 
endotracheal intubation.  Goal 
oxygen saturation 100%. 
 
 1-6 liters/min via nasal cannula. 
 10-15 liters/min via NRB mask. 
 15 liters/min via BVM 
Adult Medication Reference
 
See Pediatric Color Coded Reference Appendix for pediatric dosages 
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Medication Adult Dosing 
Pralidoxime 
(2-PAM) 
 
Indications:  
 Antidote for Nerve Agents or 
Organophosphate Overdose. 
 Administered as part of Mark I 
kit. 
Nerve Agent/Organophosphate Poisioning 
 600mg via Auto-Injector IM per kit, 1-3 kits. 
  
 
Sodium Bicarbonate 
 
Indications:  
 A buffer used in acidosis to 
increase the pH in Cardiac 
Arrest, Hyperkalemia or Tricyclic 
Overdose. 
Poisoning/Substance Abuse/OD/Toxicology 
 0.5-1 mEq/kg IV/IO 
 
Cardiac Arrest/Known Hyperkalemia/Acidosis/TCA Overdose 
 1 mEq/kg IV/IO 
Tetracaine 0.5% 
 
Indications: 
 Topical anesthetic for eye injuries 
Eye Injuries 
 1-2 drops to affected eye; repeat every 5 minutes as needed. 
Vasopressin 
Indications: 
 Cardiac Arrest 
Cardiac Arrest; Asystole, Pulseless Electrical Activity, Ventricular 
Fibrillation, Ventricular Tachycardia (without pulses) 
 40 units IV/IO in place of first or second dose of Epinephrine 
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          Appendix 
 
Weight 3-5 Kg (Avg 4.0 Kg) 
 
Vital Signs 
Heart Rate:   120-150 
Respirations: 24-48 
BP Systolic:  70 (+/-25) 
 
Equipment 
ET Tube: 2.5 - 3.5 
Blade Size: 0 - 1 
 
Defibrillation 
Defibrillation:   8 J, 15 J 
Cardioversion: 2 J, 4 J 
 
Normal Saline    80 ml 
 
Adenosine: 
1st Dose-  0.4 mg 
Repeat Dose- 0.8 mg 
Albuterol  2.5 mg 
 
Amiodarone 20 mg 
Atropine- Bradycardia 0.08 mg 
- Organophosphate Poison 0.2 mg 
Calcium Chloride 81mg 
Dextrose 10% 20 ml 
Diazepam (IV) 1 mg 
(Rectal)                  2 mg 
Diphenhydramine             HOLD 
Dopamine (800 mg in 500 cc) 
2 mcg/kg/min 0.3 ml/hr 
5 mcg/kg/min 0.9 ml/hr 
10 mcg/kg/min 1.7 ml/hr 
20 mcg/kg/min 3.3 ml/hr 
Epinephrine 1:10,000 0.04 mg 
Epinephrine 1:1000 Nebulized 2.5 mg 
Epinephrine Auto-Injector Pedi (IM) MC 
Fentanyl  2 mcg 
Glucagon  0.5 mg 
Glucose Oral 1 tube 
Hydrocortisone 10 mg 
Hydroxocobalamin 300 mg  
 
Ipratropium w/ albuterol 500 mcg 
Levalbuterol                    0.63 mg 
Lidocaine: 
- Cardiac Arrest 4 mg 
-Traumatic Brain Injury 6 mg 
- Intraosseous 2 mg 
Lorazepam 0.4 mg 
Magnesium Sulfate 
- RAD 150 mg 
- Torsades 200 mg 
Methylprednisolone 4 mg 
Midazolam 0.2 mg 
Morphine Sulfate 0.4 mg 
Naloxone 0.4 mg  
Norepinephrine   0.1mcg/kg/min 
Ondansetron - IV 0.4 mg 
- ODT 4 mg 
Pralidoxime IV 300 mg 
- Infusion 80 mg/hr 
Proparacaine 2 drops 
Sodium Bicarbonate 8 mEq 
Tretracaine 2 drops 
 
Weight 6-7 Kg (Avg 6.5 Kg) 
 
Vital Signs 
Heart Rate:   120-125 
Respirations: 24-48 
BP Systolic:  85 (+/-25) 
 
Equipment 
ET Tube: 3.5 
Blade Size: 1 
 
Defibrillation 
Defibrillation:   10 J, 20 J 
Cardioversion: 2 J, 5 J 
 
Normal Saline    130 ml 
 
Adenosine: 
1st Dose- 0.65 mg 
Repeat Dose- 1.3 mg 
Albuterol 2.5 mg 
 
Amiodarone 30 mg 
Atropine- Bradycardia 0.13 mg 
- Organophosphate Poison 0.32 mg 
Calcium Chloride 130 mg 
Dextrose 10% 35 ml 
Diazepam (IV) 1 mg 
(Rectal) 3 mg 
Diphenhydramine HOLD 
Dopamine (800 mg in 500 cc) 
2 mcg/kg/min 0.5 ml/hr 
5 mcg/kg/min 1.3 ml/hr 
10 mcg/kg/min 2.5 ml/hr 
20 mcg/kg/min 5.0 ml/hr 
Epinephrine 1:10,000 0.065 mg 
Epinephrine 1:1000 Nebulized 2.5 mg 
Epinephrine Auto-Injector Pedi (IM)  MC 
Fentanyl  3 mcg 
Glucagon  0.5 mg 
Glucose Oral 1 tube 
Hydrocortisone 10 mg 
Hydroxocobalamin 400 mg  
 
Ipratropium w/ albuterol 500 mcg 
Levalbuterol                    0.63 mg 
Lidocaine: 
- Cardiac Arrest            6.5 mg 
-Traumatic Brain Injury 9.75 mg 
- Intraosseous               3.25 mg 
Lorazepam                     0.65 mg 
Magnesium Sulfate 
- RAD  300 mg 
- Torsades                   350 mg 
Methylprednisolone        6.0 mg 
Midazolam                     0.3 mg 
Morphine Sulfate            0.6 mg 
Naloxone                        0.6 mg  
Norepinephrine   0.1mcg/kg/min 
Ondansetron - IV              0.6 mg 
- ODT 4 mg 
Pralidoxime IV                325 mg 
- Infusion 130 mg/hr 
Proparacaine 2 drops 
Sodium Bicarbonate 12 mEq 
Tretracaine 2 drops 
 
Weight 8-9 Kg (Avg 8.5 Kg) 
 
Vital Signs 
Heart Rate:   120 
Respirations: 24-32 
BP Systolic:  92 (+/-25) 
 
Equipment 
ET Tube: 3.5 -4.0 
Blade Size: 1 
 
Defibrillation 
Defibrillation:   20 J, 40 J 
Cardioversion: 5 J,  9 J 
 
Normal Saline    170 ml 
 
Adenosine: 
1st Dose- 0.85 mg 
Repeat Dose- 1.7 mg 
Albuterol 2.5 mg 
 
Amiodarone 40 mg 
Atropine- Bradycardia 0.17 mg 
- Organophosphate Poison 0.42 mg 
Calcium Chloride 172 mg 
Dextrose 10% 43 ml 
Diazepam (IV) 2 mg 
(Rectal) 4 mg 
Diphenhydramine HOLD 
Dopamine (800 mg in 500 cc) 
2 mcg/kg/min 0.7 ml/hr 
5 mcg/kg/min 1.6 ml/hr 
10 mcg/kg/min 3.2 ml/hr 
20 mcg/kg/min 6.5 ml/hr 
Epinephrine 1:10,000 0.085 mg 
Epinephrine 1:1000 Nebulized 2.5 mg 
Epinephrine 1:1000 IM 0.085 mg 
Fentanyl  4 mcg 
Glucagon  0.5 mg 
Glucose Oral 1 tube 
Hydrocortisone  20 mg 
Hydroxocobalamin 600 mg  
 
Ipratropium w/ albuterol 500 mcg 
Levalbuterol                    0.63 mg 
Lidocaine: 
- Cardiac Arrest            8.5 mg 
-Traumatic Brain Injury 12.75 mg 
- Intraosseous               4.25 mg 
Lorazepam                     0.85 mg 
Magnesium Sulfate 
- RAD 350 mg 
- Torsades                   400 mg 
Methylprednisolone        8.0 mg 
Midazolam                      0.4 mg 
Morphine Sulfate            0.8 mg 
Naloxone                        0.8 mg 
Norepinephrine   0.1mcg/kg/min  
Ondansetron - IV              0.8 mg 
- ODT 4 mg 
Pralidoxime IV                420 mg 
- Infusion 210 mg/hr 
Proparacaine 2 drops 
Sodium Bicarbonate 20 mEq 
Tretracaine 2 drops 
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Weight 10-11 Kg (Avg 10.5 Kg) 
 
Vital Signs 
Heart Rate:   115-120 
Respirations: 22-30 
BP Systolic:  96 (+/-30) 
 
Equipment 
ET Tube: 4.0 
Blade Size: 1 
 
Defibrillation 
Defibrillation:   20 J, 40 J 
Cardioversion: 5 J, 10 J 
 
Normal Saline    210 ml 
 
Adenosine: 
1st Dose- 1.05 mg 
Repeat Dose- 2.1 mg 
Albuterol 2.5 mg 
 
Amiodarone 50 mg 
Atropine- Bradycardia 0.21 mg 
- Organophosphate Poison 0.52 mg 
Calcium Chloride 210 mg 
Dextrose 10% 50 ml 
Diazepam (IV) 2 mg 
(Rectal) 5 mg 
Diphenhydramine 12.5 mg 
Dopamine (800 mg in 500 cc) 
2 mcg/kg/min 0.8 ml/hr 
5 mcg/kg/min 2.0 ml/hr 
10 mcg/kg/min 4.0 ml/hr 
20 mcg/kg/min 8.0 ml/hr 
Epinephrine 1:10,000 0.105 mg 
Epinephrine 1:1000 Nebulized 5 mg 
Epinephrine Auto-Injector Pedi (IM)0.15 mg 
Fentanyl  5 mcg 
Glucagon  0.5 mg 
Glucose Oral 1 tube 
Hydrocortisone 20 mg 
Hydroxocobalamin 700 mg  
 
Ipratropium w/ albuterol 500 mcg 
Levalbuterol                    0.63 mg 
Lidocaine: 
- Cardiac Arrest            10.5 mg 
-Traumatic Brain Injury 15.75 mg 
- Intraosseous               5.25 mg 
Lorazepam                     1 mg 
Magnesium Sulfate 
- RAD 400mg 
- Torsades                   500 mg 
Methylprednisolone        10 mg 
Midazolam                      0.5 mg 
Morphine Sulfate            1 mg 
Naloxone                        1 mg  
Norepinephrine   0.1mcg/kg/min 
Ondansetron- IV              1 mg 
- ODT 4 mg 
Pralidoxime IV                540 mg 
- Infusion 210 mg/hr 
Proparacaine 2 drops 
Sodium Bicarbonate 20 mEq 
Tretracaine 2 drops 
 
Weight 12-14 Kg (Avg 13 Kg) 
 
Vital Signs 
Heart Rate:   110-115 
Respirations: 20-28 
BP Systolic:  100 (+/-30) 
 
Equipment 
ET Tube: 4.5 
Blade Size: 2 
 
Defibrillation 
Defibrillation:   30 J, 50 J 
Cardioversion: 6 J, 15 J 
 
Normal Saline    260 ml 
 
Adenosine: 
1st Dose-  1.3mg 
Repeat Dose- 2.6 mg 
Albuterol  2.5 mg 
 
Amiodarone 60 mg 
Atropine- Bradycardia 0.26 mg 
- Organophosphate Poison        0.65 mg 
Calcium Chloride                            259 mg 
Dextrose 10%                                60-80 ml 
Diazepam (IV)                               3 mg 
(Rectal) 6 mg 
Diphenhydramine 12-14 mg 
Dopamine (800 mg in 500 cc) 
2 mcg/kg/min 0.8 ml/hr 
5 mcg/kg/min 2.5 ml/hr 
10 mcg/kg/min 5.0 ml/hr 
20 mcg/kg/min 10 ml/hr 
Epinephrine 1:10,000 0.13 mg 
Epinephrine 1:1000 Nebulized 5 mg 
Epinephrine Auto-Injector Pedi (IM)0.15 mg 
Fentanyl  6.5 mcg 
Glucagon  0.5 mg 
Glucose Oral 1 tube 
Hydrocortisone 30 mg 
Hydroxocobalamin 900 mg  
 
Ipratropium w/ albuterol 0.5 mcg 
Levalbuterol                    0.63 mg 
Lidocaine: 
- Cardiac Arrest 13 mg 
-Traumatic Brain Injury 19.5mg 
- Intraosseous               6.5 mg 
Lorazepam                     1.2 mg 
Magnesium Sulfate 
- RAD 500 mg 
- Torsades 650 mg 
Methylprednisolone 12 mg 
Midazolam 0.6 mg 
Morphine Sulfate 1.2 mg 
Naloxone 1.2 mg  
Norepinephrine   0.1mcg/kg/min 
Ondansetron- IV              1.4 mg 
- ODT 4 mg 
Pralidoxime IV                660 mg 
- Infusion 260 mg/hr 
Proparacaine 2 drops 
Sodium Bicarbonate 26 mEq 
Tretracaine 2 drops 
 
Weight 15-18 Kg (Avg 16.5 Kg) 
 
Vital Signs 
Heart Rate:   100 - 115 
Respirations: 20-26 
BP Systolic:  100 (+/-20) 
 
Equipment 
ET Tube: 5.0 
Blade Size: 2 
 
Defibrillation 
Defibrillation:   30 J, 70 J 
Cardioversion: 8 J, 15 J 
 
Normal Saline    330 ml 
 
Adenosine: 
1st Dose- 1.65 mg 
Repeat Dose- 3.3 mg 
Albuterol 2.5 mg 
 
Amiodarone 80 mg 
Atropine- Bradycardia 0.33 mg 
- Organophosphate Poison 0.82 mg 
Calcium Chloride 330 mg 
Dextrose 10% 80 ml 
Diazepam (IV) 3 mg 
(Rectal) 8 mg 
Diphenhydramine 20 
Dopamine (800 mg in 500 cc) 
2 mcg/kg/min 1.2 ml/hr 
5 mcg/kg/min 3 ml/hr 
10 mcg/kg/min 6 ml/hr 
20 mcg/kg/min 12 ml/hr 
Epinephrine 1:10,000 0.165 mg 
Epinephrine 1:1000 Nebulized 5 mg 
Epinephrine Auto-Injector Pedi (IM)0.15 mg 
Fentanyl  8 mcg 
Glucagon  0.5 mg 
Glucose Oral 1 tube 
Hydrocortisone 30 mg 
Hydroxocobalamin 1200 mg  
 
Ipratropium w/ albuterol 500 mcg 
Levalbuterol                    0.63 mg 
Lidocaine: 
- Cardiac Arrest            16.5 mg 
-Traumatic Brain Injury 24.75 mg 
- Intraosseous               8.25 mg 
Lorazepam                      1.6 mg 
Magnesium Sulfate 
- RAD 650 mg 
- Torsades                   800 mg 
Methylprednisolone        16 mg 
Midazolam                      0.8 mg 
Morphine Sulfate            1.6 mg 
Naloxone                        1.6 mg  
Norepinephrine   0.1mcg/kg/min 
Ondansetron - IV              1.6 mg 
- ODT 4 mg 
Pralidoxime IV                810 mg 
- Infusion 330 mg/hr 
Proparacaine 2 drops 
Sodium Bicarbonate 32 mEq 
Tretracaine 2 drops 
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Weight 19-22 Kg (Avg 20.75 Kg) 
 
Vital Signs 
Heart Rate:   100 
Respirations: 20-24 
BP Systolic:  100 (+/-15) 
 
Equipment 
ET Tube: 5.5 
Blade Size: 2 
 
Defibrillation 
Defibrillation:   40 J, 85 J 
Cardioversion: 10 J, 20 J 
 
Normal Saline    410 ml 
 
 
Adenosine: 
1st Dose- 2.075 mg 
Repeat Dose- 4.15 mg 
Albuterol 2.5 mg 
 
Amiodarone 100 mg 
Atropine- Bradycardia 0.41 mg 
- Organophosphate Poison 1.0 mg 
Calcium Chloride 416 mg 
Dextrose 10% 100 ml 
Diazepam (IV) 4.0 mg 
(Rectal) 10 mg 
Diphenhydramine 30 
Dopamine (800 mg in 500 cc) 
2 mcg/kg/min 1.6 ml/hr 
5 mcg/kg/min 3.9 ml/hr 
10 mcg/kg/min 7.8 ml/hr 
20 mcg/kg/min 16 ml/hr 
Epinephrine 1:10,000 0.2075 mg 
Epinephrine 1:1000 Nebulized 5 mg 
Epinephrine Auto-Injector Pedi (IM)0.15 mg 
Fentanyl  10 mcg 
Glucagon  1 mg 
Glucose Oral 1 tube 
Hydrocortisone 40 mg 
Hydroxocobalamin 1500 mg  
 
Ipratropium w/ albuterol 500 mcg 
Levalbuterol                    0.63 mg 
Lidocaine: 
- Cardiac Arrest 20.75 mg 
-Traumatic Brain Injury 31.125mg 
- Intraosseous               10.375 mg 
Lorazepam                      2.0 mg 
Magnesium Sulfate 
- RAD 850 mg 
- Torsades 1050 mg 
Methylprednisolone 20 mg 
Midazolam 1 mg 
Morphine Sulfate 2 mg 
Naloxone 2 mg  
Norepinephrine   0.1mcg/kg/min 
Ondansetron - IV              2 mg 
- ODT 4 mg 
Pralidoxime IV                1020 mg 
- Infusion 415 mg/hr 
Proparacaine 2 drops 
Sodium Bicarbonate 42 mEq 
Tretracaine 2 drops 
 
Weight 24-28* Kg (Avg 27 Kg) 
 
Vital Signs 
Heart Rate:   90 
Respirations: 18-22 
BP Systolic:  105 (+/-15) 
 
Equipment 
ET Tube: 6.0 
Blade Size: 2-3 
 
Defibrillation 
Defibrillation:   50 J, 100 J 
Cardioversion: 15 J, 30 J 
 
Normal Saline    540 ml 
 
Adenosine: 
1st Dose-  2.7 mg 
Repeat Dose- 5.4 mg 
Albuterol  2.5 mg 
 
Amiodarone 130 mg 
Atropine- Bradycardia 0.5 mg 
- Organophosphate Poison 1.3 mg 
Calcium Chloride 540 mg 
Dextrose 10% 135 ml 
Diazepam (IV) 5.0 mg 
(Rectal) 13 mg 
Diphenhydramine 40 mg 
Dopamine (800 mg in 500 cc) 
2 mcg/kg/min 2 ml/hr 
5 mcg/kg/min 5 ml/hr 
10 mcg/kg/min 10 ml/hr 
20 mcg/kg/min 20 ml/hr 
Epinephrine 1:10,000 0.27 mg 
Epinephrine 1:1000 Nebulized 5 mg 
Epinephrine Auto-Injector Adult (IM)0.3 mg 
Fentanyl  13.5 mcg 
Glucagon  1 mg 
Glucose Oral 1 tube 
Hydrocortisone 60 mg 
Hydroxocobalamin 1900 mg  
 
Ipratropium w/ albuterol 500 mcg 
Levalbuterol                    0.63 mg 
Lidocaine: 
- Cardiac Arrest 27 mg 
-Traumatic Brain Injury 40.5 mg 
- Intraosseous 13.5 mg 
Lorazepam 2.8 mg 
Magnesium Sulfate 
- RAD 1100 mg 
- Torsades 1350 mg 
Methylprednisolone 28 mg 
Midazolam 1.4 mg 
Morphine Sulfate 2.8 mg 
Naloxone 2 mg  
Norepinephrine   0.1mcg/kg/min 
Ondansetron - IV 2.8 mg 
- ODT 4 mg 
Pralidoxime IV 1350 mg 
- Infusion  540 mg/hr 
Proparacaine  2 drops 
Sodium Bicarbonate 54 mEq 
Tretracaine  2 drops 
 
Weight 30-36 Kg (Avg 33 Kg) 
 
Vital Signs 
Heart Rate:   85-90 
Respirations: 16-22 
BP Systolic:  115 (+/-20) 
 
Equipment 
ET Tube: 6.5 
Blade Size: 3 
 
Defibrillation 
Defibrillation:   60 J, 150 J 
Cardioversion: 15 J, 30 J 
 
Normal Saline    720 ml 
 
Adenosine: 
1st Dose-  3.6 mg 
Repeat Dose- 7.2 mg 
Albuterol  2.5 mg 
 
Amiodarone 180 mg 
Atropine- Bradycardia 0.5 mg 
- Organophosphate Poison 1.8 mg 
Calcium Chloride 718 mg 
Dextrose 10% 180 ml 
Diazepam (IV) 7.2 mg 
(Rectal)                        18 mg 
Diphenhydramine                           50 mg 
Dopamine (800 mg in 500 cc) 
2 mcg/kg/min 2.7 ml/hr 
5 mcg/kg/min 7 ml/hr 
10 mcg/kg/min 14 ml/hr 
20 mcg/kg/min 28 ml/hr 
Epinephrine 1:10,000 0.36 mg 
Epinephrine 1:1000 Nebulized 5 mg 
Epinephrine Auto-Injector Adult (IM)0.3 mg 
Fentanyl  18 mcg 
Glucagon  1 mg 
Glucose Oral 1 tube 
Hydrocortisone 80 mg 
Hydroxocobalamin 2500 mg  
 
Ipratropium w/ albuterol 500 mcg 
Levalbuterol                    0.63 mg 
Lidocaine: 
- Cardiac Arrest 36 mg 
-Traumatic Brain Injury 54 mg 
- Intraosseous               18 mg 
Lorazepam                     3.6 mg 
Magnesium Sulfate 
- RAD 1450 mg 
- Torsades 1800 mg 
Methylprednisolone 36 mg 
Midazolam 1.7 mg 
Morphine Sulfate 3.6 mg 
Naloxone 2 mg  
Norepinephrine   0.1mcg/kg/min 
Ondansetron- IV              3.6 mg 
- ODT 4 mg 
Pralidoxime IV                1800 mg 
- Infusion 720 mg/hr 
Proparacaine 2 drops 
Sodium Bicarbonate 72 mEq 
Tetracaine 2 drops 
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2013
Minimum Standards for Interfacility Transfers:
1.Staffing, Training
Minimum staffing at the Intermediate level requires one EMT-Intermediate and one EMT-Basic.  
Minimum staffing at the Advanced Level requires one Advanced EMT and one EMT-Basic. 
Minimum staffing at the Paramedic level requires one EMT-Paramedic and one Advanced EMT/ 
EMT-Intermediate/EMT-Basic, in accordance with 105 CMR 170.305(C)(2).
Minimum staffing 
EMTs providing patient care during Interfacility Transfers must meet the following requirements as 
outlined in 105 CMR 170.000 et al:
a. current certification as an EMT in Massachusetts;
b. completion of Department approved supplemental training that is specific to and 
consistent with levels of certification of involved EMTs and includes 
· expanded roles and responsibilities
· additional, approved treatment modalities, equipment, devices, and technologies; 
and
· ambulance service policies and procedures regarding ALS Interfacility Transfers 
c. has maintained current authorization to practice pursuant to the Affiliate Hospital 
Medical Director’s review of clinical competency
Guidelines for approved ALS Interfacility Transfer training programs have been issued separately by 
the Department.  It shall be the responsibility of the transferring ambulance service to ensure and to 
verify appropriate training of its personnel providing ALS Interfacility Transfers.  This includes 
ensuring that all its personnel successfully complete refresher training in providing ALS Interfacility 
Transfers at least every two years, and whenever new equipment or medication is approved for use 
on interfacility transfer calls.
2. Affiliation Agreements; Medical Control
An ambulance service must be licensed at an ALS level by the Department to provide ALS care 
during Interfacility Transfers, and it must maintain an affiliation agreement, in accordance with 105 
CMR 170.300, with a hospital licensed by the Department for Medical Control, pursuant to 105 CMR 
130.1501-130.1504 of the Hospital Licensure regulations. Such affiliation agreements must 
designate an Affiliate Hospital Medical Director (105 CMR 170.300(A)(2) and 105 CMR 
130.1502(C)), whose  medical oversight functions are defined in 105 CMR 130.1503. Standards for 
Affiliate Hospital Medical Directors are defined in 105 CMR 130.1504.
3. Communications:
All communications with a Medical Control physician must be recorded.
4. Scope of Practice:
Section 170.360(A) of the EMS Regulations states, “No ambulance service or agent thereof shall 
transport a patient between health care facilities who is receiving medical treatment that is beyond 
the training and certification capabilities of the EMTs staffing the ambulance unless an additional 
health care professional with that capability accompanies the patient...” Depending on the 
individual’s condition, there may be situations in which a physician or some other specialist’s 
presence might be necessary; such determination shall be made by the on-line medical control 
physician in consultation with the physician at the sending hospital.  All involved in this decision 
should consider whether the benefits of the transfer sufficiently outweigh the risks; a patient’s 
greatest benefit may result from being transported by a standard IFT crew to a higher level of 
hospital care rather than delay for other transport.
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Protocol Continues
The scope of practice for each EMT level is defined (1) in regulation (105 CMR 170.810, 170.820 
and 170.840), (2) through established training programs approved by the Department, and (3) 
through the Statewide Treatment Protocols consistent with the Interfacility Transfer Guidelines. 
The following are patient condition classifications and corresponding requirements for EMT personnel 
during ambulance transport:
a. Routine, scheduled transport; Patient clearly stable for transport with no requirement for airway 
management and no device in place that is actively running or requires any maintenance or 
monitoring. Patient may have a device in place, but device must be locked and clamped, not 
require any maintenance and not be actively running. Such inactive devices may include, but are 
not limited to, IVs, nasogastric tubes, feeding tubes, PICC lines, bladder irrigation and wound 
vacs (wound vacs that are self-contained, gravity draining or battery powered can be transported 
by BLS providers).
Minimum Staffing:  BLS licensed ambulance service; two EMT-Basics
b. Patient clearly stable for transport (as above) who has a “maintenance” IV running without 
additives; (e.g., cancer patient transported for radiation therapy, with unadulterated crystalloid IV 
solution running). Advanced EMTs may transport patients with Dextrose-containing IV solutions.
Minimum Staffing:  ALS-Advanced EMT or ALS-Intermediate  licensed ambulance service; one 
EMT-Intermediate or Advanced EMT attending to patient care and one EMT-Basic driving
c. Patient with an acute or sub acute problem, who is either completely or, at least, to the best of a 
facility’s ability, stabilized; who has the potential to become less stable during transport.  
Instrumentation or medication running must be consistent with the Interfacility Transfer 
Guidelines.
Minimum Staffing: ALS-Paramedic licensed ambulance service; one EMT-Paramedic and one 
Advanced EMT, EMT-Intermediate or EMT-Basic, in accordance with 105 CMR 170.305(C)(2). 
The EMT with the highest level of certification must attend to patient care.
d. Patient with an acute problem with high potential to become unstable;  Critical care patient with 
any other instrumentation or medication running that is not included in the Interfacility Transfer 
Guidelines.
Minimum Staffing: Appropriate additional medical personnel (per 105 CMR 170.360(A)) must 
accompany the patient during transfer; any level of ambulance service licensure; two EMT-
Basics.  The ALS Interfacility Transfer Subcommittee recommends that the referring hospital 
consider Critical Care Transport for such a patient.  In the event that CCT is unavailable, medical 
personnel accompanying the patient must be able to manage all equipment and instrumentation 
associated with the patient’s care and provide advanced resuscitative measures if needed.
e. Critical Care Transports (see 105 CMR 170.000, for regulatory requirements regarding critical 
care transport).
Under no circumstances shall EMTs function or be assigned to transfers beyond, or potentially 
beyond, the scope of their training and level of certification.  The scope of practice for all EMTs is 
limited to the levels of EMT certification and training and by licensure level of the ambulance 
service by which they are employed.
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If (1) a patient’s medical condition necessitates immediate transport to another health care 
facility and (2) the patient’s medical treatment during transport will exceed the level of 
licensure of the transferring ambulance service and/or level of certification of the 
transferring ambulance’s personnel, and (3) the transferring facility will not provide 
appropriate additional personnel pursuant to 105 CMR 170.360(A), Critical Care Transport 
by ground or air should be employed.
The transferring facility may at any time opt to exceed these minimum requirements by 
transferring patients in BLS ambulances with appropriate medical personnel as defined in 
170.360(A) or by Critical Care Ground or Air Transport.
5. Quality Assurance/Quality Improvement
a. Ambulance services providing ALS Interfacility Transfers shall be required to have 
quality assurance/quality improvement policies specific to ALS Interfacility Transfers in 
conjunction with both their affiliate hospital medical directors and their ambulance service 
medical directors, if any, and include at a minimum:
· review of appropriateness of transfers, denials, and conformance with EMTALA 
regulations;
· review of critical skills (e.g., intubations, cardiac arrest management, IV therapy), and 
other measures of system function as deemed appropriate by the Department;
· steps for system improvement and individual remediation, available for Department 
review, of cases found to be deficient in critical interventions
b. Ambulance services shall report to the Department and the Affiliate Hospital Medical 
Director any violations of 105 CMR 170.000, this Administrative Requirement and/or 
prevailing treatment protocols as they relate to ALS Interfacility Transfers.
c. EMT skill maintenance and didactic knowledge will be continually assessed and 
appropriate measures taken to ensure quality of patient care by affiliate hospital medical 
directors and by ambulance service medical directors, if any.
Patient ALS Transfer Procedure
Once an ALS Interfacility Transfer has been deemed appropriate by the transferring ambulance 
service (see “Scope of Practice” above), paramedic staff, upon arrival at the transferring facility, 
will:
· receive a report from the staff of the transferring facility;
· assess the patient; and
· in cases where the patient’s care during the transfer exceeds the standing-order scope of 
practice as defined by the current version of the Statewide Treatment Protocols for an EMT-
Paramedic or the patient is unstable or is likely to become unstable as defined previously 
(see “Scope of Practice” above) will provide a concise, complete and accurate patient 
report to an On-Line Medical Control physician, according to the EMS service’s and the 
Affiliate Hospital’s policies and procedures.  When EMTs have a concern regarding the 
safety of the patient being transferred, the EMT-Paramedic will contact an On-Line Medical 
Control physician for guidance.
The report should include, at a minimum, the following information:
a.   Names of transferring and receiving facilities;
b.   Patient’s diagnosis;
c.   Reason(s) for transfer;
d.   Brief history of present illness and any intervention(s) which has occurred to date;
e.   Pertinent physical findings;
f.    Vital signs;
g.   Current medications and IV infusions;
h.   Presence of or need for additional medical personnel;
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i.    Anticipated problems during transport, if any; 
j.    Anticipated transport time; and
k.   Staffing configuration of the transporting ambulance
NOTE:  Complete copies of all pertinent medical records, including X-Rays, CT Scans, consultative 
notes and ECGs, as available, must accompany the patient to the receiving facility.
When necessary, the Medical Control Physician and paramedic will discuss with the transferring 
physician the orders for maintenance of existing and/or addition of new therapies according to the 
needs of the patient, within the scope of existing treatment protocols and EMT scope of practice.  The 
Medical Control Physician will be responsible for all actions/interventions initiated by the EMS 
personnel during transport unless the referring physician accompanies the patient.
If the transferring physician is unavailable, or the patient is unstable, the Medical Control Physician 
may recommend to the transferring facility additional therapies prior to the transfer of the patient in the 
interest of patient safety and quality care.  
In some situations, consistent with the intent of EMTALA, the transfer of a patient not stabilized for 
transport may be preferable to keeping that patient at a facility incapable of providing stabilizing care.  
If the transferring facility cannot provide appropriate medical care or appropriately trained and 
experienced personnel to accompany the patient, alternative means of transfer, including Critical Care 
Transport, must be utilized.  The use of a local Emergency Ambulance Service is strongly discouraged 
in such a situation.  All such responses must be reported by the ambulance service to the 
Department’s Division of Health Care Quality and the Affiliate Hospital Medical Director for review.  It 
is primarily the responsibility of the referring physician and Medical Control Physician to determine the 
appropriate method of transferring an unstable patient.
When a facility sends its own staff with the patient during transfer (additional medical personnel) and 
the patient’s condition deteriorates en route, EMS personnel must contact the Medical Control 
Physician for appropriate intervention orders and notify the receiving facility of the change in patient 
status.
If the accompanying staff is an RN s/he will maintain patient care responsibility, functioning within his/
her scope of practice and under the orders of the transferring physician.  The Paramedic and the RN 
will work collaboratively in the provision of patient care.  If the patient’s condition deteriorates en route, 
the Paramedic may assume full responsibility in conjunction with their Medical Control Physician for 
care that exceeds the RN’s scope of practice and/or the transferring physician’s medical orders.  Prior 
to transfer with an RN, the referring physician must contact the service’s 
Medical Control Physician and provide staffing rationale.
If the accompanying staff includes a physician from the transferring facility, that physician shall be in 
charge of patient care.  Prior to transfer, the transferring physician accompanying the patient must 
contact the service’s Medical Control Physician and coordinate patient care between the physician-in-
charge and the paramedic practicing within the Statewide Treatment Protocols.  Clear lines of 
command and responsibility shall be established prior to transport.  
Interstate ALS Interfacility Transfers
Interstate transfers are permitted.  Paramedics must obtain Medical Control through normal channels, 
through the Affiliation Agreement for Medical Control of the ambulance service for whom they are 
working.  Appropriate provisions for re-contacting the Medical Control physician en route, if necessary, 
should be made prior to departure from the transferring facility. If a transfer originates out of state and 
no contact with Medical Control Physician is possible, the transfer should be made at the BLS level 
only with appropriate additional personnel provided by the transferring facility.
Protocol Continued
A3
The purpose of this section is to determine which patients must be transported by critical care 
transport (CCT). Scenarios and circumstances beyond the scope of practice of the paramedic 
(including, but not limited to those described below) require CCT. CCT can be furnished by any of 
the following:
o Licensed critical care service
o An advanced life support (ALS) vehicle with hospital MD and / or RN on board. (A 
respiratory therapist is acceptable in place of MD and / or RN for ventilator 
management only)
o Any advanced (ALS) or basic life support (BLS) vehicle staffed by a self-contained 
and properly equipped critical care team.
If CCT is unavailable AND sending facility staff is unavailable, AND this patient has a condition 
requiring time-sensitive intervention AND it is approved by MEDICAL CONTROL, this patient may 
be transferred by any ALS ambulance, provided that all interventions are within the scope of 
practice of the transporting paramedic and vehicle.
The MEDICAL CONTROL physician and SENDING PHYSICIAN should be in direct communication if 
there are any concerning issues prior to patient transport.
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B1 – PEDIATRIC PATIENTS (8 years of age or younger)
q Any neonate patient (30 days of age or younger) requiring transfer to a higher level of care.
q Any pediatric patient with critical illness or injury.
NOTE: On-line MEDICAL CONTROL should be involved in determining whether pediatric 
patients require critical care
q Any pathology associated with the potential for imminent upper airway collapse and / or 
obstruction (including but not limited to airway burns, toxic inhalation, epiglottitis, 
retropharyngeal abscess, etc.). If any concerns whether patient falls into this category, 
contact MEDICAL CONTROL.
NOTE: On-line MEDICAL CONTROL should be involved in determining whether pediatric 
patients require critical care
q Any intubated pediatric patient requiring an interfacility transfer.
q All conditions that apply to adult medical patients also require CCT for the pediatric patient.
      B2 – ADULT MEDICAL PATIENTS
q Unless approved by MEDICAL CONTROL, patients requiring more than three (3) medication 
infusions by IV pump, not including maintenance fluids must be transported by CCT.
q Unless approved by Medical Control, any patient receiving more than one vasoactive 
medication infusion must be transported by CCT. 
q Any patient who is being actively paced (either transvenous or transcutaneous) must be 
transported by CCT.
q Patients being transferred due to an issue with a ventricular assist device.
q Patients with an intra-aortic balloon pump.
q Any patients with a pulmonary artery catheter.
NOTE: Central lines may be transported by ALS IFT
q Any patient with an intracranial device requiring active monitoring.
NOTE: Except for chronic use devices, such as ventriculoperitoneal shunts, etc.
q Any pathology associated with the potential for imminent upper airway collapse and / or 
obstruction (including but not limited to airway burns, toxic inhalation, epiglottitis, 
retropharyngeal abscess, etc.). If any concerns whether patient falls into this category, 
contact MEDICAL CONTROL.
NOTE: If any concerns about whether patient falls into this category, contact MEDICAL 
CONTROL.
q Any patient being artificially ventilated for ARDS or Acute Lung Injury. 
Protocol Continued
Part C – General Protocols for ALS Interfacility Transfer Care
q Vital signs should be obtained and documented every ten (10) minutes, unless otherwise required by 
protocol.
 If clinically indicated, patients will have continuous monitoring of electrocardiogram (ECG) and / or pulse 
oximetry (SpO2).
 All artificially ventilated patients (and all other patients where it is clinically indicated) will have 
continuous monitoring of waveform capnography. 
q The recommended route for medication infusions in the ALS IFT setting is the peripheral intravenous (IV) 
line. Intraosseous (IO) lines may also be used.
 Medications may also be administered through any central venous catheter
 Paramedics may administer medication boluses, infusions and fluids through administration sets 
connected by the sending facility to subcutaneous devices (e.g., Port-a-Cath)
q Patients who are being transferred ALS between facilities should have peripheral intravenous (IV) access, if 
possible.
 Paramedics should attempt to establish IV access if no attempts have been made at the sending 
facility. Paramedics are authorized to establish IO access if warranted by the patient’s condition.
q All monitoring and therapy will be continued until care is transferred to the receiving medical staff.
q Paramedics may not accept any medications from the sending facility for the purposes of bolus 
administration during transport.
q Any patient who qualifies for spinal immobilization per pre-hospital statewide treatment protocols who has 
not been cleared by CT scan or appropriate physician assessment must be fully immobilized for transport. If 
there is identification of a clinical concern of thoracic or lumbosacral spine injury, the patient should be 
immobilized with a long board and log roll precautions used at all times.
 If any confusion arises regarding the need for spinal immobilization MEDICAL CONTROL will be 
contacted and the MEDICAL CONTROL physician and the SENDING PHYSICIAN should be in direct 
communication.
 If appropriately trained and authorized, EMTs may follow Protocol 6.4 Selective Spinal Assessment following 
consultation with the sending physician.
q Paramedics must be familiar with the treatments and interventions instituted at sending facility.
q Patient care documentation should include, at a minimum:
 Patient’s diagnosis / reason for transfer
 Brief history of present illness / injury
 Brief overview of interventions performed by sending facility
 Pertinent physical examination findings and recent vital signs
 Current medications and IV infusions
 Presence of or need for additional medical personnel
q For all patients being transferred to an emergency department, who are critically ill, unstable, or have a 
change in clinical status en route, EMTs should notify receiving emergency department via CMED prior to 
arrival. If local CMED is unavailable, entry notes should be made by telephone (on a recorded line, if 
possible).
q Paramedics will contact on-line MEDICAL CONTROL for:
 Any intervention(s) that exceed the standing order scope of practice as defined by the current 
version of the Massachusetts Pre-Hospital Statewide Treatment Protocols for an EMT-Paramedic.
 Any patient that is unstable or is likely to become unstable.
 When there is any concern regarding the safety of the patient being transferred.
 Any significant patient care related questions or issues prior to transfer or en route.
q The MEDICAL CONTROL physician and SENDING PHYSICIAN should be in direct communication if there are any 
concerning issues prior to patient transport. 
q On occasion good medical practice and the needs of patient care may require deviations from these 
protocols, as no protocol can anticipate every clinical situation. In those circumstances, EMS personnel 
deviating from the protocols shall only take such actions as allowed by their training and only in conjunction 
with their ON-LINE MEDICAL CONTROL PHYSICIAN.
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q It is recommended that central access and / or two large bore IV lines are in place prior to 
transport.
q Care during transport:
 Administer high-flow supplemental oxygen
 Continuous cardiac monitoring
 Heart rate, blood pressure, neurologic evaluations documented every 5 – 10 minutes
·    Target heart rate = 60 – 80 bpm
·    Target systolic blood pressure = 90 – 100 mm Hg
·     Continually assess mentation.
·     If patient is outside of these parameters, contact MEDICAL CONTROL.
q If not approved by on-line MEDICAL CONTROL prior to transport, you must contact MEDICAL 
CONTROL to adjust all medication infusions:
 Adjust antihypertensive medications initiated at sending facility (until systolic blood 
pressure is less than 100 mm Hg and/or MAP is less than 60 mm Hg):
·    If Labetalol infusion has been initiated by sending facility, increase by 2 mg / minute 
every 10 minutes (to a maximum of 8 mg/minute)
·     If Esmolol infusion has been initiated by sending facility, increase by 50 mcg / kg / 
minute every 4 minutes (to a maximum of 300 mcg / kg / minute)
·     If Nitroprusside infusion has been initiated by sending facility, increase by 0.5 mcg / 
kg / minute every 5 minutes (to a maximum of 4 mcg / kg / minute)
 Discontinue drip and contact medical control for instructions if:
·    Systolic blood pressure < 90 mm Hg, or;
·    Heart rate < 60 bpm
 If no medication infusion has been initiated to control blood pressure and / or heart rate, 
MEDICAL CONTROL may order the administration of metoprolol 5 mg IV every 5 minutes to a 
maximum of 15 mg.
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Symptoms of a Transfusion Reaction during Infusion of Packed RBCs (PRBCs)
Acute Hemolytic Reaction
Fever, hypotension, flushing, wheezing, dark and / or red colored 
urine, oozing from IV sites, joint pain, back pain, chest tightness
Nonhemolytic Febrile Reaction
Fever, chills, rigors, vomiting, hypotension
Allergic Reaction
Urticaria, hives (usually without fever or hypotension)
Anaphylactic Reaction
Dyspnea, wheezing, anxiety, hypotension, bronchospasm, abdominal 
cramps, vomiting, diarrhea
Volume Overload
Dyspnea, hypoxia, rales, tachycardia, jugular vein distention
Transfusion-Related Acute Lung Injury (“TRALI”)
Dyspnea, hypoxia, rales (usually without fever or signs of pulmonary 
edema)
q STOP the infusion if any of the above symptoms are discovered!
q Start infusion of normal saline
q Contact MEDICAL CONTROL
q Treat hypotension and anaphylactic reaction with standing orders (established pre-hospital 
protocols)
q If minor allergic reaction (urticaria / wheezing) administer Benadryl, 50 mg IV
q If SpO2 is below 90% or patient experiences wheezing / rales, administer high-flow 
supplemental oxygen
q If SpO2 is below 90% and accompanied by rales, administer Lasix, 40 mg IV
I
F
T
 
P
r
o
t
o
c
o
l
s
,
 
P
a
r
t
 
D
2
ALS Interfacility Transfer Protocols
Part D2- Blood Transfusion Reaction
Massachusetts Department of Public Health Office of Emergency Medical Services
Statewide Treatment Protocols version 2015.1
A3
q Seizures (either generalized motor or nonconvulsive) should be quickly controlled.
 After assessing airway, breathing, and applying high-flow oxygen:
·    Lorazepam, 2-4 mg IV/IO/IM every 2 minutes up to 0.1 mg / kg, or
·    Diazepam, 5– 0 mg IV/IO/IM/PR, or
·    Midazolam 2.5-5mg IV/IO/IM/IN
·    MEDICAL CONTROL can authorize administration of Midazolam for seizure activity
q For an ischemic CVA, if a tPA (tissue plasminogen activator) infusion will be continued during 
the transport, follow these guidelines:
 Sending facility staff should withdraw excess tPA from the bottle, so that the bottle will 
be empty once the full dose has infused.
Example:  100 mg bottle of tPA contains 100 mL of fluid when reconstituted; if the 
total dose being administered is 70 mg, then the facility should remove 30 mL of 
fluid from the bottle before departure.
 When the pump alarm indicates that the bottle is empty, you should take the following 
steps to ensure that the drug contained within the administration tubing is administered to 
the patient:
·   Remove the IV tubing from the tPA bottle and spike a bag of 0.9% NS and restart 
the infusion; the pump will stop infusing when the preset volume has been 
administered.
q If systolic blood pressure is found to be greater than 180 mm Hg or diastolic blood pressure is 
found to be greater than 105 mm Hg consult MEDICAL CONTROL, then:
 Adjust antihypertensive medications initiated at sending facility:
·    If Labetalol has been initiated by sending facility;
 Increase by 2 mg/minute every 10 minutes (to a maximum of 8 mg/minute) 
until systolic blood pressure is less than 180 mm Hg and/or diastolic blood pressure 
is less than 105 mm Hg
 Discontinue drip and contact medical control for instructions if the reduction in 
MAP is greater than 30% of initial BP or SBP < 140 mm Hg, DBP < 80, or heart rate 
< 60 bpm
·    If Nicardipine has been initiated by sending facility;
 Increase by 2.5 mg / hour every 5 minutes (to a maximum of 15 mg / hour) 
until systolic blood pressure is less than 180 mm Hg and/or diastolic blood 
pressure is less than 105 mm Hg
 Discontinue drip and contact medical control for instructions if the reduction in 
MAP is greater than 30% of initial BP or SBP < 140 mm Hg, DBP < 80, or heart rate 
< 60 bpm
q For any acute worsening of neurologic condition (e.g., acutely worsening neurological deficits, 
development of severe headache, acute hypertension, vomiting, etc.):
 If patient is receiving tPA, discontinue the infusion.
 Contact MEDICAL CONTROL for further instructions.
 Contact receiving hospital emergency department with an update on patient’s condition 
and an estimated time of arrival.
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q If post-arrest induced hypothermia (PAIH) therapy in progress at the time of IFT ALS arrival, it 
should be continued during the transport.
q Pre-transport temperature should be documented, and temperature should be monitored with 
vital signs every five minutes.
q The temperature target for post-arrest induced hypothermia (PAIH) is 32° C – 34°C (89°F – 
93°F).
q If pre-transport or inter-transport temperature is less than or equal to 34°C:
 Maintain temperature with cold packs placed in the groin, axillae, and on the chest and 
sides of neck.
 Discontinue any cold saline infusion.
q If pre-transport or inter-transport temperature is greater than 34°C:
 Continue cooling with cold packs placed in the groin, axillae, and on the chest and sides 
of neck.
 Continue or initiate cold saline infusion, initially chilled and maintained at approximately 
4°C, at 30 mL / kg over 30 minutes.
q Core temperature should be monitored if possible for transport times longer than 20 minutes.
q Patients should be handled gently (due to risk of arrhythmias).
q ALS IFT crews will not discontinue PAIH unless ordered to do so by MEDICAL CONTROL.
q If patient temperature is less than 31°C, contact MEDICAL CONTROL and utilize any external 
warming devices (blankets, etc.) to actively rewarm patient until the temperature is greater than 
31°C.
 If ordered by MEDICAL CONTROL and available, consider infusion of 250 mL IV boluses of 
warmed normal saline solution, until the temperature is greater than 31°C.
q If hemodynamically significant dysrhythmias or bradycardia of any type develop, or if the patient 
develops significant bleeding, PAIH should be stopped, MEDICAL CONTROL contacted, and active 
rewarming pursued.
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q Patients who are in labor with concern for imminent delivery must be accompanied by sending 
facility staff.
q In high-risk situations, a physician / registered nurse will accompany the patient for transport.
q If any confusion arises regarding the need for additional OB staff MEDICAL CONTROL will be 
contacted and the MEDICAL CONTROL physician and SENDING PHYSICIAN should be in direct 
communication.
q In addition to the documentation standards listed in the General ALS IFT Care Guidelines, 
when transporting an obstetrical patient, the following should be documented:
 The presence of a fetal heart rate before and after transfer
 Estimated date of confinement, maternal history of any complications
 Condition of membranes, dilation
 Gravida / Para
 Timing and nature of contractions
 Fetal Position
q Patients should be transported in a left-lateral position or sitting upright, if possible.
q Document that the fetal heart rate was evaluated prior to transport and upon arrival.
q If patient should develop eclamptic seizures:
 After assessing airway, breathing, and applying high-flow oxygen:
·    Lorazepam, 2-4 mg IV/IO/IM every 2 minutes up to 0.1 mg/kg, or 
Diazepam, 5 – 10 mg IV/IO/IM/PR, or
Midazolam 2.5-5mg IV/IO/IM/IN
·    MEDICAL CONTROL can authorize administration of Midazolam and administration of 
magnesium sulfate (4 g over 3 minutes) for seizures.
q MEDICAL CONTROL can authorize administration of Midazolam and administration of 
magnesium sulfate (1 - 4 g over 3 minutes) for seizure activity. IF
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q Paramedics should be familiar with the care and treatment the patient has received.
q Consider discontinuing or avoiding all medication infusions (except for basic IV fluids) 
to expedite transfer.
q Receiving facility should be contacted to ensure rapid transfer to cardiac cath lab.
q Patients should receive appropriate supplemental oxygen therapy.
q All other interventions per state-wide treatment protocol, if not already administered:
 Aspirin, 325 mg PO
q If patient continues to experience chest discomfort:
 Nitroglycerine (if systolic blood pressure is greater than 100 mm Hg), 0.4 mg SL tablet or 
spray; may be repeated in 5 minute intervals for a total of three (3) doses
 Morphine, 2 – 4 mg slow IV push; or,
 Fentanyl, 1 mcg / kg slow IV push, to a maximum of 150 mcg
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q The transport paramedic must be familiar or become familiar through consultation (i.e., with a 
drug reference or discussion with hospital staff) on the following attributes of each drug the 
patient has received prior to and will receive during transport:
 The type and name of medication being administered.
 The indication and contraindications for administration of the medication.
 The correct dose, rate, and mixture of medication.
 Any titration indications or instructions.
 Any specific medical control instructions.
 Any patient-specific information 
 Any adverse effects of the medication being administered.
 The seven rights of medication administration should always be considered, even when 
transporting patients between facilities.
 Right patient, drug, dose, route, time, outcome, documentation
q Paramedics may not accept any medications from the sending facility for the purposes of bolus 
administration during transport.
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Any of the following medications or medication classes, not currently part of the EMT Paramedic 
Statewide Treatment Protocols, may be maintained if initiated at the sending facility, and can only 
be titrated through specific IFT protocols and by on-line MEDICAL CONTROL.
· Aminophylline
· Analgesics
· Anticonvulsants
· Antidotes
· Antidysrhythmics
· Antihypertensive agents
· Anti-infectives (e.g., antibiotics, anti-sepsis)
· Benzodiazepines
· Blood products
· Chemotherapeutic agents
· Electrolyte infusions
 Potassium, limited to 10 mEq / hour
 Magnesium, maintenance infusion limited to 2 g / hour
· Glycoprotein IIb / IIIa inhibitors
· Heparin
· Insulin infusions
· Intravenous steroids
· Mannitol infusions
· Octreotide
· Paralytics
· Parenteral nutrition
· Proton Pump Inhibitors
· Sedatives
· Standard IV infusion fluids (including 10% Dextrose)
· Thrombolytic agents
· Vasodilators (including all forms of Nitroglycerin)
· Vasopressors
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The following medications / types of medications must be administered by IV pump:
· Anticoagulant
· Anticonvulsants
· Antidysrhythmics
· Antihypertensives
· Electrolyte Solutions
· Insulin
· Paralytics
· Sedatives
· Thrombolytics
· TPN
· Vasodilators
· Vasopressors
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q Heating devices, automatic and rapid infusers are prohibited for ALS IFT use.
q Infusion / bloodbank documentation should be transported with the patient.
q Paramedics will not initiate a blood product infusion.
q At least one additional IV line should be in place.
q Paramedic will not administer any medications through an IV line which is being used to infuse 
blood or a blood product.
q Ensure the blood and / or blood products are infusing at the prescribed rate.
q Monitor and record the patient’s vital signs every 5 – 10 minutes.
q If any signs and symptoms of transfusion reaction, proceed immediately to the 
TRANSFUSION REACTION PROTOCOL (Part 3.2)
q Blood products should be infusing for at least 20 minutes prior to departure, to reduce 
the risk of transfusion reaction.
 The only exception to this is for administration of fresh frozen plasma (FFP) for patients 
suffering life-threatening intracranial bleeding
q When the transfusion has finished:
 Record transfusion end-time and post-infusion vital signs.
 Disconnect infusion set tubing from primary line.
 Flush primary line with normal saline only.
 Place any used supplies into a clean biohazard marked container or bag.
 Deliver all empty transfusion bags and tubing to the receiving facility with the patient.
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q All artificially ventilated patients must be transferred on a ventilator.
q All ventilators must be able to meet the demands of the patient’s condition, taking into 
consideration all settings and features described or stipulated by the sending facility and / or 
physician.
q Ventilators may not be full control mode only and must be capable of meeting the patient’s 
ventilatory needs.
q Unless the transfer is time sensitive in nature (e.g., STEMI, aortic dissection, acute CVA, 
unstable trauma, etc.), the following requirements apply to ventilator use and / or adjustment:
 Patients must be observed, by the sending facility, for a minimum of 20 minutes after 
any adjustment in ventilator settings.
 Patients should be on the transport ventilator for 20 minutes prior to departure.
q On-line MEDICAL CONTROL is required for any instance when adjustment of the ventilator 
settings is needed.
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Paramedics who operate at the ALS IFT level are expected to have a thorough understanding of 
the functions and operations of the infusion pump they will utilize (whether property of the 
ambulance service or sending facility). 
Paramedics are expected to not only control the basic functions of the pump, but also be able to 
dynamically troubleshoot pump issues. Prior to transport, paramedics must be proficient at the 
following:
q How to turn the pump on and off.
q How to load and safely eject the administration set into pump.
q The importance of having spare tubing.
q How to suspend pump operation.
q How to adjust the infusion rate, if necessary.
q How to clear air bubbles from the tubing.
q How to troubleshoot problems (e.g., occlusion alarms).
q How the specific service addresses low battery or power issues.
It is strongly recommended that paramedics be trained and practiced on the infusion pump 
they will be using in the field.
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q Obtain and document the indication for placement of the pleural chest tube.
q Ensure that the chest tube is secured to the patient, and that the drainage system remains in an 
upright position and below the level of the patient’s chest at all times.
q Regularly evaluate lung sounds and vital signs.
 Signs and symptoms of a tension pneumothorax include: Dyspnea, tachypnea, 
decreased / absent lung sounds on affected side, hypotension, tachycardia, jugular venous 
distention, tracheal deviation (late sign)
q Tubes and connections should be evaluated following any movement of the patient to ensure 
leak-proof operation and chest tube patency.
q Check the following initially and after moving the patient:
 Ensure the dressing remains dry and occlusive.
 Ensure there are no kinks or dependent loops (e.g., a loop or turn in the tubing that forces 
the drainage to move against gravity to reach the collection chamber) in the tubing.
 Amount of water in the water seal chamber; if the water level appears low ask a staff 
member if it requires refilling prior to departure.
q Monitor the following items after routine assessment of patient’s vital signs:
 Drainage (document the appearance and amount of fluid, at the start and at the 
conclusion of transport)
 Bubbling in the water seal chamber
 Gentle rise and fall of the water level, which corresponds with the patient’s respirations is 
called “tidalling” and indicates that the system is functioning properly.
q Troubleshooting / problems
 Abnormal bubbling in the water seal chamber
 Remember, gentle rise and fall of the water level, which corresponds with the 
patient’s respirations is called “tidalling” and indicates that the system is functioning 
properly.
 Continuous air bubbling confirms a constant air leak from a tube connection or  
from the patient's chest (e.g., unresolved pneumothorax).
 Intermittent bubbling confirms an intermittent air leak from the patient's chest.
 No air bubbling confirms no air leak from the patient's chest and no air leak from a tube   
connection.
 If the entire chest tube is removed from the chest: Cover with a three-sided dressing 
and contact MEDICAL CONTROL.
 If the chest drainage system tips over and spills: Contact MEDICAL CONTROL; you 
may be instructed to clamp tube.
 If the chest drainage system is crushed or broken open, or the chest drain 
becomes detached from the chest tube: Contact MEDICAL CONTROL immediately, do not 
reconnect; you may be instructed to place the end of the chest tube in a bottle of sterile water 
to create a seal.
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Airway/Respiratory 
Management EMT 
 
 
EMT-I AEMT PARAMEDIC 
BVM 
X X X X 
Capnography 
 X X X 
Chest Tube Maintenance 
   ∆ 
Cleared, Opened, Heimlich 
X X X X 
CPAP 
   
X 
(Adult only) 
Endotracheal Intubation 
 X  X 
Endotracheal Suctioning 
 X X X 
Supraglottic Airways 
  X X 
Nasogastric Tube 
 X  X 
Nasopharyngeal Airway 
X X X X 
Nasotracheal Intubation 
   X 
Nebulizer Treatment 
* * X X 
Needle Decompression 
   X 
Oral Suctioning 
X X X X 
Oropharyngeal Airway 
X X X X 
Oxygen Administration 
X X X X 
Pulse Oximetry 
X X X X 
Tracheostomy Maintenance 
   X 
Ventilator Operation 
   ∆ 
(Adult only) 
 
Legend:
X  Skill allowed under protocol and in MA permitted Scope of Practice.
*  Skill allowed under protocol with medical director approval and training.
∆  Skills allowed under protocol for IFT use only
q Skills allowed only under Paramedic-Basic/ALS-assist staffing and training.
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Routes of Access/ 
Medication Administration EMT 
 
 
EMT-I AEMT PARAMEDIC 
Auto Injector X X X X 
Blood Products    ∆ 
Endotracheal     
Inhalation MDI/* MDI/* X X 
Intramuscular   X X 
Intraosseous   X 
 
X 
Intravenous   X X 
Intravenous Pump    ∆/X 
Oral X X X X 
Intranasal X X X X 
Rectal   Assist 
(Diastat) 
X 
Subcutaneous   X X 
Sublingual Assist Assist X X 
Central Line Maintenance    ∆ 
Peripheral Venous Access  X X X 
Intraosseous Access   X X 
 
Legend:
X  Skill allowed under protocol and in MA permitted Scope of Practice.
*  Skill allowed under protocol with medical director approval and training.
∆  Skills allowed under protocol for IFT use only
q Skills allowed only under Paramedic-Basic/ALS-assist staffing and training.
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· Glucagon (IV/IO/IM/IN/SC)
· Ipratroprium Bromide (MDI/Nebulizer)
· Lidocaine HCL 2% (following IO Insertion)
· Naloxone (IV/IO/IM/IN)
· Nitroglycerin (SL)
· Albuterol (MDI/Nebulizer), Adult & 
Pediatric
· Dextrose (IV/IO)
· Epinephrine (Via Auto-Injector for 
anaphylaxis)
Advanced EMTs may administer the following medications (in addition to those of an EMT):
Legend:
X  Skill allowed under protocol and in MA permitted Scope of Practice.
*  Skill allowed under protocol with medical director approval and training.
∆  Skills allowed under protocol for IFT use only
q Skills allowed only under Paramedic-Basic/ALS-assist staffing and training.
Cardiac Management EMT 
 
 
EMT-I AEMT PARAMEDIC 
Application of 12 Lead ECG 
   X 
Application of 3 or 4 lead 
ECG 
   X 
CPR - Cardiopulmonary 
Resuscitation 
X X X X 
Defibrillation - AED 
X X X X 
Defibrillation - Manual 
   X 
Induced Therapeutic 
Hypothermia 
* * * X 
(Adult Only) 
Interpretation of 12 Lead 
ECG 
   X 
Interpretation of 3 or 4 lead 
   X 
Synchronized Cardioversion 
   X 
Transcutaneous Pacing 
   X 
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Other Skills EMT 
 
EMT-I AEMT PARAMEDIC 
Blood Draw 
 X X X 
Blood Glucose Analysis 
* * X X 
Burn Care 
X X X X 
Cervical Spinal Immobilization 
X X X X 
Childbirth 
X X X X 
Cold Pack 
X X X X 
Extrication 
X X X X 
Eye Irrigation (Morgan Lens) 
   X 
Hot Pack 
X X X X 
Restraints - Pharmacological 
   X 
Restraints - Physical 
X X X X 
Selective Spinal Assessment 
* * * * 
Spinal Immobilization - Lying 
(Long board) 
X X X X 
Spinal Immobilization - Seated 
(K.E.D.) 
X X X X 
Spinal Immobilization - Standing 
X X X X 
Splinting 
X X X X 
Splinting - Traction 
X X X X 
Wound Care - Occlusive Dressing 
X X X X 
Wound Care Pressure Bandage 
X X X X 
 
Legend:
X  Skill allowed under protocol and in MA permitted Scope of Practice.
*  Skill allowed under protocol with medical director approval and training.
∆  Skills allowed under protocol for IFT use only
q Skills allowed only under Paramedic-Basic/ALS-assist staffing and training.
 
  
